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Me Methyl 
Et Ethyl 
Pr Propyl 
i-Pr Iso-propyl 
Bu Butyl 
t-Bu Tertiary-butyl 
Ph Phenyl 
R Alkyl 
Ar Aryl 
Tos Toluene-4-sulphonyl 
NMR Nuclear magnetic resonance 
s Singlet 
d Doublet 
t Triplet 
q Quartet 
m Multiplet 
b Broad 
J Coupling constant 
ppm Parts per million 
TMS Tetramethylsilane 
IR Infra red 
sh shoulder 
MS Mass spectrum 
CD Circular dichroism 
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VCD Vibrational circular dichroism 
[(X] Specific rotation 
c Concentration (g/100 ml) 
ee Enantiomeric excess 
GLC Gas-liquid chromatography 
RT Retention time 
HPLC High pressure liquid chromatography 
TLC Thin-layer chromatography 
mp Melting point 
bp Boiling point 
DME 1,2-Dimethoxyethane 
THE Tetrahydrofuran 
ADC Acetolactate decarboxylase 
ALS II Acetolactate synthase isozyme II 
PLE Pig liver esterase 
FAD Flavin adenine dinucleotide 
TPP Thiamine pyrophosphate 
EEDQ 1-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline 
gly Glycine 
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SUMMARY 
Several sytheses of a-acetolactate analogues (2-hydroxy-3-oxo 
carboxylic esters) and related compounds were developed. The action of 
the enzyme acetolactate decarboxylase upon these compounds was 
studied. 
A synthesis of 3-bromo-2-oxo carboxylic acids, esters and amides 
was developed. Inhibition studies using methyl 3-bromo-3-methyl-2-oxo 
butanoate with pig liver esterase indicated that the esters were not 
suitable mechanism-based inhibitors of the enzyme. 
A synthesis of 3-hydroxy-2-oxo carboxylic esters was developed. 
These compounds were found to isomerise, via alkyl group migration, to 
the corresponding 2-hydroxy-3-oxo carboxylic esters upon treatment 
with catalytic quantities of dibutyl tin oxide. Cyclic substrates gave 
access to 6,7 and 8-membered ring-expanded products. 
A one-step synthesis of 2-hydroxy-3-oxo carboxylic esters, in 
high yield, from the corresponding c43-unsaturated esters was 
developed. This involved the use of acidic manganate (VII) in aqueous 
acetone and was found to be superior to any synthesis of acyclic 2- 
hydroxy-3-oxo carboxylic esters published to date. 
The enzyme acetolactate decarboxylase (ADC) was found to 
decarboxylate the (S)-isomers of CY-acetolactate and its analogues to 
give the corresponding (R)-(-hydroxyketones in high optical purity. 
The (R)-substrates were decarboxylated to (R)-ß. 1'-hydroxyketones via 
prior isomerisation to (S)-(-acetolactate analogues by a tertiary 
ketol rearrangement involving carboxylate group migration. As a result 
(-acetolactate analogues with non-identical substituents at the 2- and 
3-positions gave structurally different OF-hydroxyketone products upon 
decarboxylation with ADC. In the case of C-acetolactate, a substrate 
with identical substituents at the 2- and 3-positions, both 
enantiomers were converted into (R)-(-)-acetoin with an enantiomeric 
excess greater than 98%. This represents an unusual example of the 
enzymic conversion of both enantiomers of a racemic substrate into a 
single enantiomer of product. The behaviour of the enzyme towards a 
range of substrates gave some insight into the nature of the enzyme 
active site. 
ADC was found to catalyse, stereospecifically, the incorporation 
of deuterium into the (R)-isomer of racemic acetoin at the methine 
position. The chirality of the deuterated and non-deuterated 
components of the partially deuterated mixture was analysed in situ by 
vibrational circular dichroism measurements. 
Acetolactate synthase isozyme II (ALS II) was used to generate 
QE-acetolactate and its homologues from simple 2-oxo carboxylic acids. 
These were decarboxylated in situ by ADC to give the corresponding 
a-hydroxyketones of high optical purity. In one example 
01-acetohydroxybutyrate was generated by the action of ALS II upon 2- 
oxobutanoate. The structure of the single c-hydroxyketone prepared by 
ADC-catalysed decarboxylation of the 06-acetohydroxybutyrate indicated 
that the (S)-isomer of Qf-acetohydroxybutyrate had been generated. 
Model studies were carried out on 2-hydroxycyclohexanone for the 
stereospecific reduction of the enzymatically produced 
Ck-hydroxyketones to 1,2-diols. No signifiant chiral induction was 
observed with sodium borohydride in a range of solvents or with 
lithium aluminium hydride. 
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INTRODUCTION 
The work presented in this thesis falls into three main areas: 
a) The synthesis of potential mechanism-based inhibitors of 
hydrolytic enzymes. 
b) The synthesis of 2-alkyl-2-hydroxy-3-oxo carboxylic esters. 
c) The action of the enzyme acetolactate decarboxylase upon 
2-alkyl-2-hydroxy-3-oxo carboxylic esters. 
Irreversible enzyme inhibitors 
Many classes of molecules have been shown to cause specific 
inhibition of some target enzyme. The effects in vivo can be 
beneficial, as in the inhibition of microbial penicillinases, or the 
consequences can be toxic. An understanding of the mechanism of the 
inhibition process can help in the rational designing of drugs with 
optimum in vivo specificity. 
Specific inhibitors of hydrolytic enzymes, peptidase inhibitors 
in particular, have a use in the purification of enzymes from culture 
media. For example, in the process of obtaining one particular enzyme 
from a cell paste, enzymes additional to the desired one may become 
concentrated in the purified fractions. If one of these extraneous 
enzymes has protease activity then it may destroy other proteins, and 
these may include the enzyme. It is therefore neccessary to inhibit 
protease action during enzyme isolation. 
Irreversible enzyme inhibitors may be divided into two 
categories. The first comprises active site directed reagents. These 
molecules are structural analogues of normal substrates but have some 
12 
reactive functionality, such as a haloketone, epoxide, sulphonyl 
halide or phosphoryl halide. Having the required likeness to normal 
substrates they bind to the target enzyme in the usual manner of 
enzyme-substrate interaction. Their mode of action relies upon some 
nucleophilic amino acid side-chain of the target enzyme being close 
enough to the reactive group of the inhibitor molecule for there to be 
a displacement reaction between them leading to covalent modification 
of the active site. 
The second category of irreversible enzyme inhibitor differs from 
the first in that the reactive functionality is latent in the 
inhibitor molecule. The reactivity is only uncovered during the 
enzymic process after binding of the enzyme and substrate. The 
specific action of the enzyme is neccessary to convert the original 
innocuous substrate into the reactive entity. The activation only 
occurs at the active site. If chemical reaction occurs between the 
activated substrate and the active site of the enzyme before the two 
can diffuse apart then only the target enzyme is modified and has its 
activity destroyed. 
A review by Walsh' covers the different classes of mechanism- 
based inhibitors that have been studied. 
A mechanism-based inhibitor of hydrolytic enzymes 
The idea for a mechanism-based inhibitor of hydrolytic enzymes 
arose from the observation that 3-bromo-3-methyl-2-oxobutanoate (1) 
reacts with water to give isobutyric acid2 (Scheme 1. a). 
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This observation may be explained by either of two mechanisms. 
The first (Scheme 1. b) involves loss of carbon dioxide and bromide ion 
to generate a ketene (2) which is then hydrated. The second (Scheme 
1. c) postulates a reversible nucleophilic attack at the carbonyl group 
followed by loss of carbon dioxide and bromide ion to generate the 
observed product. 
If the acid (1) is masked as an ester or amide (3) then neither 
of the two postulated mechanisms can operate. If the protected species 
(3) is incubated with an enzyme capable of hydrolysing the peptide 
bond then the free acid will be generated at the active site of the 
enzyme. Any adjacent nucleophile at the active site might then be 
acylated by either of the two mechanisms postulated (Scheme 1. d). 
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Synthesis of potential mechanism-based inhibitors of hydrolytic 
enzymes 
In order to synthesise 3-bromo-2-oxo esters and amides such as 
compound (3) it was decided to attempt bromination of 2-oxo acids 
followed by esterification or coupling to suitable protected amino 
acids. It was planned to use 2-hydroxy acids as precursors of the 2- 
oxo acids (Scheme 2). 
1 
F? ---ý02H -°. 
OH 
Ri 
1t02H 
e 
0 
Rl RI 
R2 
C02H 
ro R2C02R 
Br 0 Br 0 
Scheme 2 
Synthesis of 2-oxo carboxylic acids 
Literature methods for the oxidation of 2-hydroxy acids to 2-oxo 
acids often involve more than one step, for example, formation of the 
t-butyl amide to protect the carboxyl function3 prior to oxidation. 
Some methods employ vigorous conditions which might destroy sensitive 
functional groups present in the molecule, for example, the 
preparation of benzoylformic acid by alkaline potassium manganate 
(VII) oxidation of mandelic acid. 
4 
It was decided to develop a mild procedure for the direct 
conversion of 2-hydroxy acids to 2-oxo acids. 
A mild method for the oxidation of 1,2-diols to hydroxyketones5 
has been reported. This involves the brominolysis of dioxostannolan 
derivatives of 1,2-diols (Scheme 3. a). It was decided to explore the 
potential of this method for the oxidation of 2-hydroxy acids (Scheme 
3. b). 
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RNtrC02H 
Bu Bu 
Scheme 3 
Reaction of equimolar amounts of 1,2-diols and dibutyl tin oxide 
in refluxing benzene gave the five-membered cyclic dialkyl tin 
derivatives (4). 6 Linear structures have been ruled out since no OH 
stretch could be observed in the infrared spectrum. Molecular weight 
estimationS7 have shown these compounds to be monomeric in dilute or 
polar solvents and to exist as dimers at higher concentrations in non- 
polar solvents. There is also evidence for higher oligomers. Mossbauer 
parameters8 are consistent with a dimer in the solid state, 
pentacoordinate at tin. 
David and co-workers9 performed 119Sn NMR. experiments on a range 
of dioxostannolans derived from chiral 1,2-diols. All 119Sn resonances 
were observed 121-180 ppm upfield of the 4-coordinate Me4Sn reference, 
a range characteristic of tin with coordination greater than four. 
Only one resonance for each compound was observed implying that the 
two tin atoms of the dimers present were in a symmetrical environment. 
C2 symmetry is the only possible symmetry from the association of two 
chiral monomers. 
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H 
Ph' 0 
00 
+n-0 HO HO 
_ 1- 
OMe 00 
(S) (6) 
This suggests the structure (5). Within each monomeric unit of 
the dimer, tin binds equatorially to one oxygen atom of the parent 
diol, apically to the other and apically to the equatorial oxygen of 
the other monomeric subunit acting as a ligand to the first. X-ray 
data show the structure of dioxostannolan of (6) in the solid state to 
be of the above described geometry. 
'° 
David and co-workers5 worked with a range of glycols derived from 
partially protected glucose and galactose. These were reacted with 
dibutyl tin oxide in benzene with azeotropic removal of water. 
Evaporation of the benzene gave the crude dioxostannolans which were 
used without purification. Brominolysis of the dioxostannolans was 
carried out by addition of bromine in dichloromethane to either the 
dioxostannolan in benzene in the presence of 4A molecular sieves or 
the dioxostannolan in dichloromethane in the presence of tributyl tin 
methoxide at room temperature. Yields were slightly higher by the 
latter procedure but the former was preferred since this made 
chromatographic separation of the product hydroxyketones less 
difficult. The reaction occured at the speed of titration with 
bromine. However, in the absence of hydrogen bromide scavengers the 
reaction often became slow after the addition of two thirds of the 
stoichiometric amount of bromine. It was thought that acid generated 
17 
in the medium by the reaction may have been attacking unreacted 
dioxostannolan causing Sn-0 bond fission and generating unreactive 
material. Yields were found to be higher in the presence of a hydrogen 
bromide scavenger. 
Inhibitors of the valine-isoleucine biosynthetic pathway 
9H H QH 
RCOC02H o McCO C02H ----r Me -CHCO2H ----" Me HCOC02H 
--- P. Mec%C02H R= Me Valine 
Hz 
R= Et Isoleucine 
Scheme 4. The valine-isoleucine biosynthetic pathway 
Two new classes of powerful herbicides have been developed which 
act by inhibiting the first common enzyme of the valine-isoleucine 
biosynthetic pathway, acetolactate synthase, (acetolactate pyruvate 
lyase (carboxylating), E. C. 4.1.3.18)10111 (Scheme 4). 
These comprise the sulphonylureas sulfometuron methyl and 
chlorosulfuron, marketed by Du Pont, and the imidazolinones 2-(4- 
isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)nicotinic acid and 2-(4- 
isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-3-quinoline carboxylic 
acid marketed by American Cyanamid. These herbicides are the most 
potent so far discovered. Consequently there is much commercial 
interest in the biosynthesis of valine and isoleucine. In particular, 
the natural products from the acetolactate synthase-catalysed step, 
C-acetolactate, C-acetohydroxybutyrate and their analogues are 
required for biological testing. 
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Synthesis of 2-hydroxy-3-oxo carboxylic esters 
RRR 
Pb(OAc) NaOH 
C02Et 4 C02Et C02" 
00 OAc 0H 
(7) R= Me 
(8) R= Et 
Scheme 5 
The standard syntheses of the natural substrates IX-acetolactate 
(7) and C'-acetohydroxybutyrate (8) are based on the acetoxylation of 
2-methyl and 2-ethylacetoacetates respectively, as developed 
originally by Krampitz12 (Scheme 5). These syntheses proceed in low 
and variable yield2 particularly when carried out on a small scale. 
Other, multi-step, syntheses have been developed with a view to 
the introduction of isotopic labels or the production of optically 
pure material. 
The two published chiral syntheses13,14 both involve the chemical 
resolution of a stable acid which was later transformed into the more 
labile O-keto acid. The synthesis developed by Hill and co-workers13 
(Scheme 6) involved attack of a Grignard reagent upon ethyl pyruvate 
in very low yield. Neglecting the resolution steps, the overall yield 
of methyl a-acetolactate (9) was only 10%. 
HCaCHMgBr OH 
RCOC02Et HC=-CC(OH)RC02Et---ý HC-E! CC(OH)RC02H 
(resolved with quinine) 
CH2N2 Hg2+-resin 
-----ý HC=-CC(OH)RC02Me McCOC(OH)RC02Me 
H+/H2O (9) 
Scheme 6 
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t-BuOK TosOH/benzene 
MeCOMe + BrCHMeC02Et -, Me2C McCO2Et 
Ba(O H)2 Hz CH2N2 
McýHýOji C)MeC02Et McCC(OH)MeCO2H 
(resolved with quinine) 
loMeC02Me 03 
Me -----> McCOC(OH)MeC02Me 
J 
Scheme 7 
The syntheses by Crout and co-workers14 (Scheme 7) produced 
methyl -acetolactate in 34% yield, neglecting the resolution steps. 
Syntheses of -acetolactate have been developed2 which allow 
isotopic substitution by incorporation of labelled ethyl acetoacetate 
(Scheme 8) or labelled acetic acid (Scheme 9). The former gave ethyl 
-acetolactate in 42% yield. The latter gave the dibenzyl-protected 
-acetolactate (10) in 10% overall yield. 
* 
MeI/NaOEt 
* 
NaOEt/(AcO)2 
Me COCH2C02Et Me COCHMeCO2Et t 
* 
NaHC03/H20 
Me COC(OAc)MeCO2Et Me COC(OH)MeC02Et 
Scheme 8 
* 
BnBr/Me4NOH 
* 
LiH 
Me CO2H Me C02Bn ----- Me COCH2 C02Bn 
Na/MeI 
* 
Na/(BzO)2 
----ý- Me COCHMeC02Bn Me COC(OBn)Me C02Bn 
(10) 
Scheme 9 
Bn = benzyl; Bz = benzoyl 
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Several recent syntheses of 2-hydroxy-3-oxo carboxylic acids 
proceed by epoxidation of the enol form of 3-oxo carboxylic esters, 
either as the equilibrium mixture with the 3-oxo carboxylic ester or 
trapped as the silyl enol ether. 
15-20 During work up, rearrangement of 
the 2,3-epoxy-3-hydroxycarboxylic ester gives the 2-hydroxy-3-oxo 
carboxylic ester. Langlois and co-workers, 
17 
using this method, 
achieved a 76% yield of methyl 1-hydroxycyclopentan-2-one carboxylate 
(11) (Scheme 10). 
SiR3 R3Si. 
C02Me C02Me C02Me 
H 
C02hle 
(11) 
Scheme 10 
However, this procedure failed completely with acyclic systems 
such as a-acetolactate. The other references cited above involve 
polycyclic systems where the 2-hydroxy-3-oxo carboxylic ester is part 
of a cyclohexane ring. 
It was decided to develop a synthesis of 2-hydroxy-3-oxo 
carboxylic esters applicable to Ql-acetolactate and its analogues. 
It is well known that at acidic pH potassium manganate (VII) will 
convert alkenes into hydroxyketones2l'22 (Scheme 11. a). 
It was decided to attempt to extend this chemistry to 2-alkyl- 
substituted aß-unsaturated esters to generate analogues of 
c-acetolactate (Scheme 11. b). 
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R2 KMn04 2 
o R1CH=C<R3 Rl 
OH 
R3 Ip7+ 
22 
b R1CHC<CO2R3 - Rl 
p02R3 OH 
Scheme 11 
For the reaction of potassium manganate (VII) with alkenes, the 
diol is the major product at pH >9 for cyclic systems or pH >12 for 
acyclic compounds. 
23 The hydroxyketone is the major product at pH 4 to 
pH 6 and both products are observed at intermediate pH. The 
hydroxyketones are not formed via the diols since the latter are 
stable to potassium manganate (VII) under the hydroxyketone-forming 
conditions. 
24,25 Formation of the diols, the reaction 
stereochemistry26,180 labelling27 and kinetic studies28,29 support 
the existence of the hypomanganate intermediate (12) (Scheme 12). 
03 0 Mný 
----ý 
R 12 H2.. 
-= 
R 
Rý 0_ 
(12? 
R 
__Mn=O 
ý 
R 
5% 
R 
R OMn-OH 
- 
R OH 
KMn04 
I 
Scheme 12 
The kinetic results support the view that the diol and the 
hydroxyketone are formed from a common intermediate since the second- 
order rate constant is the same at pH 6.8 and pH 13.28 
Mn02 
22 
Deuterium labelling studies performed by Wolfe and Ingold23 
support the mechanism detailed in Scheme 12. There is oxidative 
decomposition of the cyclic hypomanganate ester (12) followed by 
hydrolysis of the resulting manganate (IV) ester, in that order, to 
give the hydroxyketone and manganese dioxide. The dimerisation of the 
cyclic hypomanganate ester (12) followed by disproportionation to the 
manganate (IV) and (VI) species is qualitatively similar to the well 
known oxidative and hydrolytic reactions of inorganic hypomanganate 
(Mn043-). 23 
Acetolactate decarboxylase 
2-Alkyl-2-hydroxy-3-oxo acids are analogues of the natural 
substrates for the enzyme acetolactate decarboxylase (2-hydroxy-2- 
methyl-3-oxobutanoate carboxy-lyase, EC 4.1.1.5). The natural 
substrates for this enzyme are Q-acetolactate (2-hydroxy-2-methyl-3- 
oxobutanoate) (7) and c-acetohydroxybutyrate (2-ethyl-2-hydroxy-3- 
oxobutanoate) (8). 
The mechanism of enzymic decarboxylation of /-keto acids 
The m ch". nism o` action of the enzyme acetoacetate decarboxylase 
(EC 4.1.1.4) in decarboxylating the normal substrate, acetoacetate, 
has been well established. 
30 It is summarised in Scheme 13. 
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0 
E-NH2 C02H 
.. -- 
H' + H2O 
ýý 
)NH-E 
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>=0 NH? --E 
Scheme 13 
``NH-E 
The E -amino group of a lysine residue at the active site forms a 
protonated Schiff's-base with the carbonyl group of the acetoacetate 
substrate. This "electron-sink" facilitates the withdrawl of electrons 
from the carboxylate group resulting in loss of carbon dioxide. 
Product is liberated by hydrolysis of the Schiff's base. 
The above mechanism is consistent with the following 
observations. Formation and later hydrolysis of a Schiff's base must 
lead to exchange of the carbonyl group oxygen atom with oxygen from 
water. This has been observed. 
31 Acetoacetate decarboxylase is not 
inhibited by sodium borohydride alone but is irreversibly inhibited by 
sodium borohydride in the presence of acetoacetate. 
32 This is 
consistent with the formation of a Schiff's base between the enzyme 
and substrate which is then reduced by the sodium borohydride, thereby 
preventing release of product by hydrolysis. 
Sodium borohydride has been used to trap Schiff's base 
intermediates. Incubation of the the enzyme with sodium borohydride 
and 3-14C-acetoacetate32 resulted in incorporation of radioactivity 
into the protein which could not be removed by dialysis. Acid 
hydrolysis followed by chromatography yielded a single radioactive 
compound identified as ti-N-isopropyllysine. 
33 
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The uses of acetolactate decarboxylase 
This enzyme is of great potential use to the brewing industry. 
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The fermentation of beer is divided into two major stages; a main 
fermentation and a maturation. During the main fermentation, over a 
period of about six days, the bulk of the fermentable sugars is 
metabolised. During maturation the beer becomes saturated with carbon 
dioxide, the colloidal stability is improved and the flavour of the 
beer is allowed to reach its final level. Except for the adjustment in 
flavour, which can take up to three weeks, the other properties can be 
achieved within a short process time using known technology. Flavour 
maturation is the rate limiting step in beer maturation. 
The volatile diketone, butan-2,3-dione, plays a major role in 
determining the flavour of the beer. The precise adjustment of the 
concentration of this compound in beer is a very important objective 
in the maturation process. In small concentrations it contributes to 
the desired flavour but above 0.1 ppm it conveys an objectionable 
taste to the beer. 
The source of butan-2,3-dione in the beer is the non-enzymatic 
oxidative decarboxylation of QE-acetolactate (7), produced by the yeast 
in the main fermentation (Scheme 14). The butan-2,3-dione once 
produced is converted enzymatically to acetoin (13) and thence to 2,3- 
butandiol (14) by yeast cell reductases during maturation. The 
oxidative decarboxylation of the (X-acetolactate is slow compared to 
the ensuing reductase-catalysed steps and is therefore the rate 
limiting step in the removal of butan-2,3-dione and its precursor, 
(X-acetolactate, from beer. 
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Addition of acetolactate decarboxylase to maturing beer by-passes 
the rate limiting production of butan-2,3-dione by channelling 
CY-acetolactate directly to acetoin (Scheme 14). Godtfredsen and co- 
workers34 have shown that the maturation process can be shortened to 
less than twenty four hours, simply by adding the enzyme to the beer, 
and still produce beer of the same quality as that matured 
conventionally. This represents a four-fold reduction in the overall 
brewing time and is potentially a great cost saving modification. 
At the time of writing, acetolactate decarboxylase has not yet 
been used on a commercial scale in the brewing industry, because 
insufficient quantities of the purified enzyme are available. 
The properties of a-acetolactate and acetoin 
The absolute configurations of the enantiomers of methyl 
ü-acetolactate have been found to be (S)-(+)- and (R)-(-)- by 
correlation with primary standards. 
35 Similarly, acetoin has been 
found to have the absolute configurations (R)-(-) and (S)-(+). 
36 
26 
(k-Acetolactate is unstable in aqueous solution and undergoes 
decarboxylation. At low pH this process is rapid. At high pH a 
degenerate rearrangement13 occurs leading to racemisation of optically 
pure fk-acetolactate. The racemisation occurs at a significant rate 
only above pH 12.9.37 The mechanism of the rearrangement has been 
studied using isotopically labelled GY-acetolactate2 and has been shown 
to be an intramolecular tertiary ketol rearrangement with migration of 
the carboxylate group (Scheme 15. a) rather than migration of methyl 
group (Scheme 15. b). 
TT !2 
0- 
a ý0ý0 HO 
H 
b 0-2 C02 
ý0 ý`0 H0 0 
Scheme 15 
Since the base-catalysed rearrangement of 01-acetolactate results 
in racemisation, the transition state must be partly, if not wholly, 
represented by a meso-structure (15), in which a syn arrangement of 
the C-0 bonds is found. 
If the anti arrangement of the C-0 bonds (16) were to pertain 
exclusively in the transition state then racemisation could not occur 
since the configuration at the new chiral centre after rearrangement 
would be the same as the configuration at the chiral centre in the 
starting material. 
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The stereochemistry of the acetolactate decarboxylase-catalysed 
decarboxylation of CY-acetolactate 
Much work has been done using acetolactate decarboxylase isolated 
from Aerobacter aerogenes. Loken and co-workers38 have established the 
pH optimum for the decarboxylation to lie between pH 6.2 and 6.4 in 
phosphate buffers. The enzyme was shown not to be dependent on 
divalent metal cations and also not inhibited by ethanol. Its 
specificity for (x-acetolactate and its analogues has been demonstrated 
by Juni. 39 It does not act upon acetoacetic acid or 2-oxobutan-1,4- 
dioic acids. 
The (S)-isomers of CY-acetolactate (7) and a--acetohydroxybutyrate 
(8), the biological precursors of valine and isoleucine respectively, 
are the prefered substrates39 for the enzyme from Aerobacter 
aerogenes. The (R)-isomers are decarboxylated also but at 1/20 the 
rate of decarboxylation of the (S)-isomers. 
The acetoin product from the decarboxylation of (S)- 
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a-acetolactate was found to have the (R)-(-)-configuration. 
13 
It is presumed that the reaction procedes via an enediol 
intermediate (17) (Scheme 16). 
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Protonation of the intermediate (17) might occur at the carbon 
atom that was originally the acetyl carbon atom of a-acetolactate 
(Scheme 16. a) or at the carbon atom that was originally the chiral 
centre (Scheme 16. b). 
* 
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* 
MeMgI 
Me COC(OH)MeC00 _ ----ý Me COCH(OH)Me 
gI0 
Met C(O(18) H)Me 
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NaI04 
* Me2 CO + MeCHO 
Scheme 17 
The site of protonation has been established by Crout and co- 
workers. 37 [3-14C]-(x-Acetolactate was incubated with the acetolactate 
decarboxylase isolated from Klebsiella aerogenes. The acetoin produced 
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was alkylated with methyl magnesium iodide and the diol (18) was 
cleaved with sodium periodate. The cleavage products were isolated as 
the 2,4-dintrophenylhydrazones (Scheme 17). Most of the radioactivity 
(80%) was found to reside in the acetone component of the periodate 
cleavage and the remainder (20%) in the acetaldehyde portion. This 
showed that protonation of the postulated enediol intermediate in the 
enzymatic decarboxylation occured at the carbon atom to which the 
carboxylate group was originally attached. This result, together with 
the earlier observation that (R)-acetoin is the product obtained from 
(S)-CY-acetolactate, shows that the carboxylate group was replaced by 
hydrogen with inversion of configuration (Scheme 18). 
Me 
C02 0 
HOS Me 
Scheme 18 
Me 
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HR 
Relatively few decarboxylases are known to operate with overall 
inversion of configuration. These include 6-phosphonogluconate 
dehydrogenase, 40 sterol 4-carboxylic acid decarboxylase, 
41 UDP 
glucuronate carboxylase (EC 4.1.1.35)42 and aspartate 
0-decarboxylase. 43 
In contrast, retention of configuration has been observed in the 
enzymic (X-decarboxylation of amino acids in all the cases studied so 
far. 44-50 Pyruvate kinase51 and isocitrate dehydrogenase52 are also 
known to operate with retention of configuration. 
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CHAPTER 1 
The synthesis of 3-bromo-2-oxo carboxylic esters and amides: Potential 
mechanism-based inhibitors of hydrolytic enzymes 
As described in the introduction, it was intended to follow the 
synthetic sequence below (Scheme 1.1). 
1 R1 Br R1 R1 
02H 
RZ_, 
t/CO2H 
R2 
C02H 
R2 
C02R 
riý 
OH 
t0 
Br 0 Br 0 
Scheme 1.1 
Synthesis of 2-oxo carboxylic acids using novel organo-tin chemistry 
The dibutyl dioxostannolans (19) of a range of 2-hydroxy acids 
were prepared by reaction of equimolar quantities of the 2-hydroxy 
acid and dibutyl tin oxide in boiling benzene with azeotropic removal 
of water using a Dean-Stark apparatus (Table 1.1). 
0 Bu2Sn0 R` O 
OH 0 
OH 
Bu Bu 
(19) 
Table 1.1 
Entry R dioxostannolan 
19a Ph crystalline solid 
19b Me2CH glass 
19c Et glass 
19d Me glass 
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In only one case, (19a), was the dioxostannolan crystalline. The 
others were obtained as glasses and could not be crystallised. 
David et a15 found that the dioxostannolans from 1,2-diols 
decomposed on silica gel to regenerate the original 1,2-diols. 
Dioxostannolan (19a) behaved similarly, giving two spots by silica gel 
TLC, the less polar compound co-running with mandelic acid. This 
reactivity of dioxostannolans precluded the use of silica gel 
chromatography for their purification. The crude dioxostannolans were 
used as such. 
Treatment of the dioxostannolan (19a) with one equivalent of 
bromine in dichloromethane gave the 2-oxo acid (20a) (Scheme 1.2). The 
reaction mixture was applied to a short silica gel column and washed 
with carbon tetrachloride to remove the organo-tin byproducts. The 
2-hydroxy acid was eluted with ethyl acetate in nearly pure form (84% 
yield) and converted into its 2,4-dinitrophenylhydrazone. 
Rý ýn 
Br2 
ý---ý" RýC02H 
0'0 
Bu Bu. 
(19) (20) 
Scheme 1.2 
Table 1.2 
Entry R Yie1d/% 
20a Ph 84 
20b Me2CH 43 
20c Et 0 
20d Me 0 
*as the 2,4-dinitrophenylhydrazone 
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Similar treatment of (19b) gave the 2-oxo acid (20b) which was 
isolated as its 2,4-dinitrophenylhydrazone in 43% yield. Brominolysis 
of the dioxostannolans (19c) and (19d) simply resulted in reisolation 
of the 2-hydroxy acids. 
This oxidation procedure worked well only for mandelic acid. This 
however, possesses no hydrogen at the 3-position and cannot be 
brominated to give the 3-bromo-2-oxo species required for inhibition 
studies with esterases. The 2-oxo acid (20b) was only obtained pure as 
its 2,4-dinitrophenylhydrazone. In order to use this compound for the 
synthesis of 3-bromo-3-methyl-2-oxobutanoic acid, the free 2-oxo acid 
would have to be generated, lowering an already poor yield. This 
oxidation method failed completely with the straight-chain examples 
(19c) and (19d) and offers no advantages over conventional literature 
procedures. 
Oxidations using N-bromosuccinimide 
A second approach to the generation of 3-bromo-2-oxo acids from 
2-hydroxy acids was required. N-Bromosuccinimide is known to oxidise 
secondary alcohols to ketones53 and 2-hydroxy esters to 2-oxo 
esters. 54 
Mild oxidations with N-bromosuccinimide have often been carried 
out in aqueous acetone or aqueous dioxane. 
55,56 N-gromosuccinimide 
becomes a more powerful oxidant in aqueous t-butyl alcohol or aqueous 
t-butyl alcohol in pyridine but with a concomitant decrease in 
selectivity. Light has been found not to be neccessary for the 
reaction. This, combined with the polar solvents in which the reaction 
occurs, implies a mechanism involving "positive" bromine rather than a 
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free radical pathway. 
The by-products from the initial oxidation are succinimide and 
hydrogen bromide. If the latter has the opportunity to react with N- 
bromosuccinimide then bromine is generated which can brominate the 
ketone product from the initial oxidation. This has been used 
preparatively to generate a-bromoketones57 and 3-bromo-2-oxo esters. 
54 
The presence of pyridine or calcium carbonate in the reaction mixture 
suppresses the bromination reaction by scavenging hydrogen bromide. 
57 
It was decided to prepare to methyl 3-bromo-3-methyl-2- 
oxobutanoate (21) (a suitable candidate for testing with pig liver 
esterase as a mechanism-based inhibitor) using the N-bromosuccinimide 
reaction, and similarly to prepare 3-bromo-3-methyl-2-oxobutanoic acid 
for coupling to amino acids as potential mechanism-based inhibitors of 
peptidases. 
Very few 2-hydroxy acids are available commercially and which 
are suitable for transforming into the 3-bromo-2-oxo esters or amides 
for the enzyme inhibition studies envisaged here. By contrast, 
00-unsaturated esters are readily available commercially or readily 
synthesised. These may be di-hydroxylated and oxidised to 3-hydroxy-2- 
oxo esters with a range of alkyl substituents at the 3-position. It 
was decided to attempt to synthesise such compounds and to transform 
the remaining hydroxyl group into a leaving group by tosylation, 
mesylation or bromination. 
Synthesis of 3-bromo-2-oxo carboxylic acids, esters and amides 
Commercially available 2-hydroxy-3-methylbutanoic acid was 
esterified with diazomethane in high yield. Treatment with two 
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equivalents of N-bromosuccinimide in boiling carbon tetrachloride gave 
methyl 3-bromo-3-methyl-2-oxobutanoate (21) in 83% yield (Scheme 1.3). 
02H 
CH2N2 C02Me NBS ý, /C02Me 
H 
Br0 
(21) 
cýkeýe 1" 
C02H 
NBS 02H glyOMe 
Br01 EEDQ 
(22) 
Scheme 1.4 
Ph 'ýNH2 ý02H ý(ONHýýPh 
Br-0 
(22) (24) 
Scheme 1.5 
CONH"'ýC02Me 
Br 0 
(23) 
Similar treatment of 2-hydroxy-3-methylbutanoic acid with N- 
bromosuccinimide gave, essentially quantitatively, 3-bromo-3-methyl-2- 
oxobutanoic acid (22) (Scheme 1.4). Attempted coupling of the acid 
(22) to glycine methyl ester using standard peptide coupling 
procedures based on dicyclohexylcarbodiimide58 failed. However, use of 
the coupling agent 1-ethoxycarbonyl-2-ethoxy-l, 2-dihydroquinoline 
(EEDQ)59 gave the bromo keto amide (23) in 48% isolated yield. 
Reaction of the acid (22) with benzylamine in dry dichloromethane 
yielded the benzylamide of 2-methylpropanoic acid (24) (Scheme 1.5). 
Formation of this compound can be explained by either of the two 
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mechanisms dicussed in the main introduction for the interaction 
between 3-bromo-3-methyl-2-oxobutanoic acid and nucleophiles. 
Synthesis of methyl 3-hydroxy-3-methyl-2-oxobutanoate 
Commercially available 3,3-dimethylacrylic acid was esterified in 
61% yield by the action of anhydrous methanol and hydrogen chloride. 
The latter was generated by addition of acetyl chloride to the 
methanol prior to reaction with the acid. A similar yield of the ester 
was obtained by the more conventional procedure of esterification with 
methanol and a catalytic amount of sulphuric acid. 
ýC02H AtCl >/CO2Me 
MeOH 
H22 
- 02Me H HC02 
+H rH 
(25) 
Scheme 1.6 
Dihydroxylation with aqueous hydrogen peroxide and formic acid 
gave the 2,3-dihydroxy ester (25) in 61% yield after chromatography 
(Scheme 1.6). 
Oxidation of the diol (25) using N-bromosuccinimide in boiling 
carbon tetrachloride in the presence of calcium carbonate gave only a 
30% yield of methyl 3-hydroxy-3-methyl-2-oxobutanoate (26) after 
chromatography (Scheme 1.7). 
Changing the solvent to aqueous dioxane56 gave only a 42% yield 
of the ester (26). However, performing the reaction in carbon 
tetrachloride with illumination and heat from a tungsten lamp raised 
the isolated yield of (26) to 86%. 
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The increase in yield in the presence of light suggests that 
both ionic and free radical mechanisms occur under these conditions in 
the non-polar solvent, carbon tetrachloride. 
In comparison with the above optimised oxidation procedure, the 
use of pyridinium chlorochromate60 gave none of the desired product. 
Jones oxidation61 gave a 34% yield of the ester (26). An attempt was 
also made to apply the procedure dicussed in the main introduction 
involving brominolysis of the dibutyl dioxostannolan derivatives of 
1,2-diols to give hydroxyketones. 
5 Reaction of the diol (25) with 
dibutyl tin oxide in boiling benzene gave the crude dioxostannolan 
derivative (27) (Scheme 1.8). 
C02Me 
02MeC02Me --4M. - 
H 
02Me 
HH 0" 
U2 
H0 
(25) (27) crude (7) 
Cnhama 1_R 
Brominolysis of (27) gave the crude 3-hydroxy-2-oxo ester (26). 
However attempted purification by distillation gave rise to 
considerable amounts of methyl a-acetolactate (7). The implications of 
this are explored in chapter 4. 
All attempts to manipulate the tertiary hydroxyl group of the 3- 
hydroxy-2-oxo ester (26) were unsuccessful. Details of the attempted 
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tosylation, mesylation and bromination are given in the experimental 
section, chapter 6. 
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CHAPTER 2 
Inhibition of pig liver esterase 
Pig liver esterase (EC 3.1.1.1) (PLE) has been shown to be 
composed of three different subunits. 62 Commercial preparations of PLE 
contain at least five isozymes, each comprising three subunits. Junge 
and co-workers62 have isolated the isozymes by preparative isoelectric 
focussing. The two major components isolated, each trimeric in one 
subunit, were found to have markedly different kinetic properties. 
One isozyme exhibited cholinesterase activity. It hydrolysed 
butyryl choline and other typical cholinesterase substrates (medium 
chain length mono-acyl esters) at a pH optimum between 8 and 9. This 
isozyme was inhibited by 0.01 M physostigmine and fluoride ion, both 
typical cholinesterase inhibitors. 
The other major isozyme had a pH optimum of 6.5 and acted 
preferentially on short-chain aliphatic esters but not upon butyryl 
choline. It was inhibited by organophosphates and phenylmethyl 
sulphonyl fluoride but not by 0.01 M physostigmine or fluoride ion. 
In conducting inhibition studies on PLE isozyme mixtures, the 
differing nature of the isozymes must be taken into account. It may be 
possible selectively to inhibit one of the major isozymes using one of 
the inhibitors mentioned above such that only one type of esterase 
activity is being examined. 
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Inhibition studies with methyl 3-bromo-3-methyl-2-oxobutanoate 
Inhibition trials of PLE with methyl 3-bromo-3-methyl-2- 
oxobutanoate (21) were carried out at a constant pH of 7.2 by means of 
an autotitrator supplying aqueous sodium hydroxide. The ester (21) was 
incubated with PLE after which ethyl butyrate was added. The activity 
of the PLE was measured by the initial rate of hydrolysis of ethyl 
butyrate. 
Methyl 3-bromo-3-methyl-2-oxobutanoate (21) was kept as a stock 
solution in dry methanol. Aliquots were mixed with water at pH 7.2. It 
was noticed that on dissolution there was a rapid uptake of alkali 
from the autotitrator, stoichiometric with the methyl 3-bromo-3- 
methyl-2-oxobutanoate added. In all the incubations, equilibration of 
the methyl 3-bromo-3-methyl-2-oxobutanoate with the water was allowed 
before addition of the PLE. Figure 2.1 shows the variation of residual 
esterase activity with incubation time. 
4- 
u 
cl 
E 
E 
O 
E 
0 
0 
Incubation Timelh 
Figure 2.1 
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At the concentration of methyl 3-bromo-3-methyl-2-oxobutanoate 
used (0.76 mM) and an incubation time of 1 minute, 7% of the maxinmum 
40 
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activity was observed. At longer incubation times the esterase 
activity recovered, reaching 50% of maximum activity after 20h. 
Incubation of PLE with 1.13 mM sodium bromide gave no measurable 
inhibition. 
The interaction between the methyl ester (21) and water was 
investigated by proton NMR spectroscopy. Methyl 3-bromo-3-methyl-2- 
oxobutanoate dissolved in d4-methanol was added to pH 7.2 phosphate 
buffer and the proton NMR spectrum was determined. The reaction was 
complete in less than the time it took to run the spectrum. The new 
product showed signals attributable to methyl 3-hydroxy-3-methyl-2- 
oxobutanoate (28) (Scheme 2.1). 
yi'C02Me H2O 
v+ 
ýC02Me 
) 
Br 
ý0 
H0 
(21) (28) 
Scheme 2.1 
PLE 02H 
HO 0 
(29) 
PLE was added to the solution. A slow hydrolysis of the methyl 
ester was observed by proton NMR. 
From these observations the results from the inhibition studies 
may be rationalised as follows. Dissolution of the methanolic methyl 
3-bromo-3-methyl-2-oxobutanoate in water led to loss of bromide ion to 
give methyl 3-hydroxy-3-methyl-2-oxobutanoate (28). This compound, not 
bromide ion, inhibited the PLE. The hydroxy compound (28) was itself 
hydrolysed to the acid (29) and methanol (Scheme 2.1) which together 
inhibited the PLE to a lesser extent, giving the observed recovery of 
activity. 
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Since the methyl 3-bromo-3-methyl-2-oxobutanoate (21) had been 
completely hydrolysed to methyl 3-hydroxy-3-methyl-2-oxobutanoate (28) 
before any PLE was added to the reaction, these results do not shed 
any light on the possible mechanism-based inactivation of PLE by bromo 
keto esters. There remains the possibility of attempting to synthesise 
and test chioro keto esters or other substrates in which the bromine 
has been replaced by a less labile leaving group. 
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CHAPTER 3 
Synthesis of CY-acetolactate analogues 
H 
C02 Me TH 
+0, 
H 
02 Me 02 Me 
(30) (31) (9) 
11 
Methyl 01-acetolactate (9) was synthesised by oxidation of the 
dihydroxy ester (31) derived from methyl tiglate (30) by reaction with 
hydrogen peroxide-formic acid63 (Scheme 3.1). Oxidation of the diol 
(31) with N-bromosuccinimide gave methyl a-acetolactate (9) in an 
isolated yield of 58%. A better yield of 70% was obtained following 
the procedure described in chapter 1 whereby the dioxostannolan 
derivative of the dihydroxy ester was subjected to brominolysis. The 
yield for the dihydroxylation step was 62%, giving CI-acetolactate (9) 
from methyl tiglate (30) in an overall yield of 43%. 
Manganate (VII) oxidation of CYß-unsaturated esters 
A synthesis of 2-hydroxy-3-oxo carboxylic esters in one step from 
the corresponding a/3-unsaturated esters, and in high yield, was 
developed. 
KMn04 I AcOH I acetone / H2 0 
02Me 
(30) 
Scheme 3.2 
HC02Me 
(9) 
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Following the method of Srinivasan and Lee22 for the manganate 
(VII) oxidation of alkenes to ü-hydroxyketones, methyl tiglate (30) 
was treated with potassium manganate (VII) in aqueous acetone in the 
presence of approximately 2% acetic acid at 25°C (Scheme 3.2). Methyl 
a-acetolactate (9) was isolated in 50% yield. Performing the reaction 
at lower temperatures resulted in higher yields (Table 3.1). The 
highest yield was obtained at -10°C. 
Table 3.1 
Temperature/°C Yield/% 
50 38 
25 50 
20 67 
-10 80 
A range of Qß-unsaturated esters was treated with potassium 
manganate (VII) and acetic acid in aqueous acetone at -10°C. High 
yields of the corresponding C-acetolactate ester analogues were 
obtained in all cases except for the cyclic derivative (33k) where a 
62% yield was observed (Table 3.2). 
The products were purified by distillation except for the aryl 
analogues (33h, i, j). The p-nitrophenyl derivative (331) was a 
crystalline solid easily purified by recrystallisation. Compounds 
(33h) and (33j), were viscous oils, which were purified by flash 
chromatography to avoid the risk of decomposition at the high 
temperatures required for distillation. 
This procedure appears to have general applicability for the 
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synthesis of acyclic a-acetolactate analogues from c3-unsaturated 
esters in high yield, and is far superior to any other method 
published in the literature to date. 
RECH=< 
R2 
cm 
CýR3 
R1 
R2 
C02R3 
0 
(32) 
Table 3.2 
(33) 
Entry R1 R2 R3 Yield/% 
33a13 Me Me Me 80 
33b Me Et Et 80 
33c Et Et Et 87 
33d Et Me Et 82 
33e Pr Me Et 70 
33f Bu Me Et 82 
33g t-Bu Me Et 80 
33h Ph Me Et 68 * 
331 p-N02Ph Me Et 83 
33j p-MeOPh Me Et 86 
33k15 Me 62 
* not optimised 
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Synthesis of C -unsaturated esters 
Of the CYß-unsaturated esters used as substrates for the manganate 
(VII) oxidation described above, only methyl tiglate (30) and methyl 
1-hydroxy-2-cyclopentanone carboxylate (32k) were available 
commercially. The others were synthesised by coupling aldehydes with 
the appropriate 2-alkyl-substituted phosphonate via the phosphonate 
modification64 to the Wittig reaction (Scheme 3.3). 
1) NaH R2 
(Et0)2PCHC02Et RICH( 
R2 2) R1CHO C02E t 
(34) 
Scheme 3.3 
Table 3.3 
Entry R1 R2 Yield/% E-isomer/% 
34a65 Me Et 53 24 
34b66 Et Et 72 54 
34c67 Et Me 62 87 
34d65 Pr Me 68 86 
34e68 Bu Me 64 87 
34f69 t-Bu Me 71 54 
34g Ph Me 81 100 
34h p-N02Ph Me 38 100 
341 p-MeOPh Me 67 100 
It was found neccessary to use a slight excess of the phosphonate 
over the sodium hydride to ensure complete reaction of the latter. If 
sodium hydride was present during addition of the aldehyde to the 
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deprotonated phosphonate then the ensuing product mixtures contained 
appreciable amounts of ß'y-unsaturated esters in addition to the 
desired aß--unsaturated esters. 
The aryl substituted esters (34g, h, i) gave exclusively the 
E-isomer. Isomer mixtures were obtained in the other cases. All of the 
esters were isolated as oils by distillation except for (34h) which is 
a crystalline solid. Appreciable amounts of the product (34h) 
co-crystallysed with unreacted p-nitrobenzaldehyde. The quoted yield 
of 38% refers to the isolated material only. 
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CHAPTER 4 
The tertiary ketol rearrangement of 3-hydroxy-2-oxo esters 
1 
R2 *3 
0 
R2,1 
ý, 2 R3 
ýý'0ýý' OööH 
Scheme 4.1 
The tertiary ketol rearrangement of cl-hydroxyketones (Scheme 4.1) 
has been shown to be catalysed by heat, 7° hot metal surfaces, 71 light 
(via photoenolisation), 
72 acids, bases and Lewis acids. 
CO2 Me -\ý 
H -- 
ýHC02Me 
0 
(26) (9) 
S'hpmp 4_7 
The tertiary ketol rearrangement of 3-hydroxy-2-oxo esters has 
not been described in the literature (except as a result of this 
work). 
73 It was noted in chapter 1 that distillation of crude methyl 
3-hydroxy-2-methyl-2-oxobutanoate (26) in the presence of organo-tin 
residues resulted in rearrangement to its isomer methyl a-acetolactate 
(9) (Scheme 4.2). The other methods described in chapter 1 to produce 
the hydroxy keto ester (26) involved distillation as the final 
purification step. In none of these was any rearrangement of (26) to 
methyl (X-acetolactate (9) observed. 
Compound (26) when treated with 5 mol% of dibutyl tin oxide in 
boiling toluene was observed, by GLC, to be converted quantitatively 
into methyl Qt-acetolactate (9) which was isolated in 81% yield. 
48 
Exposing methyl ü-acetolactate to the same conditions resulted in no 
observable change and to re-isolation of (9). 
Treatment of the ester (26) with a representative selection of 
Lewis acid catalysts under conditions known to effect the simple 
tertiary ketol rearrangement gave no rearrangement to methyl 
CY-acetolactate. The use of aluminium trichloride-acetic anhydride- 
acetic acid, 
74 aluminium t-butoxide75 and alumina75 failed to generate 
methyl a-acetolactate. Treatment of (26) with boron trifluoride 
etherate-acetic anhydride-acetic acid76 led to acetylation of the 
tertiary hydroxyl group, to give the diester in 58% Isolated yield, 
with no rearrangement. Methods involving aqueous acids and 
alkalis77'78 are not applicable in this case since ester hydrolysis 
would occur with concomitant decarboxylation. 
The simple ketol (35), when treated with dibutyl tin oxide in 
boiling toluene, was converted into a 61: 39 mixture of the starting 
compound and its isomer (36) (Scheme 4.3). 
H OH 
(35) (36) 
Scheme 4.3 
This result shows that the carboxylic ester function is not 
essential to the rearrangement and that dibutyl tin oxide catalyses 
the simple tertiary ketol rearrangement, under essentially neutral 
conditions. 
In order to explore the scope of this dibutyl tin oxide-catalysed 
rearrangement, a series of 3-hydroxy-2-oxo esters was prepared. 
Details of their synthesis is given at the end of this chapter. 
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Isomerisation of symmetrical substrates 
Esters (37b) and (37c), higher homologues of the hydroxy keto 
ester (26), rearranged upon treatment with catalytic dibutyl tin oxide 
in boiling toluene quantitatively to give the CY-acetolactate analogues 
in high isolated yield (Table 4.1). The diphenyl example (37d) gave an 
approximately 1: 1 equilibrium mixture of starting material and its 
isomer (38d), from which the latter was isolated by chromatography in 
38% yield. 
R 
C02R1 R,,, 02 Rl 
HO H 
(37) 
Table 4.1 
(38) 
Entry R R1 Yield/% 
38a Me Me 81 
38b Pr Et 80 
38c Bu Et 88 
38d Ph Et 38 
Isomerisation of the cyclic substrates (39a, b, c) furnished the 
ring-expanded Of-acetolactate analogues (40a, b, c) in high isolated 
yield (Table 4.2). 
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0002Et 
(CN2)n 
H 
(39) 
Table 4.2 
H 
(CHý 02Et 
(40) 
Entry n Yield/% 
40a 4 90 
40b 5 79 
40c 6 90 
Formation of the six- and eight-membered ring products was 
quantitative. However, for the six- to, seven-membered isomeration 
(39b) an equilibrium mixture of 97: 3 was obtained in favour of the 
ring-expanded product. 
Isomerisation of non-symmetrical substrates 
The reversible nature of the rearrangement was demonstrated by 
exposing 2-hydroxy-3-oxo esters, with different alkyl substituents at 
the 2- and 3-positions, to the rearrangement conditions. In each case 
one of the alkyl substituents was methyl (Scheme 4.4). 
Me RR 
R» 02Et 
HO 00 
(00002Et 
McHCO 
Et 
00 2 
(41) (42) (43) 
Scheme 4.4 
In all cases an equilibrium mixture of the two isomeric 2- 
hydroxy-3-oxo esters was obtained (Table 4.3). The proton NMR spectrum 
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of the product mixture from the isomerisation of ethyl 2-ethyl-2- 
hydroxy-3-oxobutanoate (42a) (Figure 4.1) indicated that none of the 
3-hydroxy-2-oxo ester was formed. The equilibrium mixtures for the 
isomeric pairs (41d, 43d) and (41g, 43g) were obtained by 
isomerisation of the corresponding 3-hydroxy-2-oxo esters. 
Table 4.3 
Entry R Ratio (41)/(43) 
42a Et 1.0 
42b Pr 2.0 
42c Bu 2.5 
42d i-Pr 0.9 
42e t-Bu 2.5 
42f p-N02Ph 1.2 
42g Ph 2.7 
42h p-MeOPh 6.6 
On the basis of steric hindrance, the thermodynamic product 
distributions would be expected to favour the isomers with a 
substituent larger than methyl at the 3-position adjacent to the 
carbonyl group rather than at the more crowded 2-position. This is the 
general trend observed with the exception of the i-Pr example (42d). 
The observed product ratios correspond to small energy 
differences between the isomers, the most extreme case being only 350 
Jmo1-1 at 298 K. 
All the isomerisations were carried out in toluene, a solvent in 
which polar interactions should be minimal. 
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The components of the product mixtures could not be separated 
satisfactorily on TLC. However, resolution of the p-nitrophenyl 
example (42f) was achieved by HPLC on a C18 reverse phase column with 
methanol-water as eluant. In principle, each isomeric 2-hydroxy-3-oxo 
ester could be separated by preparative HPLC and the re-isolated 
starting material recycled. This gives access to the (Y-acetolactate 
analogues with bulky groups at the 2-position. To synthesise the 
CB-unsaturated ester precursors required for the manganate (VII) 
reaction would be difficult. Preparation of the 2-substituted 
phosphonate would require harsh conditions and might prove to be 
difficult or impossible. 
Thus for synthesis of a-acetolactate analogues with bulky groups 
at the 2-position, preparation of the less sterically hindered isomer, 
isomerisation to the product mixture and isolation of the rearranged 
product by preparative HPLC may be practical for the preparation of 
small quantities of such compounds. 
Synthesis of 3-hydroxy-2-oxo carboxylic esters 
1 
(Et0)2PCH2C01Et --- - RFC CHC02Et ----ý R 02Et -----ý 02Et 
RR1CH0 4HTHH 
Scheme 4.5 
Coupling of the appropriate ketones and ethyl bromoethanoate via 
the phosphonate modification to the Wittig reaction64 gave the 
013-unsaturated ester series (Table 4.4). 
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>==EHC02Et 
' Rl 
(45) 
Table 4.4 
Entry R R' Yield/% E-isomer/% 
45a107 Pr Pr 64 
45b Bu Bu 66 
45c108 Ph Ph 70 
45d109 i-Pr Me 70 85 
45e110 Ph Me 75 87 
45f111 /S Me 51 85 
45g112 
LI 70 
45h81 66 
45i64 
0 
76 
45j81 
0 
74 
45k81 
0 
74 
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Di-hydroxylation using hydrogen peroxide-formic acid63 (Table 
4.5) and subsequent N-bromosuccinimide oxidation furnished the desired 
3-hydroxy-2-oxo esters (47) (Table 4.6). Compounds (44a) and (44b) 
were prepared from the c43-unsaturated esters without isolation of the 
dihydroxy ester (Table 4.7). 
It was not found possible to carry the aß-unsaturated esters 
(45f), (45g) and (45k) through the synthesis. All attempts to 
oxygenate the alkene double bond failed. Attempts using hydrogen 
peroxide-formic acid, osmium tetroxide79'80 and via epoxidation with 
m-chloroperoxybenzoic acid were all unsuccessful. 
-RI 
'R 02Et 
HH 
(46 ) 
Table 4.5 
Entry R R' Yield/% 
46a Pr Pr 40 
46b Bu Bu 30 
46c i-Pr Me 30 
46d Ph Me 46 
46e 79 
46f 39 
56 
- -R 
tR O2Et 
H 
Table 4.6 
(47) 
Entry R R1 Yield/% 
47a Pr Pr 79 
47b Bu Bu 93 
47c i-Pr Me 19 
47d Ph Me 78 
47e 60 
47f 51 
;, 
RR 
HC02 Et --ý- --a Rz 
02 Et 
R 
(44) 
Table 4.7 
Entry R R1 Yield/% 
44a 
44b 
Ph Ph 
0 
30 
35 
57 
CHAPTER 5 
Biotransformations with acetolactate decarboxylase 
The properties of the enzyme used 
The acetolactate decarboxylase (ADC) used in these studies was 
donated by Novo Industri A/S. It was used in crude form isolated from 
selected strains of Bacillus brevis. 
Data for the purified enzyme have been obtained and information 
pertinent to this study is given below. 
The temperature activity profile is shown in Figure 5.1. Under 
the assay conditions used the pure enzyme was stable up to 40°C. At 
high temperatures (>50°C) there is appreciable non-enzymatic 
decarboxylation of substrate. 
The pH activity profile is shown in Figure 5.2. The most active 
range is between pH 5.5 and 6.5. However, 50% of maximum activity may 
be obtained at pH extremes of 4.3 and 7.2. 
Temperature activity profile (pH 0) pH activity profile (30'C) 
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Figure 5.1 
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Figure 5.2 
Acetolactate decarboxylase-catalysed decarboxylation of natural 
cnhcrraf 
0. -Acetohydroxybutyrate 
c-Acetolactate (7) and CY-acetohydroxybutyrate (8) were 
synthesised as their methyl and ethyl esters respectively by the 
method outlined in chapter 3. It was neccessary to generate the 
corresponding acids for incubation with the enzyme acetolactate 
decarboxylase (ADC). Hydrolysis with aqueous alkali carries with it 
the risk of ß-keto ester cleavage (Scheme 5.1). 
0 Me 0O 
Me 
Me OK - MeýO me -A-, O' HO COZ 
OH 
I PLE / pH 7.5 
0 Me 0R tH (7) R= Me 
O C02Et 
OH (8) R= Et 
Scheme 5.1 
However, it was found that hydrolysis of a-acetolactate analogues 
catalysed by pig liver esterase (PLE) was possible at pH 7.5 (the 
optimum pH for this enzyme82). Hydrolysis of an ester gives an alcohol 
and an acid with a consequent lowering of pH. Hence the progress of 
the reaction can be followed by titration with alkali, the amount of 
alkali added to maintain a constant given pH being proportional to the 
extent of reaction. 
Ethyl 01-acetohydroxybutyrate (33b) was hydrolysed at pH 7.5 using 
PLE. The progress of the reaction was monitored by the uptake of 
aqueous sodium hydroxide delivered by an autotitrator (Figure 5.3. a). 
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Figure 5.3 
After complete hydrolysis the reaction mixture was acidified to 
pH 6.5. Decarboxylation of an acid gives rise to an increase in pH by 
loss of the weak acid, carbon dioxide, from the system. Progress of 
the decarboxylation can be monitored at constant pH by titration with 
acid. 
ADC was added to the reaction mixture and the decarboxylation 
followed by uptake of hydrochloric acid delivered at pH 6.5 by an 
autotitrator (Figure 5.3. b). 
The autotitrator trace for the decarboxylation reaction (Figure 
5.3. b) showed two distinct rates; a faster reaction up to 50% 
completion and a slower reaction thereafter, suggesting that one 
enantiomer of the acid was being decarboxylated at a higher rate than 
the other. 
The hydrolysis and decarboxylation was also performed in 
phosphate buffer at pH 7.2 and monitored by proton NMR spectroscopy on 
a continuous wave spectrometer at 220 MHz. The PLE-catalysed 
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hydrolysis step was observed to generate ethanol and small changes in 
chemical shift were observed between the ester and the acid. 
The ADC-catalysed decarboxylation step gave a rapid development 
of signals attributable to 3-hydroxypentan-2-one (48), (Figure 5.4. b), 
up to 50% reaction, and a slower consecutive development of signals 
attributable to the isomeric hydroxy ketone, 2-hydroxypentan-3-one 
(49), (Figure 5.4. c, d). The ethanol generated in the hydrolysis step 
was used as an internal standard to evaluate the quantities of acid 
and decarboxylated products present during the decarboxylation 
reaction. These data are displayed in the progress curves of Figure 
5.5. 
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Figure 5.5 
H (49) 
The notable feature of this experiment is that the generation of 
the two Q'-hydroxyketones was sequential. Production of ketol (48) had 
virtually ceased before any ketol (49) was observed. 
In a similar experiment, racemic ethyl a-acetohydroxybutyrate 
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(33b) was treated with PLE and ADC consecutively at pH 7.2 in 
phosphate buffer. The hydroxyketone products were extracted into 
carbon tetrachloride and the proton NMR spectrum examined in the 
presence of a two-fold excess of the chiral solvating agent (S)-(+)- 
2,2,2-trifluoro-l-(9-anthryl)ethanol (50)83 (Figure 5.6. a). The 
spectrum was re-recorded in the presence of added racemic hydroxy 
ketones (Figure 5.6. b). The latter spectrum shows a splitting of the 
signals due to the enantiomer pairs of ketols (48) and (49) in rapid 
reversible equilibrium with the chiral solvating agent (50). The 
diagnostic peaks are the acetyl methyl of (48) at 0.8 ppm and the 
methyl doublet of (49) at 1.1 ppm. Comparison of the peak heights of 
the split signals revealed the optical purities of (48) and (49) to be 
93% ee and >95% ee respectively. 
Hill and co-workers13 have suggested that the slow 
decarboxylations of the (R)-enantiomers of ü-acetohydroxybutyrate (8) 
and CI-acetolactate were caused by racemisation of the substrates to 
give the preferred (S)-isomers. However, the known, racemising, base- 
catalysed tertiary ketol rearrangement of a-acetohydroxy acids, which 
occurs by migration of the carboxylate group is unlikely here since it 
proceeds in vitro at a significant rate only above pH 12.9.13,37 
That both a-hydroxyketones were generated in high optical purity 
implies that both the decarboxylation and the rearrangement were under 
enzymatic control. A rationalisation of the results is given in Scheme 
5.2. 
Here it is proposed that the (S)-isomer of ü-acetohydroxybutyrate 
is decarboxylated with inversion of configuration to give (R)-3- 
hydroxypentan-2-one (48) rapidly. Furthermore, the (R)-isomer of 
63 
(48) 
0 
1''--' (49) 
OM 
6 
00 (50) 
2Ä 1.0 
pPM 
Figure 5.6 
64 
a-acetohydroxybutyrate is rearranged by the enzyme to (S)-2-hydroxy-2- 
methyl-3-oxopentanoate (51) and then decarboxylated with inversion of 
configuration to give (R)-2-hydroxypentan-3-one (49). 
ÖZ Me 
0 
HO"'ý Et 
(S) 
C02 Me 
0 
*", 
L 
Et'" OH 
02 
' OH 
r_ 
Et Mee 
0 
HO Et e 
0000, 
(R)-(48) 
Me 
OH Et H 
0 
(R) (S)-(51) (R)-(49) 
Scheme 5.2 
To rearrange (R)-c -acetohydroxybutyrate (8) to (S)-2-hydroxy-2- 
methyl-3-oxopentanoate (51) with intramolecular migration of the 
carboxylate group requires a syn arrangement of the carbonyl oxygen 
atom and the hydroxyl oxygen atom. An anti arrangement would result in 
(R)-2-hydroxy-2-methyl-3-oxopentanoate. 
The sequential production of the Qc-hydroxyketones (48) and (49) 
can be explained by making the assumption that (S)-c-acetohydroxy 
butyrate is much more tightly bound to the enzyme than (R)-(-aceto 
hydroxybutyrate and thus acts as a competitive inhibitor for the 
conversion of (R)-CY-acetohydroxybutyrate to (R)-2-hydroxypentan-3-one. 
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GL'-Acetolactate 
On the basis of the interpretation of the ADC-catalysed 
decarboxylation of ü-acetohydroxybutyrate (8) it was predicted that 
complete decarboxylation of racemic (k-acetolactate (7) should lead 
exclusively to (R)-(-)-acetoin, the (R)-isomer of CY-acetolactate 
being converted into (R)-acetoin via prior rearrangement into 
(S)-G*-acetolactate (Scheme 5.3). 
02 He 
e HO 
H0 Me 
(S)- (1) (R) 
C02 Me 01 
0 "' 0H Me Me 
OH 0 
(R)-(7) (S) 
Scheme 5.3 
Sequential hydrolysis of racemic methyl ü"-acetolactate (7) with 
PLE and complete decarboxylation with ADC generated (R)-(-)-acetoin. 
NMR analysis as before indicated an ee of 92%. 
The experiment was repeated but using the two enzymes 
simultaneously, not sequentially. Consequently, non-enzymatic 
decarboxylation of Cf-acetolactate was minimised. Only one enantiomer 
of the resulting acetoin could be detected by the NMR analysis 
indicating an ee of >98% (Figure 5.7) 
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To confirm that (R)-(-)-acetoin was the product of the 
decarboxylation of a-acetolactate, the experiment was repeated inside 
a polarimeter cell. Comparison of the specific rotation obtained with 
that reported84 for optically pure (R)-(-)-acetoin indicated that the 
product was indeed (R)-(-)-acetoin of 100% optical purity within 
experimental error. 
The 100% conversion of racemic substrate into a single enantiomer 
of product by enzyme action alone is unknown in the literature except 
as a result of this work. 
85 Sih86 has published work in which a 
carefully chosen substrate was processed by a hydrolytic enzyme under 
pH conditions which caused racemisation of the starting material. That 
amounted to an in situ recycling of the "wrong" isomer to the prefered 
substrate in order for the enzyme to process the starting material 
completely. 
Otha and co-workers87 have investigated the production of 
optically pure a-hydroxyketones by enzymatic hydrolysis of the 
acetylated precursors (52) (Scheme 5.4). 
PhCO 
OAc 
P. miso 
PhCOOAcR + PhC 
OH 
Scheme 5.4 
Incubation of a range of GY-acetoxyacylophenones (52) with the 
yeast Pichia miso IAM 4682 gave 50% de-acylation of starting material, 
both product and recovered starting material having high enantiomeric 
excesses. However, all of the examples quoted contained the PhCO 
fragment. No simple alkyl hydroxyketones were examined. 
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ADC-catalysed decarboxylation of unnatural substrates: 
2-Hydroxy-2-methyl-3-oxopentanoate 
PLE ADC Hy 
= 
HCO2Et 
PLE 
*- 02 
(53) 
C-1e-e CS 
(49) (48) 
The PLE-catalysed hydrolysis of racemic ethyl 2-hydroxy-2-methyl- 
3-oxopentanoate showed apparent enantioselectivity, as indicated by 
the progress curve in Figure 5.8. After 50% hydrolysis there was a 
six-fold decrease in the rate of reaction. 
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The completely hydrolysed substrate was treated with ADC in 1M 
phosphate buffer at pH 7.2 and the decarboxylation followed by proton 
NMR. The production of signals corresponding to 2-hydroxypentan-3-one 
(49) was observed, followed by the slower growth of signals 
attributable to the isomeric CY-hydroxyketone, 3-hydroxypentan-2-one 
(48) (Scheme 5.5). Overall, the same product distribution was obtained 
as that for the ADC-catalysed decarboxylation of the isomeric 
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substrate (x-acetohydroxybutyrate (8). 
The decarboxylation was also performed at pH 7.7 in 1M phosphate 
buffer. The results were the same as above except that an unidentified 
compound was observed which disappeared during the course of the 
reaction as shown by the progress curves below (Figure 5.9). 
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Its proton NMR spectrum was qualitatively similar to that of the 
acid (53) but shifted to lower field by about 0.1 ppm. Signals from 
both the acid (53) and the unidentified compound were observed 
together in the same spectra. This ruled out the possibility of 
rapidly reversible eqilibria such as protonated/non-protonated acid 
where a single, time-averaged set of signals would be seen. The sheer 
quantity of this unidentified compound also ruled of the possibility 
of it being due to an enzyme-substrate complex. In relative molar 
terms the amount of ADC present with respect to substrate was 
vanishingly small. 
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2-Ethyl-2-hydroxy-3-oxopentanoate 
Complete decarboxylation of racemic 2-ethyl-2-hydroxy-3- 
oxopentanoate with ADC gave 4-hydroxyhexan-3-one (54) (Scheme 5.6). 
PLE ADC 
o ff 
02 Et --ý- "0H C02 C. 
(5S) (54) 
Cncýma S. F. 
NMR analysis of the optical purity of the hydroxyketone (54) was 
not possible because of the complex splitting patterns of the signals 
in the proton MIR spectrum. It was attempted, by selective decoupling, 
to generate singlet resonances suitable for the observation of 
diastereomeric splitting on complexation with the chiral solvating 
agent (50). However, due to artifacts generated by the decoupling 
process, assignment of the signals from the minor isomer was not 
possible. 
The decarboxylation of racemic 2-ethyl-2-hydroxy-3-oxopentanoate 
(55) was followed by polarimetry. A specific rotation of -76° (c=0.48, 
0.05 M phosphate buffer, pH 7.2,289 nm, 26°C) was obtained for the 
(-hydroxyketone product (54). The specific rotation of optically pure 
4-hydroxyhexan-3-one (54) is not known in the literature and so no 
estimate of optical purity could be made by comparison with such a 
value. However, the specific rotation obtained for the homologue, (R)- 
(-)-acetoin, by hydrolysis and decarboxylation of racemic methyl 
a-acetolactate conducted inside a polarimeter cell gave a value 
consistent with that obtained from chemically synthesised optically 
pure (R)-(-)-acetoin, within experimental error, as detailed on page 
68. Thus the specific rotation obtained for 4-hydroxyhexan-3-one (54) 
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obtained by this method may be assumed to represent optically pure 
material. 
2-Hydroxy-2-methyl-3-oxohexanoate 
Incubation of racemic ethyl 2-hydroxy-2-methyl-3-oxohexanoate 
with PLE and ADC gave the two isomeric hydroxyketones (56) and (57). 
NMR analysis indicated ees of >90% and 92% respectively (Scheme 5.7). 
HH 
PLE/ADC 
02Et -O- + 
(56) (57) 
Scheme 5.7 
2-Hydroxy-3-oxo-2,4,4-trimethylpentanoate 
Ethyl 2-hydroxy-3-oxo-2,4,4-trimethylpentanoate proved not to be 
a substrate for PLE. Brief exposure to 3M sodium hydroxide solution 
liberated the carboxylate ion. Treatment with ADC at pH 6.5 resulted 
in no change over a2h period. This tertiary-butyl a-acetolactate 
analogue was not a substrate for ADC. 
1-Hydroxycyclopentan-2-one carboxylate 
Methyl 1-hydroxycyclopentan-2-one carboxylate (58) was not a 
substrate for PLE. Hydrolysis to the acid (59) was achieved by brief 
exposure to 3M potassium hydroxide solution (Scheme 5.8). 
OH NaOH OH ADC H 
± 
UC02Me LJI -----ß 
(58) (59) (60) 
Scheme 5.8 
Treatment with ADC at pH 6.5 led to 43% reaction of the acid, as 
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judged by uptake of hydrochloric acid from an autotitrator. 
2-Hydroxycyclohexanone (60) was isolated in 37% yield. Analysis of the 
optical purity of the hydroxyketone (60) by proton NMR was not 
possible owing to the gross overlapping of signals. Polarimetry also 
was of no use since the optical rotation of enantiomerically pure 
2-hydroxycyclohexanone is not known in the literature. 
The failure of ADC to decarboxylate the cyclic CY-acetolactate 
analogue (59) completely may be rationalised as follows. The (S)- 
isomer was decarboxylated preferentially, as observed for 
Ci-acetolactate (7) and CL-acetohydroxybutyrate (8). However, the 
enzyme, unable to decarboxylate the (R)-isomer of the cyclic substrate 
(59), was also unable to catalyse carboxylate migration to give the 
preferred (S)-isomer of (59). 
For carboxylate migration, the carbon-carboxylate bond must be 
perpendicular to the plane of the trigonal carbonyl group. In the (R)- 
isomer of the cyclic substrate (59) this is most readily achieved when 
the carboxylate group is axial to the ring. However, if the (R)-isomer 
of (59) is bound at the carboxylate group and hydroxyl group with the 
ring in the chair form and the carboxylate group equatorial to the 
ring (61), then in order to bring the carboxylate group axial to the 
ring, and allow carboxylate group migration, the alternative chair 
conformation (62) must be adopted (Scheme 5.9. a). 
If the shape of the active site is that envisaged in structure 
(61) then conformational change in the substrate to the alternative 
chair form (62) would not be possible. Hence, the substrate would not 
be able to adopt the conformation necessary for carboxylate group 
migration. 
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In the case of the corresponding acyclic example, 2-ethyl-2- 
hydroxy-3-oxopentanoate (55), in which both enantiomers were found to 
be decarboxylated by ADC, the conformational restraints are much less 
severe. Assuming the same model for the active site, it can be seen 
using molecular models that the complete freedom of rotation about 
each spa bond should allow the (R)-isomer of (55) to adopt either 
conformation, (63) or (64), (Scheme 5.9. b), within the constraints of 
the active site, thus allowing carboxylate group migration giving the 
preferred (S)-isomer. 
The same conclusions may be reached by similar arguments if it is 
assumed that the carbonyl group and the adjacent alkyl substituents 
are responsible for binding instead of the carboxylate group and the 
hydroxyl function. 
If the ADC-catalysed decarboxylations proceed via an enediol 
intermediate, then the very fact that the cyclic substrate (59) was 
74 
decarboxylated means that the proposed enediol intermediate must be of 
the cis-geometry (65), (Scheme 5.10), since in this case the trans- 
geometry is obviously not possible. 
H OH 
C02 LoHl 
(S)-t59) (65) 
Crhamo 5_In 
Cis-enediol intermediates have precedent in the literature. Rose 
and co-workers88'89 have published evidence for a cis-enediol 
intermediate in the manganese-dependent aldose-isomerase-catalysed 
reactions (Scheme 5.11). 
RCH(OH)CHO «qr- RCOCH2OH 
rhpma 5_il 0 
Deuterium labeling studies showed that the hydrogen transfer was 
intramolecular and suprafacial. This implied that the same group at 
the enzyme active site was involved in both proton abstraction and 
donation. In each of the eight cases examined, the stereochemical 
outcome could only be rationalised on the basis of protonation at C-1 
or C-2 of a cis-enediol. 
ADC-catalysed deuterium incorporation into acetoin 
It is assumed that the ADC-catalysed decarboxylation of 
Ot-acetolactate proceeds via an enediol intermediate which is 
protonated to give the acetoin product (Scheme 5.12). 
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The reversibility of the last step was demonstrated by incubation 
of racemic acetoin and ADC in D20. The reaction was followed by proton 
NMR spectroscopy. The quartet arising from the methine proton was seen 
to fall to half of its original integrated value with respect to the 
other acetoin signals. Deuterium NMR showed that deuterium had been 
incorporated at the carbon atom bearing the hydroxyl group. This 
observation suggested that the exchange was attributable to the 
reversible operation of the last step in the ADC-catalysed 
decarboxylation reaction and that exchange was stereospecific and 
probably limited to the (R)-(-)-isomer, the normal product of the 
decarboxylation (Scheme 5.13). 
ABC / D20 
o0 
1H0H00 
Scheme 5.13 
Since the C-H and C-D stretching regions are widely separated, 
the use of vibrational circular dichroism (VCD) offered the 
opportunity to determine the absolute configurations of the deuterated 
and non-deuterated components of the mixture without prior chemical 
separation. 
The measurement of VCD is still in its infancy compared to the 
more established electronic CD in the UV-visible region. Recent 
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advances in instrumentation have extended the range of VCD to 
600 cm 
1. However, few such instruments exist and few specra have been 
published. 
The vibrational infra red circular dichroism and normal infra red 
spectra of the partially deuterated acetoin mixture and (R)-(-)- 
acetoin of normal isotopic composition were determined separately in 
carbon tetrachloride. IR and CD measurements made in the C-D 
stretching region (2250cm 
1 
to 2050cm 1) are shown in Figure 5.10. The 
stereoselective nature of the proton-deuteron exchange was 
demonstrated clearly by the negative CD bands found for the partially 
deuterated sample. 
Figure 5.11 shows the IR and CD curves in the C-H stretching 
region. The non-deuterated component of the partially deuterated 
mixture gave rise to a CD spectrum positive in sign, whereas (R)-(-)- 
acetoin of normal isotopic composition exhibited a corresponding curve 
negative in sign. This indicated that the non-deuterated component 
from the enzyme-catalysed reaction was enriched in (S)-(+)-acetoin and 
that the deuterated component had the same configuration as (R)-(-)- 
acetoin. The intensity of the optical activity of the partially 
deuterated mixture was approximately half that of the normal (R)-(-)- 
isomer of acetoin. This is consistent with the inference, based on 
proton NMR observations made during the enzymatic experiment, that 
only one enantiomer of acetoin had undergone exchange. 
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Biotransformations with acetolactate synthase isozyme II and 
acetolactate decarboxylase 
Acetolactate synthase isozyme II 
Acetolactate synthase, the first common enzyme in the 
biosynthesis of valine and isoleucine, is found in bacteria, yeast and 
higher plants. In enteric bacteria there are several isozymes of 
acetolactate synthase with varying properties. Acetolactate synthase 
isozyme II (ALS II) from Salmonella typhimurium is distinguished from 
the other isozymes in that it is not inhibited by valine, leucine or 
isoleucine at concentrations up to 10 mM. 
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ALS II is known to catalyse the homologous self-condensation 
reactions of pyruvate and 2-oxobutanoate to give et-acetolactate (7) 
and its higher homologue (55) (Scheme 5.14. a, b). 
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However, in the presence of both substrates, the heterologous 
reaction dominates to produce ( -acetohydroxybutyrate (8) (Scheme 
79 
5.12. e). 
91 
The enzyme has two substrate binding positions. 
91 The first 
utilises thiamine pyrophosphate (TPP) to bind keto acid and bring 
about decarboxylation, an essentially irreversible reaction. The 
"active aldehyde" (66) is condensed with keto acid bound at the second 
site to give the observed CY-acetolactate analogues and regeneration of 
TPP (Scheme 5.15). 
RRH 
+ R1000O- 
PPO S PP S1 
TPP Anion 
R __ 
h 
R200002 N+ 2 ý C02 
PP sH 
R 
- C02 H 
pp Sl 
C61) 
R2 
)+8 COZ + TPP Anion 
Scheme 5.15 
Schloss and co-workers92 have isolated hydroxyethyl TPP, the 
decarboxylated adduct of ALS II and pyruvate, using chemical quench 
experiments to trap the reaction intermediates in the enzymic 
reaction. They also incubated ALS II with an equimolar mixture of 
pyruvate and 2-oxobutanoate in which the carboxylate group of the 
pyruvate was enriched in 
13C. Measurement of the isotope rato of the 
evolved carbon dioxide by mass spectrometry indicated a 19-fold 
preference of pyruvate for the first site (carboxylate loss) over 2- 
oxobutanoate. The latter was found to be the preferred substrate for 
the second site. 
It has been reported93 that (S)-CY-acetolactate, but not 
(R)-CY-acetolactate, is a substrate for the reductoisomerise enzyme of 
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Salmonella typhimurium. From this it has been concluded13 that the 
c-acetolactate generated, via the acetolactate synthase, is of the 
(S)-configuration. 
Surprisingly, nothing has been reported concerning the 
configuration of the GY-acetohydroxybutyrate (8) or higher homologues 
of a-acetolactate formed by condensations of keto acids catalysed by 
ALS. 
Schloss and co-workers90 have developed a procedure for the 
large-scale production and purification of ALS II. Plasmid pDU9, which 
encodes the large and small subunits of Salmonella typhimurium ALS II 
and valine transaminase, was transformed into E. coli HB1OI. The enzyme 
was expressed in large quantities in the harvested E. coli. The 
enzyme-FAD complex is stable aerobically in the dark or anaerobically 
in light. Although the reactions catalysed by ALS II involve no net 
oxidation or reduction, the enzyme has a requirement for FAD, TPP and 
divalent metal cations. The metal plays no role in catalysis other 
than to assist in binding TPP to the enzyme. 
A sample of purified ALS II was kindly donated by Dr J. V. Schloss. 
The studies reported here were conducted using this sample. 
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The combined use of ALS II and ADC 
Homologous condensations 
Sodium pyruvate was incubated with ADC and ALS II with its 
required cofactors, FAD and TPP (stoichiometric with the enzyme) and 
magnesium chloride. Under these conditions the enzyme has a half-life 
of approximately 3 h. 
90 The reaction was followed by proton NMR 
spectroscopy. A rapid production of acetoin was observed (Scheme 
5.16. a). 
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No c -acetolactate was observed since sufficient ADC had been 
employed to process the acid (7) as soon as it was formed. 
Similar incubation of sodium 2-oxobutanoate with the two enzymes 
gave the homologous CY-hydroxyketone (54) (Scheme 5.14, b), at a rate 
about an order of magnitude slower than the pyruvate condensation. The 
condensation and decarboxylation was also followed by polarimetry. On 
the basis of complete conversion of starting material to 4-hydroxy 
hexan-3-one (54) the specific rotation of the product, so far 
unreported, was found to be -81° at 26°C. This is very similar to the 
rotation of the lower homologue, (R)-(-)-acetoin with a rotation of 
-84o. 
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With these homologous condensations the product from the ADC- 
catalysed decarboxylation does not depend upon the configuration of 
the acetohydroxy acid precursor. In both cases the (R)-hydroxyketones 
were produced. 
Treatment of 2-oxo-2-phenylethanoic acid with ADC and ALS II as 
before led to no observable reaction over a 10 h period. The acid was 
not a substrate for ALS II. 
Heterologous condensations 
An equimolar mixture of pyruvate and 2-oxobutanoate was incubated 
with ADC and ALS II as before. The reaction was followed by proton NMR 
spectroscopy. 
ALS 11 ADC 
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Scheme 5.17 
Observations up to 90% reaction indicated the exclusive 
generation of 3-hydroxypentan-2-one (48) (Scheme 5.17). This 
hydroxyketone arises from ADC-catlysed decarboxylation of (S)- 
c-acetohydroxybutyrate (8). None of the isomeric CC-hydroxyketone, 
2-hydroxypentan-3-one (49) (which would have been generated from the 
(R)-acid (8) by carboxylate migration prior to decarboxylation) was 
observed. This indicated that the ALS II-catalysed condensation of 
pyruvate and 2-oxobutanoate generated stereospecifically 
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(S)-c--acetohydroxybutyrate (8). 
The remaining phase of the reaction saw the growth of diverse 
small signals which may be attributable to the homologous 
condensations of pyruvate or 2-oxobutanoate respectively followed by 
decarboxylation to give the corresponding hydroxyketones. The 
condensation and decarboxylation was also followed by polarimetry. On 
the basis of complete conversion of starting material to 3-hydroxy 
pentan-2-one (48) the specific rotation of the product, unknown in the 
literature, was found to be -94° at 26°C. This value is similar to the 
rotations observed for acetoin and 4-hydroxyhexan-3-one obtained by 
the same method. 
Here it has been possible to determine the stereochemical outcome 
of an enzymatic reaction, in a rather novel way, not by measurement of 
optical rotations or synthesis of diastereoisomers with a chiral 
auxilliary, but simply by observing which product was formed in a 
consecutive enzyme-catalysed reaction which forms different products 
depending upon the configuration of its substrate. 
Treatment of an equimolar mixture of sodium pyruvate and 2-oxo-2- 
phenylethanoic acid with ADC and ALS II as before gave no reaction 
observable by proton NMR spectroscopy over a 10 h period. None of the 
possible products (67), (68), (69), or (13) arising from heterologous 
or homologous condensations of the keto acids and subsequent 
decarboxylation was observed (Scheme 5.18). 
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Scheme 5.18 
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These results indicate that 2-oxo-2-phenyl ethanoic acid is an 
inhibitor of the ALS II-catalysed condensation of pyruvate to 
a-acetolactate. This is not surprising in view of the results obtained 
by Stormer94 with the pH 6 acetolactate-forming enzyme from Aerobacter 
aerogenes. 1 mM Phenylpyruvate and glyoxylate caused approximately 802 
inhibition of the ALS-catalysed condensation of pyruvate to 
c-acetolactate. Competitive inhibition was observed implying that 
these two pyruvate analogues were not bound to the first site and 
decarboxylated, but perhaps competed with pyruvate for the second 
site. 
The use of proton NMR spectroscopy to follow the ALS II-catalysed 
reactions represents a considerable improvement in assay technique 
over those in the recent literature. 
92 Products are observed and 
identified directly as they form using a non-invasive technique. 
Subsequent reactions of the products may also be observed. 
The advantages of combining ALS II and ADC 
The combined use of ALS II and ADC to generate optically pure 
ü-hydroxyketones from keto acids represents an advance in the 
application of enzymes to organic synthesis. The overall effect is not 
simply to degrade, in an enantioselective manner, a molecule generated 
by chemical synthesis, as is the case with hydrolytic enzymes and 
decarboxylases when used alone. Combining ALS II and ADC allows 
carbon-carbon bond formation in the condensation of simple achiral 
compounds to give optically pure chiral products of higher molecular 
mass and greater complexity than the starting materials. 
The use of ALS II to transform commercially available 2-oxo acids 
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into (k-acetolactate analogues for use with ADC obviates the need to 
synthesise them chemically. At the time of writing, the substrate 
acceptability range for ALS II is not known. Chemical synthesis, using 
the preferred methods as described in chapter 3, will still be 
neccessary to obtain Ql-acetolactate analogues inaccessible by ALS II- 
catalysed condensations of keto acids. 
Chiral synthons from ADC-catalysed decarboxylations 
Introduction 
The optically pure Cl-hydroxyketones generated by ADC-catalysed 
decarboxylation of CY-acetolactate analogues have a potential use as 
chiral building blocks. An extension to their usefulness would be 
their conversion to the corresponding 1,2-diols by stereoselective 
chemical reduction. 
There are two possible products from a reduction of 
c-hydroxyketones; one from syn-selectivity (70) and the other from 
anti-selectivity (71) (Scheme 5.19). 
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Scheme 5.19 
Chemical methods have been developed for the stereoselective 
reduction of ü'-hydroxyketones. 
86 
Reductions giving anti-selectivity 
If the reaction conditions encourage chelation of the reducing 
agent to the substrate then the predominant diastereoisomer of the 
diol produced is generally the anti-isomer in accordance with Cram's 
cyclic model. 
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Zinc borohydride 
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In solution in ether, zinc borohydride exists as a contact ion 
pair (72). 
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In reaction with c -hydroxyketones (Scheme 5.20) the zinc 
coordinates to the two oxygen atoms of the substrate. Hydride delivery 
to the carbonyl group is related to the relative stabilities of the 
two possible zinc-mediated transition states. The larger the 
substituents attached to the Cl-hydroxyketone the more the transition 
state leading to anti-selectivity is favoured (Scheme 5.21). 
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Nakata and co-workers97 subjected a series of O-hydroxyketones to 
reduction with zinc borohydride. They obtained anti-selectivity with 
diastereomeric excesses in the range of 54-98%. 
The disadvantage of zinc borohydride is its low solubility in 
ether; concentrations greater than 0.1 M cannot be achieved. Other 
solvents such as 1,2-dimethoxyethane, in which zinc borohydride is 
much more soluble, compete with the 01-hydroxyketone substrate for 
coordination to the zinc resulting in little selectivity in the 
reduction. 98 
Aluminium hydrides 
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Katzenellenbogen and co-workers99,100 have investigated the scope 
of lithium aluminium hydride and lithium trimethoxyaluminium hydride 
for the stereoselective reduction of a-hydroxyketones (Scheme 5.22). 
Their results showed that enlarging the bulk of R1, the substituent 
attached to the carbonyl carbon atom, resulted in greater anti- 
selectivity. However, varying the size of R2, the substituent adjacent 
to the hydroxyl group, had no regular or marked effect on the 
selectivity of the reduction (Table 5.1). 
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Table 5.1 
R2 R2 
% Anti-selectivity 
LiAlH4/THF LiAl(OMe)3H/THF 
pentyl Me 64 73 
i-Pr Me 58 46 
t-Bu Me 87 85 
Ph Me 87 85 
Me pentyl 70 78 
Me i-Pr 73 66 
Me t-Bu 75 77 
Reductions giving syn-selectivity 
Syn-selectivity in the reduction of c-hydroxyketones is favoured 
under conditions where the reducing agent does not complex with the 
substrate. The reaction can be considered to proceed via the open- 
chain model as proposed by Felkin. 101 
Sodium bis(2-methoxyethoxy)aliminium hydride ("Vitride") 
9Sieh t-Bu 2 2 NnAlH2(OCH20CH1CH2OCH3)2 
Rý 2 
-78° / Toluene 
[tBUPh2SioH] 
1 
H 
` Rl 
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Nakata and co-workers97 achieved the above conditions by blocking 
the alcohol with a very bulky protecting group and using a metal 
hydride of low coordinating ability (Scheme 5.23). They found that 
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syn-selectivity was good except where the substituent adjacent to the 
protected alcohol function, R2, was methyl (Table 5.2). 
Table 5.2 
R1 R2 % Syn-selectivity 
Me pentyl 98 
Me i-Pr 96 
Me Ph 76 
Et Bu 93 
Pr Pr 86 
Bu Et 86 
pentyl Me 61 
i-Pr Me 46 
Ph Me 91 
Model reactions on racemic 2-hydroxycyclohexanone 
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(x-Hydroxyketones such as acetoin and 2-hydroxycyclohexanone 
(adipoin) form stable crystalline dieters thought to be of the 
structure (61)" The equilibrium favouring the monomer is established 
in water or polar protic solvents such as methanol or ethanol. If 
structure (61) is an accurate representation of the dimer then it is 
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necessary to regenerate the monomer before rection with a reducing 
agent can take place (Scheme 5.24). 
The reduction of 2-hydroxycyclohexanone dimer with sodium 
borohydride at room temperature was performed in water and a range of 
alcohols. The product mixtures were analysed by 
13C NMR. 
The 13C NMR signals of cis and trans cyclohexane-1,2-diol are 
widely separated. It was possible to assign the two sets of signals by 
comparison with the 
13C NMR spectrum of authentic trans- 
cyclohexane-1,2-diol. This was synthesised by reaction of cyclohexene 
with aqueous hydrogen peroxide (Scheme 5.25). 
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Of the reductions attempted the only selectivity observed was 
when isopropanol was used as solvent (Table 5.3). Even in this case 
the selectivity was poor, only 60% of the trans isomer being formed. 
Table 5.3 
Solvent % trans isomer 
water 50 
-methanol 50 
ethanol 50 
isopropanol 60 
The use of zinc borohydride or the aluminium hydrides requires 
the use of anhydrous aprotic solvents, such as ether or 
tetrahydrofuran, not conducive to the de-dimerisation of 
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CY-hydroxyketone dimers. Solutions of monomeric acyclic 
a-hydroxyketones in ether can be obtained by continuous ether 
extraction of aqueous solutions in which the monomer-dimer equilibrium 
has been established. This cannot be done with tetrahydrofuran. 
The 2-hydroxycyclohexanone monomer-dimer equilibrium in ether 
proved to be heavily in favour of the insoluble dimer. It was not 
possible to generate the monomer in solution in ether except at a very 
low concentration. 
The dimer, suspended in ether, was treated with lithium aluminium 
hydride at -78°C. A mixture of the cis and trans diols was obtained. 
There was a small excess of the cis isomer (60% of the mixture). 
Of the reductions attempted above, none was of sufficient 
stereospecificity to be useful synthetically. 
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INTRODUCTION TO EXPERIMENTAL CHAPTERS 
References are given to known compounds as they appear. Where 
possible data are compared. 
The experimental data are presented in the format approved by the 
journal Synthesis. Elemental analyses are quoted in the style used by 
the Chemical Society. 
Nuclear magnetic resonance spectra were recorded using the 
instruments listed below operating at the frequencies given in the 
table. 
Spectrometer Frequency / MHz 
1H 2H 13C 
Bruker WH 400 400.13 61.41 100.62 
Bruker AC 250 62.90 
Perkin-Elmer R34 220 
Bruker WH 180 45.28 
Bruker WH 90 22.63 
Chemical shifts are quoted in ppm from tetramethylsilane as 
internal reference unless otherwise stated. 
Mass spectra were recorded using a Kratos MS 80 spectrometer. 
Infra red spectra were recorded using a Perkin-Elmer 580-B 
spectrophotometer. 
Optical rotations were recorded using an Optical Activity LTD 
AA-1000 polarimeter. Rotations were measured at 589 nm in a2 dm path 
length cell. 
Vibrational infra red circular dichroism spectra were recorded by 
Dr A. F. Drake, Birkbeck College, London, using an own-built 
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spectrometer (Drake, A. F., J. Phys. E. Sci. Instrum., 1986,19,170). 
Measurements were performed for solutions in carbon tetrachloride. 
Melting points were determined using a Gallenkamp apparatus and 
are quoted uncorrected. 
Gas-liquid chromatographic analysis was performed using a Pye 204 
gas chromatograph. The columns used were 6 feet in length. Nitrogen 
was used as carrier gas at a flow rate of 30 ml/minute. 
High pressure liquid chromatography was performed using a Gilson 
system comprising the following components; a model 302 piston pump, a 
model 802C manometric module and aHM holochrome UV/Vis detector. 
pH-Stat experiments were performed using a Radiometer Copenhagen 
RTS882 recording titration system. 
Thin-layer chromatography was performed on Merck Kieselgel F254 
0.2 mm precoated plates. Spot detection was by UV fluorescence 
quenching, exposure to iodine vapour, potassium manganate spray or 
phosphomolybdic acid/ethanol spray. 
Flash chromatography was performed on Merck Kieselgel 60 silica 
gel (230-400 mesh). Approximately 100 g of silica gel was used per g 
of compound. The flow of solvent through the column was assisted by 
compressed air such that the solvent front moved at approximately 
4 cm/minute. 
All solvents were distilled. 
Ether refers to diethyl ether. 
Petrol refers to the petroleum fraction boiling in the range 
40-600C. 
94 
CHAPTER 6 
Prepartion of the dioxostannolan of dl-mandelic acid 
dl-Mandelic acid (6.573 g, 43 mmol) and dibutyl tin oxide (10.785 
g, 43.3 mmol) were heated together in boiling toluene (200 ml) for 
3.5 h with azeotropic removal of water using a Dean-Stark apparatus. 
The solvent was evaporated under reduced pressure and the residue was 
crystallized from chloroform to give the dioxostannolan as a white 
crystalline solid (11.916 g, 72%), mp 185-187°C. This was 
recrystallised from chloroform-benzene to a constant melting point of 
194-196°C. 
1H NMR, 220 MHz (CDC13/TMS): 6m 0.4-2.0 (complex, 18 H, butyl); 5.06 
(d, 1 H, J=7 Hz, PhCH); 7.3 ppm (complex, 5 H, Ph). 
IR (nujol mull): )i - 1640(sh), 1615 cm-1. 
MS (EI): m/z= 383(M)t, 177(SnBu)+, 105(PhCO)+, 91(PhCH2)+. 
Oxidation of dl-mandelic acid 
dl-Mandelic acid (1.972 g, 12.97 mmol) and dibutyl tin oxide 
(3.315 g, 13.3 mmol) were heated together in boiling benzene (170 ml) 
for 40 h with azeotropic removal of water using a Dean-Stark 
apparatus. The solvent was evaporated under reduced pressure/40°C to 
give the crude dioxostannolan as a white crystalline solid. This was 
suspended in dry dichloromethane (30 ml) and the flask flushed with 
nitrogen. Bromine (0.7 ml, 12.0 mmol) was added dropwise with stirring 
over 3 minutes. A deep red homogeneous solution formed which was set 
aside, in the dark, at room temperature. Decolourisation was complete 
after 3 days. The solvent was evaporated under reduced pressure/30°C 
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and the residue was applied to a short silica column (60-120 mesh, 10 
g) and eluted successively with carbon tetrachloride (450 ml) and 
ethyl acetate (400 ml). The ethyl acetate was evaporated under reduced 
pressure/40°C to give the crude keto acid as an oil (1.645 g, 11.0 
mmol, 84%). This was dissolved in 2.5 M sulphuric acid (100 ml) and 
added to a solution of 2,4-dinitrophenylhydrazine (3 g in 2.5 M 
sulphuric acid (250 ml)). The 2,4-dinitrophenylhydrazone was filtered 
off and recrystallised to a constant melting point of 197-197.50C from 
ethanol. Lit-102 mp 196-197°C. 
2-hydroxy-2-phenylethanoic acid: 
1H NMR, 220 MHz (CDC13/TMS): 6- 7.55 (m, 2 H, ortho CH); 7.73 (m, 1 H, 
para CH); 8.35 (m, 2 H, meta CH); 9.0 ppm (bs, 1 H, CO2H). 
2,4-dinitrophenylhydrazone: 
1H 
NMR, 220 MHz (d6DMSO/TMS): 6= 7.46 (complex, 3 H, meta+para Ph); 
7.79 (m, 2 H, ortho Ph); 8.16 (d, 1 H, J=9.8 Hz, NHCCHCH); 8.43 
(dd, 1 
H, J=9.8,2.7 Hz, NHCCHCH); 8.97 (d, 1 H, J=2.7 Hz, NO2CCHCNO2); 14.00 
ppm (s, 1 H, COOH). 
IR (film): Y = 3200,3100,1680,1615,1595,1505,1340 cm 
1. 
MS (EI): m/z= 330(M)t, 286(M-C02):, 103(PhCN). 
High resolution MS: C14H10N406, calc. 330.0601, found 330.0592. 
Elemental analysis: Found: C, 50.91; H, 3.03; N, 16.97. C14H10N406 
requires C, 50.37; H, 2.93; N, 16.55. 
Oxidation of racemic 2-hydroxy-3-methylbutanoic acid 
Racemic 2-hydroxy-3-methylbutanoic acid (1.006 g, 8.5 mmol) and 
dibutyl tin oxide (2.143 g, 8.6 mmol) were heated together in boiling 
benzene (100 ml) for 5.5 h with azeotropic removal of water using a 
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Dean-Stark apparatus. The benzene was evaporated under reduced 
pressure/40°C to give a glass. This was suspended in dichioromethane 
(30 ml) under nitrogen. Bromine (0.45 ml, 8.8 mmol) was added in one 
portion and the mixture was stirred in the dark for 20 h. The 
colourless solution was evaporated under reduced pressure/40°C to give 
the impure keto acid as a yellow oil. This was suspended in 3M 
sulphuric acid (100 ml) and filtered into a solution of 2,4- 
dinitrophenyihydrazine (1.8 g) in 3M sulphuric acid (100 ml). The 
precipitate was filtered off to give the 2,4-dinitrophenylhydrazone as 
a yellow solid (1.07 g, 3.6 mmol, 43%). This was recrystallised from 
ethanol-petrol to give a yellow crystalline solid mp 145-146°C. 
Lit-103 mp 191-192°C. 
1H NMR, 220 MHz (d6-DMSO/TMS): 6= 1.24 (d, 6 H, J=6.7 Hz, CH(CH3)2); 
3.14 (m, 1 H, CH(CH3)2); 5.60 (bs, 1 H, NH); 8.15 (m, 1 H, NHCCH); 
8.46 (m, 1 H, NHCCHCH); 9.0 (m, 1 H, NO2CCHCNO2); 13.55 ppm (s, 1 H, 
CO2H). 
IR (film): ))= 1705,1625,1595 cm 
1. 
MS (EI): m/z= 296(M):, 183(C6H5N304)+. 
High resolution MS: C11H12N406, calc. 296.0757, found 296.0753. 
Attempted oxidation of 2-hydroxybutanoic acid and 2-hydroxypropanoic 
acid. 
Treatment of these two hydroxy acids with dibutyl tin oxide and 
bromine as before led to recovery of starting material and no 
isolation of keto acids. 
97 
Methylation of 2-hydroxy-3-methylbutanoic acid 
To a solution of 2-hydroxy-3-methylbutanoic acid (4.027 g, 34 
mmol) in ether (100 ml) was added a solution of diazomethane 
(generated from "Diazald") in ether dropwise until a yellow 
colouration persisted. A few drops of glacial ethanoic acid were added 
to discharge the colour. The solution was dried (MgSO4) and evaporated 
under reduced pressure/20°C to give the volatile methyl ester as a 
pale yellow oil (4.339 g, 97%). (Lit-104 bp 62-63°C/15 mmHg). 
1H NMR, 220 MHz (CDC13/TMS): $=0.87 (d, 3 H, J-6.7 Hz, CCH3); 1.03 
(d, 3 H, J=6.7 Hz, CCH3); 2.08 (m, 1 H, CH); 2.80 (bs, 1 H, OH); 3.81 
(s, 3 H, OCH3); 4.07 ppm (d, 1 H, J=4 Hz, CHOH). 
IR (film): V= 3480,1730 cm 1. 
MS (+ve CI, ammonia): m/z= 150(M+18)+, 133(M+1)+. 
High resolution MS: C6H13030 (M+H), calc. 133.0864, found 133.0859. 
Methyl 3-bromo-3-methyl-2-oxobutanoate 
N-Bromosuccinimide (10.6 g, 59.6 mmol) and methyl 2-hydroxy-3- 
methylbutanoate (3.855 g, 29.2 mmol) were heated together in boiling 
carbon tetrachloride (70 ml) under nitrogen for 7 h. The mixture was 
cooled (ice bath), filtered and evaporated under reduced 
pressure/35°C. The residue was distilled in a Kugelrohr apparatus 
(100°C/15 mmHg) to give a pale yellow oil (5.062 g, 24.2 mmol, 83%). 
1H NMR, 220 MHz (CDC13/TMS): 6- 2.02 (s, 6 H, C(CH3)2); 3.93 ppm (s, 3 
H, OCH3). 
13C NMR, 22.64 MHz (CDC13; CDC13-b77.0 ppm): 6- 29.4 (C(CH3)2); 52.7 
(CBr); 60.7 (OCH3); 162.5 (CO2CH3); 190.0 ppm (CO). 
IR (film): Ü - 1745,1720 cm-1. 
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MS (EI): m/z= 208,210(M)t. 
High resolution MS: C6H9BrO3, calc. 207.9711, found 207.9738. 
GLC (10% SE30,120°C); R. r= 370s (100%). 
Elemental analysis: Found: C, 34.42; H, 4.40; Br, 38.11. C6H9BrO3 
requires C, 34.45; H, 4.31; Br, 38.28%. 
3-Bromo-3-methyl-2-oxobutanoic acid 
N-Bromosuccinimide (4.540 g, 25,5 mmol) and 2-hydroxy-3- 
methylbutanoic acid (1.496 g, 12.7 mmol) were heated together in 
boiling carbon tetrachloride (40 ml) under nitrogen for 2.25 h. The 
mixture was filtered and evaporated under reduced pressure/35°C to 
give a pale yellow oil (2.564 g, crude yield 103%). 
1H NMR, 220 MHz (CDC13/TMS): b- 2.06 (s, 6 H, C(CH3)2); 9.40 ppm (bs, 
1 H, CO2H). Succinimide impurity b- 2.83 ppm (s). Lit. 2 (CDC13/TMS) 6'0 
2.08 (s), 9.91 ppm (s). 
IR (film): 1) = 1715(b) cm 1. 
MS (EI): m/z= 197,195(M+I):, 151,149(M-OEt)+ 
High resolution MS: C5H7BrO3, cale. 193.9578, found 193.9589. 
Estimated purity by 
1H NMR, 90%. Corrected yield, 93%. 
Attempted coupling-of 3-bromo-3-methyl-2-oxobutanoic acid and glycine 
methyl ester using dicyclohexyl carbodiimide 
To a stirred suspension of 3-bromo-3-methyl-2-oxobutanoic acid 
(350 mg, 1.5 mmol) and glycine methyl ester hydrogen chloride (432 mg, 
3.43 mmol) in dichloromethane (10 ml) was added triethylamine (0.47 
ml, 3.4 mmol). To the resulting homogeneous solution was added, in one 
portion, dicyclohexyl carbodiimide (370 mg, 1.8 mmol). A white 
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precipitate formed after 5 minutes. After 7h the mixture was filtered 
and the solid was washed with dichloromethane (20 ml). The 
dichloromethane was washed with 2M hydrochloric acid (50 ml). The 
aqueous layer was back-extracted with dichloromethane (4x50 ml). The 
combined dichloromethane portions were dried (MgSO4) and evaporated 
under reduced pressure to give a pale yellow gum (669 mg). Analysis by 
1H NMR indicated none of the desired amide. 
Coupling of 3-bromo-3-methyl-2-oxobutanoic acid and glycine methyl 
ester using EEDQ 
A flask was charged with a magnetic follower, glycine methyl 
ester hydrogen chloride (128 mg, 1.01 mmol) and ethyl 1,2-dihydro-2- 
ethoxy-l-quinolinecarboxylate (EEDQ) (216 mg, 1.06 mmol), fitted with 
a subs seal stopper and flushed with nitrogen. To this was added, via 
syringe, dichloromethane (10 ml) and triethylamine (0.145 ml, 1.04 
mmol). After 2 minutes 3-bromo-3-methyl-2-oxobutanoic acid (90%, 259 
mg, 1.1 mmol) in dichloromethane (10 ml) was added to the homogeneous 
solution with stirring. A white precipitate formed and redissolved 
after a further 1h at room temperature. After 20 h the solvent was 
evaporated under reduced pressure/350C. The residue was suspended in 
ethyl acetate (30 ml), filtered and washed with saturated aqueous 
sodium hydrogen carbonate (10 ml). The aqueous phase was back- 
extracted with ethyl acetate (2x20 ml). The combined organic portions 
were washed with 1M hydrochloric acid (20 ml) and the aqueous phase 
back-extracted with ethyl acetate (2x10 ml). The combined organic 
portions were dried (MgSO4) and evaporated under reduced pressure/40°C 
and the residue was co-evaporated under reduced pressure with carbon 
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tetrachloride (20 ml) to give a white crystalline solid (231 mg, 86%). 
This was subjected to flash chromatography eluting with ethyl acetate- 
petrol 3: 7. The amide, RF 0.22 was isolated as a white crystalline 
solid (129 mg, 48%), mp 79-81°C. 
1H NMR, 220 MHz (CDC13/TMS): 6- 2.09 (s, 6 H, C(CH3)2); 3.82 (s, 3 H, 
OCH3); 4.13 (d, 2 H, J=5.8 Hz, NHCH2); 7.44 ppm (bs, 1 H, NH). 
IR (nujol mull): )/- 3330,1750,1715,1695,1675,1540 cm 
1. 
MS (+ve CI, ammonia): m/z- 283,285(M+18)+, 266,268(M+1)+. 
High resolution MS: C8H13BrNO4, (M+H), calc. 268.0007, found 268.0012. 
Elemental analysis: Found C, 36.29; H, 4.45; N, 4.80; Br, 28.47. 
C8H12BrNO4 requires C, 36.09; H, 4.51; N, 5.26; Br, 30.07%. 
Reaction of 3-bromo-3-methyl-2-oxobutanoic acid with benzylamine 
To a stirred solution of benzylamine (338 mg, 3.16 mmol) in 
dichloromethane (2 ml) under nitrogen was added 3-bromo-3-methyl-2- 
oxobutanoic acid (250 mg, 90%, 1.08 mmol) dissolved in dichloromethane 
(3 ml). A white precipitate formed rapidly. After 2h the reaction 
mixture was diluted with dichloromethane (10 ml) and washed with 1M 
hydrochloric acid (30 ml) and saturated sodium hydrogen carbonate 
solution (30 ml). The aqueous layers were separately back-extracted 
with dichloromethane (3x15 ml). The combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure/40°C to give a white gum 
(70 mg). This was subjected to flash chromatography eluting with ethyl 
acetate-petrol 1: 1. The benzylamide, RF 0.3 was isolated as a white 
crystalline solid (49 mg, 0.28 mmol, 26%). mp 91-92°c. The mp was 
unchanged on recrystallisation from water. 
1H NMR, 220 MHz (CDC13/TMS): 6- 1.16 (d, 6 H, J=6.7 Hz, C(CH3)2); 2.39 
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(septuplet, 1 H, J=6.7 Hz, CH); 4.42 (d, 2 H, J=5.3 Hz, PhCH2); 6.05 
(bs, 1 H, NH); 7.30 ppm (complex, 5H, Ph). 
IR (nujol mull): V = 3290,3070,1640,1545 cm 1. 
MS (EI): m/z= 177(M):. 
High resolution MS: C11H15NO, calc. 177.1154, found 177.1155. 
Elemental analysis: Found: C, 74.60; H, 8.86; N, 8.01. C11H15NO 
requires C, 74.58; H, 8.47; N, 7.91%. 
Methylation of 3,3-dimethyl acrylic acid (a) 
Acetyl chloride (60 ml, 0.844 mol) was added to dry methanol (150 
ml) at 0°C. To this was added 3,3-dimethyl acrylic acid (80.6 g, 0.805 
mol). The mixture was stirred at 40-50°C for 3.5 h to give a 
homogeneous solution. This was set aside at room temperature for 12 h. 
Fractions boiling up to 65°C were removed by distillation. The 
remaining solution formed two layers. The upper layer was removed and 
distilled at 135-138°C at atmospheric pressure (Lit. 
105 bp 136°C) to 
give the methyl ester as a colourless liquid (55.973 g, 0.49 mol, 
61%). 
1H NMR, 220 MHz (CDC13/TMS): 5"m 1.90 (s, 3 H, CCH3); 2.18 (s, 3 H, 
CCH3); 3.69 (s, 3 H, OCH3); 5.70 ppm (m, 1 H, CH). 
IR (film): )I = 1725,1665 cm 
1. 
MS (EI): m/z= 114 (M);. 
Methylation of 3,3-dimethyl acrylic acid (b) 
3,3-Dimethyl acrylic acid (32.419 g, 0.324 mol) was dissolved in 
dry methanol (400 ml). Concentrated sulphuric acid (1 ml) was added 
and the solution was boiled for 19 h. The bulk of the methanol was 
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distilled off at atmospheric pressure. The residue was dissolved in 
dichloromethane (50 ml). The solution was washed with 5% sodium 
hydrogen carbonate solution (2x50 ml) and distilled at atmospheric 
pressure. The ester was collected at 130-134°C as a colorless oil 
(21.393 g, 0.188 mol, 58%). 
Dihydroxylation of methyl 3,3-dimethylacrylate 
To a solution of methyl 3,3-dimethylacrylate (3.670 g, 32.2 mmol) 
in 98% formic acid (20 ml) was added a 30% solution of hydrogen 
peroxide in water (5 ml, 48 mmol). The solution was maintained at 40°C 
for 20 h. The solvents were evaporated under reduced pressure, the 
residue treated with toluene (30 ml) and again evaporated under 
reduced pressure. The crude diol was subjected to flash chromatography 
eluting with ethyl acetate-petrol 1: 1. The diol ester, 
106 RF 0.2, was 
isolated as a colourless oil (2.907 g, 19.6 mmol, 61%). 
1H NMR, 220 MHz (CDC13/TMS): 6 = 1.22 (s, 3 H, CCH3); 1.30 (s, 3 H, 
CCH3); 2.58 (bs, I H, OH); 3.19 (bs, 1 H, OH); 3.86 (s, 3 H, OCH3); 
4.01 ppm (d, 1H, J=8 Hz, CH). 
IR (film): V = 3460,1735 cm 1. 
MS (+ve CI, ammonia): m/z- 166(M+18)+, 149(M+1)+. 
GLC (3% SE30,90°C); RT= 231s, (100%). 
Oxidation of methyl 2,3-dihydroxy-3-methylbutanoate using 
N-bromosuccinimide 
A stirred suspension of N-bromosuccinimide (2.973 g, 16.7 mmol), 
calcium carbonate (1.68 g, 16.8 mmol) and methyl 2,3-dihydroxy-3- 
methylbutanoate (1.900 g, 12.8 mmol) in carbon tetrachloride (26 ml), 
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under nitrogen, was heated and illuminated by means of a NOW tungsten 
lamp. The temperature of the reaction mixture stabilised at 50°C. 
After 5 minutes a deep red colouration developed which disappeared 
over a5h period. The mixture was cooled (ice bath), flitered and the 
residue was washed with carbon tetrachloride (50 ml). The combined 
carbon tetrachloride portions were evaporated under reduced pressure. 
The residue was distilled in a Kugelrohr apparatus (120°C/10 mmHg) to 
give methyl 3-hydroxy-3-methyl-2-oxobutanoate as a pale yellow oil 
(1.604 g, 10.99 mmol, 86%). 
1H NMR, 220 MHz (CDC13/TMS): 6- 1.53 (s, 6 H, C(CH3)2); 2.65 (bs, 1 H, 
OH); 3.92 ppm (s, 3 H, OCH3). 
IR (film): l1 - 3500,1740(sh), 1730 cm 
1. 
MS (+ve CI, ammonia): m/z- 164(M+18)+. 
GLC (10% SE30,110°C); RT= 262s. 
Attempted oxidation of methyl 2,3-dihydroxy-3-methylbutanoate using 
N-bromosuccinimide (a) 
A stirred suspension of N-bromosuccinimide (7.870 g, 44.2 mmol), 
calcium carbonate (4.417 g, 44.1 mmol) and methyl 2,3-dihydroxy-3- 
methylbutanoate (6.520 g, 44.0 mmol) in carbon tetrachloride (150 ml) 
was heated at 60-70°C for 40 minutes under nitrogen. The mixture was 
cooled (ice bath), filtered and the residue was washed with cold 
dichloromethane (5x10 ml). The combined solutions were evaporated 
under reduced pressure. The residue was subjected to flash 
chromatography eluting with ethyl acetate-petrol 2: 5. Methyl 3- 
hydroxy-3-methyl-2-oxobutanoate, RF 0.53, was isolated as a colourless 
oil (1.925 g, 30%). 
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Attempted oxidation of methyl 2,3-dihydroxy-3-methylbutanoate using 
N-bromosuccinimide (b) 
To a cooled (ice bath) solution of methyl 2,3-dihydroxy-3- 
methylbutanoate (1.062 g, 7.2 mmol) in dioxane (16 ml) and water (1.6 
ml) was added N-bromosuccinimide (1.311 g, 7.36 mmol). The mixture was 
allowed to warm to room temperature. The resulting orange homogeneous 
solution was set aside at room temperature for 24 h and heated for 2h 
at 40-60°C. 2M Hydrochloric acid (10 ml) was added and the solution 
was extracted with ethyl acetate (4x30 ml). The combined extracts were 
dried (MgSO4) and evaporated under reduced pressure. The residue was 
subjected to flash chromatography eluting with dichloromethane to give 
methyl 3-hydroxy-3-methyl-2-oxobutanoate as a pale yellow oil (446 mg, 
42%). This was distilled using a Kugelrohr apparatus (150°C/15 mmHg) 
to give a pale yellow oil (277 mg, 26%). 
Attempted oxidation of methyl 2,3-dihydroxy-3-methylbutanoate using 
pyridinium chorochromate60 
A solution of methyl 2,3-dihydroxy-3-methylbutanoate (1.427 g, 
9.6 mmol) in dichloromethane (10 ml) was added to a stirred suspension 
of pyridinium chlorochromate (3.235 g, 15.0 mmol) in dichloromethane 
(10 ml). A black precipitate formed. After 1.5 h dry ether (25 ml) was 
added and the supernatant liquor was decanted. The black solid residue 
was washed with ether (3x15 ml) and the combined ether-dichloromethane 
portions were filtered through florisil. Evaporation of the solvent 
under reduced pressure gave a colourless oil (159 mg). Proton NMR 
spectroscopy indicated a very complex mixture. 
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Attempted oxidation of methyl 2,3-dihydroxy-3-methylbutanoate using 
Jones reagent61 
Concentrated sulphuric acid (23 ml) was added to a slurry of 
chromium trioxide (26.77 g, 0.268 mol) in water (20 ml) and diluted to 
a total volume of 100 ml with water. 
Methyl 2,3-dihydroxy-3-methylbutanoate (973 mg, 6.57 mmol) was 
dissolved in acetone (20 ml). The chromic acid solution (2.1 ml, 5.63 
mmol) was added dropwise. A dark green precipitate formed. Water (10 
ml) was added, the supernatant liquor decanted and extracted with 
ethyl acetate (4x40 ml). The combined extracts were dried (MgSO4) and 
evaporated under reduced pressure to give a green oil. This was 
dissolved in ether and eluted through florisil with ether. The 
solution was evaporated under reduced pressure to give methyl 3- 
hydroxy-3-methyl-2-oxobutanoate as a pale yellow oil (324 mg, 2.2 
mmol, 34X) 
Attempted oxidation of methyl 2,3-dihydroxy-3-methylbutanoate via 
brominolysis of the dioxostannolan deivative 
Methyl 2,3-dihydroxy-3-methylbutanoate (1.205 g, 8.14 mmol) and 
dibutyl tin oxide (2.075 g, 8.34 mmol) were heated together in boiling 
benzene for 8h using a Dean-Stark apparatus for the azeotropic 
removal of water. The benzene was evaporated under reduced pressure 
and the solid residue was suspended in dichloromethane (10 ml). 
Bromine (0.45 ml, 8.77 mmol) was added dropwise to the stirred 
mixture. The deep red solution was set aside at room temperature for 
12 h. The solvent was evaporated under reduced pressure, the oily 
residue was dissolved in carbon tetrachloride (2 ml) and applied to a 
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silica gel column (10 g, 60-120 mesh). The column was. eluted 
sequentially with carbon tetrachloride (700 ml) and ethyl acetate (250 
ml). The ethyl acetate portion was evaporated under reduced pressure 
to give a colourless oil (608 mg). Proton NMR indicated the presence 
of starting material, methyl 3-hydroxy-3-methyl-2-oxobutanoate and 
methyl 2-hydroxy-2-methyl-3-oxobutanoate in approximately equal 
amounts. The spectral data for these compounds are given pages 104 and 
113 respectively. 
Attempted tosylation of methyl 3-hydroxy-3-methyl-2-oxobutanoate (a). 
Toluene-4-sulphonyl chloride (1.486 g, 7.8 mmol) was added to a 
cooled (ice bath) solution of methyl 3-hydroxy-3-methyl-2-oxobutanoate 
(1.035 g, 7.1 mmol) in dry pyridine (10 ml). The homogeneous solution 
was set aside at room temperature for 48 h. The pyridine was 
evaporated at high vaccuum/15°C. The residue was dissolved in 
chloroform (30 ml). The solution was washed with 1M hydrochloric acid 
(8x25 ml), dried (MgSO4) and evaporated under reduced pressure to give 
toluene-4-sulphonyl chloride (968 mg) as identified by proton NMR. 
Attempted tosylation of methyl 3-hydroxy-3-methyl-2-oxobutanoate (b). 
To a stirred suspension of sodium hydride (80% dispersion in oil, 
140 mg, 4.7 mmol) in 1,2-dimethoxyethane (DME) (5 ml) under nitrogen 
was added dropwise, over 5 minutes, a solution of methyl 3-hydroxy-3- 
methyl-2-oxobutanoate (592 mg, 4.05 mmol) and toluene-4-sulphonyl 
chloride (798 mg, 4.18 mmol) in DME (10 ml). The mixture was stirred 
vigorously for 20 minutes. Water (20 ml) was added and the solution 
was extracted with dichloromethane (5x30 ml). The combined extracts 
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were dried (MgSO4) and evaporated under reduced pressure/30°C to give 
a yellow oil. Proton NMR indicated the presence of a very complex 
mixture. 
Attempted mesylation of methyl 3-hydroxy-3-methyl-2-oxobutanoate 
To a cooled solution (ice bath) of methyl 3-hydroxy-3-methyl-2- 
oxobutanoate (1.024 g, 7.0 mmol) and triethylamine (1 ml, 7.2 mmol) in 
dry dichloromethane (20 ml) was added methane sulphonyl chloride (0.6 
ml, 7.5 mmol) with stirring. The solution was maintained at 0°C for 30 
minutes and allowed to attain room temperature over 2 h. The solution 
was washed with 1M hydrochloric acid (2x30 ml). The washings were 
back-extracted with dichloromethane (2x20 ml). The combined 
dichloromethane portions were dried (MgSO4) and evaporated under 
reduced pressure to give a brown oil. Proton NMR indicated the 
presence of a very complex mixture. 
Attempted bromination of methyl 3-hydroxy-3-methyl-2-oxobutanoate 
To a solution of methyl 3-hydroxy-3-methyl-2-oxobutanoate (1.190 
g, 8.15 mmol) in dry tetrahydrofuran (THF) (10 ml) was added carbon 
tetrabromide (5.440 g, 16.4 mmol) and triphenylphosphine (4.278 g, 
16.3 mmol) with cooling from an ice bath. THE (20 ml) was added, the 
mixture stirred overnight at room temperature, filtered and evaporated 
under reduced pressure. The residue comprised a very complex mixture 
of compounds, as judged by proton NMR. 
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CHAPTER 7 
Incubation of methyl 3-bromo-3-methyl-2-oxobutanoate with pig liver 
esterase 
To water at 32°C was added a methanolic solution of methyl 3- 
bromo-3-methyl-2-oxobutanoate (100 . 1,79 mg/5 ml, 7.6 jk mol). The pH 
was maintained at 7.2 by delivery of sodium hydroxide (107 mM) from an 
autotitrator. A rapid uptake of alkali (0.07 ml, 7.5 1& mol) was 
observed. After 1 minute PLE (12 r1,5 mg/ml, 8 units) was added and 
the pH was maintained at 7.2 as before. After a period of incubation 
aqueous ethyl butyrate (10 ml, 12.1 mM, 0.121 mmol) was added and the 
rate of hydrolysis was recorded by the uptake of alkali from the 
autotitrator at pH 7.2. The initial rate of hydrolysis of the ethyl 
butyrate was taken as a measure of the activity of the PLE. 
Incubation time 
(minutes) 
Observed activity 
(rmol EB/minute) 
% of maximum 
activity 
1 1.0 7 
5 1.2 9 
14 1.1 8 
152 1.3 9 
294 2.1 15 
1200 7.1 50 
1530 6.3 45 
2430 6.4 45 
EB = ethyl butyrate 
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Two control experiments were performed exactly as above: 
a) pure methanol used in place of the methanolic methyl 3- 
bromo-3-methyl-2-oxobutanoate. 
b) as (a) but using 1.13 mM sodium bromide solution in place 
of the water. 
The same initial rate of hydrolysis of ethyl butyrate, 14.1 
mol/minute, was observed for both control experiments (a) and (b). 
Hydrolysis of methyl 3-bromo-3-methyl-2-oxobutanoate followed by 
proton NMR spectroscopy 
To 1M pH 7.2 phosphate buffer (0.5 ml) in an NMR tube was added 
a solution of methyl 3-bromo-3-methyl-2-oxobutanoate (14 mg, 0.07 
mmol) in d4-methanol (50 Al). The proton NMR spectrum was determined 
immediately. Signals attributable to methyl 3-hydroxy-3-methyl-2- 
oxobutanoate alone were observed. After 10 minutes PLE (20 pl, 5 
mg/ml, 13 units) was added and the solution incubated at 32°C. The 
proton NMR spectrum was determined periodically. Hydrolysis of the 
methyl ester was complete after 2 days. 
Methyl 3-hydroxy-3-methyl-2-oxobutanoate: 
1H NMR, 220 MHz (H20/CH3OH = 63.26 ppm): $=1.16 (s, 6 H, C(CH3)2); 
3.75 ppm (s, 3 H, OCHS). 
3-Hydroxy-3-methyl-2-oxobutanoate: 
1H NMR, 220 MHz (H20/CH3OH = 63.26 ppm): b= 1.36 ppm (s, 6 H, 
C(CH3)2)" 
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CHAPTER 8 
Methyl 2,3-dihydroxy-2-methylbutanoate 
To a solution of methyl tiglate (3.013 g, 27.2 mmol) dissolved in 
98% formic acid (10 ml) was added an aqueous solution of hydrogen 
peroxide (30%, 4.5 ml, 44 mmol). The solution was maintained at 50°C 
for 16 h. The solvents were evaporated under reduced pressure/35°C and 
the residue co-evaporated with toluene (2x30 ml) under reduced 
pressure/35°C. The residue was subjected to flash chromatography 
eluting with ether-petrol 9: 1. The diol ester was obtained as a pale 
yellow oil RF (ether) 0.25 (2.682 g, 18.1 mmol, 67%). This was 
distilled in a Kugelrohr apparatus (140°C/10 mmHg) to give a 
colourless oil (2.497 g, 16.9 mmol, 62%). 
1H NMR, 220MHz (CDC13/TMS): 8= 1.16 (d, 3 H, J-7 Hz, CHCH3); 1.45 (s, 
3 H, CCH3); 2.24 (d, 1 H, J=8.5 Hz, CH(0H)); 3.43 (s, I H, C(OH)); 3.8 
ppm (complex, 4 H, CHCH3; OCHS). 
IR (film): V = 3475,1735 cm-1. 
MS (+ve CI, ammonia): m/z= 166(M+18)+, 149(M+1)+. 
GLC (10% SE30,100°C); RT= 490 s (100%). 
Methyl 2-hydroxy-2-methyl-3-oxobutanoate (a) 
Methyl 2,3-dihydroxy-2-methylbutanoate (515 mg, 3.5 mmol), 
calcium carbonate (370 mg, 3.7 mmol) and N-bromosuccinimide (640 mg, 
3.6 mmol) were stirred together in dry carbon tetrachloride (10 ml) 
under nitrogen for 2h with illumination and heat from a 100 W 
tungsten lamp. The mixture was filtered and the solid washed with 
carbon tetrachloride (20 ml). The combined carbon tetrachloride 
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portions were evaporated under reduced pressure to give the crude 
methyl 2-hydroxy-2-methyl-3-oxobutanoate (404 mg, 2.8 mmol 79%). This 
was distilled in a Kugelrohr apparatus (130°C/10 mmHg) to give a very 
pale yellow oil (295 mg, 2.02 mmol, 58%). Its spectral data were 
consistent with its formulation as methyl 2-hydroxy-2-methyl-3- 
oxobutanoate (see next page). 
Methyl 2-hydroxy-2-methyl-3-oxobutanoate (b) 
Methyl 2,3-dihydroxy-2-methylbutanoate (661 mg, 4.5 mmol) and 
dibutyl tin oxide (1.128 mg, 4.5 mmol) were heated together in boiling 
benzene (100 ml) for 8.5 h with azeotropic removal of water using a 
Dean-Stark apparatus. The benzene was evaporated under reduced 
pressure/40°C and the residue was subjected to high vacuum for 20 h. 
The resulting brown oil was suspended in dichloromethane (10 ml). 
Bromine (0.24 ml, 4.7 mmol) was added dropwise with stirring. A deep 
red homogeneous solution formed which became decolourised after 15 h. 
The solution was evaporated under reduced pressure/30°C and applied to 
a silica gel column (60-120 mesh, 10 g). This was eluted successively 
with carbon tetrachloride (500 ml) and ethyl acetate (200 ml). The 
ethyl acetate was dried (MgSO4) and evaporated under reduced 
pressure/35°C to give the crude methyl 2-hydroxy-2-methyl-3- 
oxobutanoate as a pale yellow oil (600 mg, 4.1 mmol, 927). This was 
distilled in a Kugelrohr apparatus (130°C/10 mmHg) to give a 
colourless oil (455 mg, 3.1 mmol, 70%). Its spectral data were 
consistent with its formulation as methyl 2-hydroxy-2-methyl-3- 
oxobutanoate (see next page). 
112 
Oxidation of methyl tiglate with potassium manganate (VII) 
To a stirred solution of methyl tiglate (2.148 g, 18.8 mmol) and 
acetic acid (2.5 ml) in acetone (150 ml) and water at -10°C was added 
dropwise a solution of potassium manganate (VII) (6.5 g, 41 mmol) in 
acetone (130 ml) and water (50 ml). After stirring for 1h at -10°C, 
the mixture was filtered through celite and the acetone evaporated 
under reduced pressure/35°C. The aqueous solution was extracted with 
dichloromethane (3x60 ml). The combined extracts were dried (MgSO4) 
and evaporated under reduced pressure/30°C. The residue was co- 
evaporated with carbon tetrachloride (2x30 ml) under reduced 
pressure/30°C to give a colourless oil (2.314 g, 15.8 mmol, 84X). This 
was distilled in a Kugelrohr apparatus (120°C/12 mmHg) to give methyl 
2-hydroxy-2-methyl-3-oxobutanoate (2.195 g, 15.0 mmol, 80%). 
14 
The reaction was repeated on the same scale at a range of 
temperatures. 
Temperature/°C Yield/% 
50 38 
25 50 
20 67 
1H NMR, 220MHz (CDC13/TMS): 6- 1.63 (s, 3 H, C(OH)Ct3); 2.31 (s, 3 H, 
COCH3); 3.83 (s, 3 H, OCH3); 4.25 ppm (s, 1 H, OH). Lit. 
14 1.58 (s); 
1.23 (s); 3.78 (s); 4.18 ppm (s). 
13C NMR, 22.63 MHz (CDC13/CDC13 - 677.0 ppm): S = 21.4 (C(OH)CH3); 23.8 
(OCH3); 52.9 (COCH3); 80.8 (C(OH)); 171.6 (CO2CH3); 204.7 ppm (000H3). 
IR (film): )) = 3470,1750(sh), 1730 cm 
1. 
MS (+ve CI, ammonia): m/z= 164(M+18)+, 147(M+1)+. 
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High resolution MS: C6H1104, (M+H), calc. 147.0657, found 147.0656. 
GLC (3% SE30,80°C); RT= 270 s. 
Elemental analysis: Found: C, 49.25; H, 7.13. C6H10O4 requires C, 
49.31; H, 6.85%. 
Synthesis of 2-hydroxy-3-oxocarboxylic esters: general procedure; 
To a stirred soloution of the c 3-unsaturated ester 
(20 mmol) and 
acetic acid (7 ml) dissolved in water (90 ml) and acetone (300 ml), 
maintained at -10°C using an ice-salt bath, was added potassium 
manganate (VII) (5.5 g, 34.8 mmol) in portions such that the reaction 
temperature remained below -10°C. The mixture was stirred for 1h at 
-10°C. The black precipitate of manganese dioxide was filtered off 
through celite. The solid was washed with acetone (100 ml). The 
combined solutions were evaporated under reduced pressure/20°C to 
remove the acetone component. The aqueous solution was extracted with 
dichloromethane (4x100 ml). The combined extracts were dried (MgSO4) 
and evaporated under reduced pressure to furnish the crude ester which 
was purified by distillation in a Kugelrohr apparatus. 
The following 2-hydroxy-3-oxocarboxylic esters were synthesised 
as above. 
R1CH= 
RT 
CO2R3 
(32) 
R2 
R1 COyR3 
0 OH 
! 33) 
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Entry R1 R2 R3 Temp. 
/°C 
bp 
/°C/mmHg 
Yield 
/X 
33a14 Me Me Me -10 74-76/15 80 
33b Me Et Et -10 120/15 80 
33c Et Et Et -12 100/0.5 87 
33d Et Me Et -10 110/2 82 
33e Pr Me Et -10 80/0.25 70 
33f Bu Me Et -12 110/0.2 82 
33g t-Bu Me Et -12 90/0.5 80 
33h Ph Me Et -10 68 
33i p-N02Ph Me Et -10 mp 84-85°C 83 
33j p-MeOPh Me Et -10 86 
33k15 Me -12 120/0.2 62 
Ethyl 2-ethyl-2-hydroxy-3-oxobutanoate (33b) 
iH NMR, 220MHz (CDC13/TMS): bm0.87 (t, 3 H, J$7.3 Hz, C(OH)CH2CH3); 
1.30 (t, 3 H, OCH2CH3); 2.05 (m, 2 H, C(OH)CH2CH3); 2.27 (s, 3 H, 
COCH3); 4.15 (s, 1 H, OH); 4.28 ppm (q, 2 H, J=7.1 Hz, OCH2CH3). 
13C NMR, 22.63 MHz (CDC13/CDC13 -b 77.0 ppm): $-7.1 (C(OH)CH2CH3); 
13.8 (OCH2CH3); 24.4 (C(OH)CH2); 28.1 (COCH3); 62.2 (OCH2); 84.3 
(C(OH)); 170.8 (CO2CH2); 204.7 ppm (COCH3). 
IR (film): 1% - 3480,1750(sh), 1720 cm-'. 
MS (+ve CI, ammonia): m/z= 192(M+18)+, 175(M+I)+. 
High resolution MS: C8H1504, (M+H), calc. 175.0970, found 175.0975 
GLC (I0% SE30,120°C); RT= 430 s. 
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Elemental analysis: Found: C, 54.89; H, 8.36. C8H1404 requires C, 
55.16; H, 8.10%. 
Ethyl 2-ethyl-2-hydroxy-3-oxopentanoate (33c) 
1H NMR, 220MHz (CDC13/TMS): 5- 0.86 (t, 3 H, J=7.6 Hz, C(0H)CH2CH3); 
1.08 (t, 3 H, J=7.5 Hz, COCH2CH3); 1.30 (t, 3 H, J=7.1 Hz, OCH2CH3); 
2.05 (m, 2 H, C(OH)CH2); 2.65 (m, 2 H, COCH2), 4.25 ppm (complex, 3 H, 
OH, OCH2). 
13C NMR, 22.63 MHz (CDC13/CDC13 =6 77.0 ppm): 6= 7.2 (C(OH)CH2CH3, 
COCH2CH3); 14.0 (OCH2CH3); 28.3 (C(OH)CH2); 30.1 (CH2CO); 62.3 (OCH2); 
84.2 (C(OH)); 171.1 (CO2CH2); 207.7 ppm (COCH2). 
IR (film): V = 3480,1745,1720 cm-1. 
MS (EI): m/z= 188(M)t. 
High resolution MS: C9H1604, calc. 188.1049, found 188.1049. 
GLC (3% SE30,110°C); RT= 310 s. 
Elemental analysis: Found: C, 57.65; H, 8.81. C9H1604 requires C, 
57.45; H, 8.51%. 
Ethyl 2-hydroxy-2-methyl-3-oxopentanoate (33d) 
1H NMR, 220MHz (CDC13/TMS): $=1.09 (t, 3 H, J=7.5 Hz, COCH2CH3); 1.29 
(t, 3 H, OCH2CH3); 1.59 (s, 3 H, C(OH)CH3); 2.65 (m, 2 H, COCH2); 
4.25 ppm (complex, 3 H, OH, OCH2). 
13C NMR, 22.63 MHz (CDC13/CDC13 =b 77.0 ppm): $=7.4 (COCH2CH3); 13.6 
(OCH2CH3); 21.5 (C(OH)CH3); 29.5 (CH2CO); 62.1 (OCH2); 80.5 (C(OH)); 
171.4 (C02CH2); 207.4 ppm (COCH2). 
IR (film): V = 3475,1740(sh), 1725 cm-1. 
MS (EI): m/z= 174(M)t. 
High resolution MS: C8H14041 calc. 174.0892, found 174.0877. 
GLC (10% SE30,130°C); RT 340 s. 
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Elemental analysis: Found: C, 55.33; H, 8.18. C8H1404 requires C, 
55.17; H, 8.05%. 
Ethyl 2-hydroxy-2-methyl-3-oxohexanoate (33e) 
1H NMR, 220MHz (CDC13/TMS): B= 0.92 (t, 3 H, J=7.6 Hz, CH2CH2CH3); 
1.28 (t, 3 H, J=7.1 Hz, COCH2CH); 1.60 (complex, 5 H, C(OH)CH3, 
CH2Cý2CH3); 2.57 (m, 2 H, CH2CH2CH3); 4.25 ppm (complex, 3 H, OCH21 
OH). 
13C NMR, 22.63 MHz (CDC13/CDC13 = $77.0 ppm): 6= 13.2 (CH2CH2CH3); 
13.8 (OCH2C); 16.7 (CH2CH2CH3); 21.5 (C(OH)CH3); 38.0 (CH2CH2CH3); 
62.2 (OCH2); 80.7 (C(OH)); 171.4 (CO2CH2); 206.8 ppm (COCH2). 
IR (film): )/- 3470,1740(sh), 1720 cm-1. 
MS (EI): m/z= 188(M):. 
High resolution MS: C9H1604, caic. 188.1048, found 188.1034. 
GLC (10% SE30,140°C); RT= 390 s. 
Elemental analysis: Found: C, 57.26; H, 8.63. C9H1604 requires C, 
57.45; H, 8.51%. 
Ethyl 2-hydroxy-2-methyl-3-oxoheptanoate (33f) 
lH NMR, 220MHz (CDC13/TMS): 52"' 0.90 (t, 3 H, J=7.5 Hz, CH2CH2CH2CH3); 
1.28 (complex, 5 H, OCH2CH3, CH2CH2CH2CH3); 1.58 (complex, 5 H, 
C(OH)CH3, CH2CH2CH2CH3); 2.60 (m, 2 H, CH2CH2CH2CH3); 4.25 ppm 
(complex, 3 H, OCH21 OH) 
13C NMR, 22.63 MHz (CDC13/CDC13 = 677.0 ppm): $= 13.7 (OCH2CH31 
CH2CH2CH2CH3); 21.6 (CH2CH2CH2CH3); 21.9 (CH2CH2CH2CH3); 25.4 
(C(OH)CH3); 35.9 (000H2); 62.2 (OCH2); 80.7 (C(OH)); 171.3 (CO2CH2); 
206.9 ppm (COCH2). 
IR (film): Y s 3470,1740(sh), 1725 cm-'. 
MS (EI): m/z= 202(M):. 
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High resolution MS: C10H18041 calc. 202.1205, found 202.1196. 
GLC (3% SE30,130°C); RT= 260 s. 
Elemental analysis: Found: C, 50.10; H, 9.19. C10H1804 requires C, 
59.40; H, 8.91%. 
Ethyl 2-hydroxy-3-oxo-2,4,4-trimethylpentanoate (33g) 
1H NMR, 220MHz (CDC13/TMS): $=1.24 (s, 9 H, C(CH3)3); 1.29 (t, 3 H, 
J-7.1 Hz, OCH2CH3); 1.57 (s, 3 if, C(OH)CH3); 4.13 (s, 1 H, OH); 
4.26 ppm (q, 2 H, J-7.1 Hz, OCH2). 
13C 
NMR, 22.63 MHz (CDC13/CDC13 = 677.0 ppm): 6- 13.8 (COCH2CH3); 23.9 
(C(OH)CH3); 27.4 (C(CH3)3); 44.6 (C(CH3)3); 62.3 (OCH2); 80.7 (C(OH)); 
172.3 (CO2CH2); 210.5 ppm (COC(OH)). 
IR (film): )) = 3500,1740,1710 cm 1. 
MS (+ve CI, ammonia): m/z- 220(M+18)+, 203(M+1)+. 
High resolution MS: C10H18041 calc. 202.1205, found 202.1172. 
GLC (3% SE30,120°C); RT= 700 s. 
Elemental analysis: Found: C, 59.60; H, 9.27. C10H1804 requires C, 
59.40; H, 8.91%. 
Ethyl 2-hydroxy-2-methyl-3-oxo-3-phenylpropanoate (33h) 
Pale yellow oil isolated by flash chromatography eluting with ethyl 
acetate-petrol 1: 4 RF 0.37. 
1H 
NMR, 220MHz (CDC13/TMS): $=1.15 (t, 3 H, J=7.1 Hz, OCH2CH3); 1.74 
(s, 3 H, C(OH)Cn); 4.24 (q, 2 H, J=7.1 Hz, OCH2); 4.56 (bs, 1 H, OH); 
7.48 (m, 2 H, Ph); 7.61 (m, 1 H, Ph); 8.03 ppm (m, 2 H, Ph). 
13C NMR, 22.63 MHz (CDC13/CDC13 = 677.0 ppm): 6= 13.6 (OCH2CH3); 23.3 
(C(OH)CH3); 62.2 (OCH2); 79.5 (C(OH)); 128.4,129.3 (CHCHC(CO)CHCH); 
133.4 (CHCHCHCCO); 160.4 (COCCH); 172.3 (CO2CH2); 195.9 ppm (CO). 
IR (film): V = 3475,1740,1695,1600 cm-1. 
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MS (+ve CI, ammonia): m/z= 223(M+1)+. 
High resolution MS: C12H1504 (M+H), caic. 223.0971, found 223.0981. 
GLC (3% SE30,150°C); RT= 456 s (100%). 
Elemental analysis: Found: C, 64.68; H, 6.40. C12H1404 requires C, 
64.86; H, 6.31%. 
Ethyl 2-hydroxy-2-methyl-3-oxo-3-(4-nitrophenyl)-propanoate (331) 
Pale yellow solid recrystallised to constant melting point (84-85°C) 
from ethyl acetate-petrol. 
1H NMR, 220MHz (CDC13/TMS): 6= 1.19 (t, 3 H, J=7.1 Hz, OCH2CH3); 1.75 
(s, 3 H, CCH3); 4.27 (q, 2 H, J=7.1 Hz, OCH2); 8.26 ppm (complex, 4 H, 
Ar). 
13C NMR, 100.62 MHz (CDC13/CDC13 = 677.0 ppm): 6= 13.9 (OCH2CH3); 23.4 
(C(OH)CH3); 63.1 (OCH2); 80.0 (C(OH)); 123.6 (CHC(N02)C-H); 130.5 
(CHC(CO)CH); 138.7 (CHC(CO)CH); 150.2 (NO2C); 172.5 (CO2CH2); 
194.1 ppm (CO). 
IR (film): )) = 3480,3105,1745,1725,1695,1595 cm 1. 
MS (+ve CI, ammonia): m/z= 285(M+18)+, 268(M+1)+. 
High resolution MS: C12H17N2061 (M+NH4), calc. 285.1087, 
found 285.1050. 
Elemental analysis: Found: C, 53.84; H, 4.89; N, 5.32. C12H13NO6 
requires C, 53.93; H, 4.87; N, 5.24%. 
Ethyl 2-hydroxy-2-methyl-3-(4 methoxyphenyl)-3-oxopropanoate (33j) 
Pale yellow viscous oil isolated by flash chromatography eluting with 
ethyl acetate-petrol 1: 1 RF 0.46. 
1H NMR, 220MHz (CDC13/TMS): 6= 1.16 (t, 3 H, J=7.1 Hz, OCH2CH3); 1.74 
(s, 3 H, C(OH)CH3); 3.89 (s, 3 H, PhOCH3); 4.23 (q, 2 H, J-7 .1 Hz, 
OCH2); 4.69 (bs, 1 H, OH); 6.96 (m, 2 H, Ar); 8.04 ppm (m, 2 H, Ar). 
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13C NMR, 22.63 MHz (CDC13/CDC13 = 577.0 ppm): 8- 13.7 (OCH2CH3); 23.6 
(C(OH)CH3); 55.4 (OCH3); 62.1 (OCH2); 79.2 (C(OH)); 113.7 
(CHC(OCH3)CH); 125.7 (COCCH3); 131.9 (CHC(CO)CH); 163.8 (CH3OC); 172.2 
(CO2CH2); 194.2 ppm (CO). 
IR (film): ) - 3470,1740,1685,1605,1515 cm-'. 
MS (EI): m/z- 253(M+1):. 
High resolution MS: C13H17051 (M+H), calc. 253.1076, found 253.1054. 
GLC (3% SE30,180°C); RT= 474 s (97%). 
Elemental analysis: Found: C, 61.96; H, 6.52. C13H1605 requires C, 
61.90; H, 6.35%. 
Methyl 1-hydroxycyclohexan-2-one carboxylate (33k)15 
1H NMR, 220MHz (CDC13/TMS): 6- 1.8 (complex, 6 H, C(OH)CH2Cj2CH9); 
2.15 (m, 2 H, COCH2) ; 3.82 (s, 3 H, OCH3); 4.39 ppm (s, 1 H, C(OH)). 
13C NMR, 22.63 MHz (CDC13/CDC13 =ö77.0 ppm): $- 21.7 (C(OH)CH2CH2); 
26.8 (COCH2CH2); 37.5 (C(OH)CH2); 38.6 (COCH2); 52.8 (OCH3); 80.6 
(C(OH)); 170.5 (CO2CH3); 207.1 ppm (COCH2). 
IR (film): y = 3460,1745(sh), 1720 cm-1. 
MS (EI): m/z= 172(M);. 
High resolution MS: C8H12O4, Cale. 172.0736, found 172.0727. 
GLC (10% SE30,130°C); RT- 640 s. 
Elemental analysis: Found: C, 56.14; H, 7.16. C8H12O4 requires C, 
55.81; H, 6.98%. 
Synthesis of Qlß-unsaturated esters: general procedure; 
To a stirred suspension of sodium hydride (2.28g, 95 mmol) in 
1,2-dimethoxyethane (DME) (30 ml) under nitrogen was added a solution 
of the phosphonate (100 mmol) in DME (30m1), with cooling from an ice 
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bath, at a rate such the reaction temperature remained below 35°C. 
After stirring at room temperature for a further 15 minutes a solution 
of the aldehyde (110 mmol) in DME (30 ml) was added, in the same 
manner. Upon completion of the reaction a jelly-like precipitate was 
deposited. The mixture was poured onto water (150m1) and extracted 
with dichloromethane (4 100m1). The combined dichloromethane extracts 
were dried (MgSO4) and evaporated under reduced pressure to furnish 
the crude-unsaturated ester as a mixture of Z- and E-isomers. The 
mixture was purified by distillation. 
The following c43-unsaturated esters were synthesised by the above 
procedure. 
(EtO)2 HC02Et 
1) NnH 
RICH 
R2 
R2 2) R1CHO 
C02Et 
(34) 
Entry R1 R2 Time 
/h 
Yield 
/% 
E-isomer 
/% 
bp 
/°C/mmHg 
34a65 Me Et 2 53 24 61-63/15 
34b66 Et Et 6 72 54 63-69/15 
34c67 Et Me 20 62 87 60-62/15 
34d65 Pr Me 5 68 86 110/15 
34e68 Bu Me 15 64 87 140/15 
34f69 t-Bu Me 48 71 54 120/15 
34g Ph Me 15 81 100 84-85/0.25 
34h p-N02Ph Me 24 38 100 mp 78-79°C 
34i p-MeOPh Me 30 67 100 130/0.5 
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Ethyl 2-ethylbut-2-eneoate (34a) 
Lit. 65 bp 97-102°C/65 mmHg. 
1H NMR, 220MHz (CDC13/TMS): $a1.01 (m, 3 H, CCH2Cý3); 1.30 (m, 3 H, 
0CH2CH3); 1.81 (d, 2 H, J-7.6 Hz, E CHCH3); 1.96 (d, 1 H, J=7.1 Hz, Z 
CHCH3); 2.33 (m, 2 H, CCH2); 4.21 (overlapping q, 2 H, J=7.1 Hz, 
OCH2); 5.97 (q, 0.3 H, J=7.1 Hz, Z CH); 6.84 ppm (q, 0.7 H, J-7.6 Hz, 
E CH). 
IR (film): V = 1715,1655 cm-1- 
MS (EI): m/z= 142(M)t. 
High resolution MS: C8H1402, calc. 142.0993, found 142.0992. 
GLC (10% SE30,110°C); RT- 305(E), 358(Z) s. 
Ethyl 2-ethylpent-2-eneoate (34b) 
1H NMR, 220MHz (CDC13/TMS): $-1.05 (complex, 6 H, CCH2CH3, CHCH2Cn); 
1.31 (m, 3 H, OCH2CH3); 2.25 (complex, 4 H, CCH21 CHCH2); 4.20 
(complex, 2 H, OCH2), 5.86 (t, 0.4 H, Ja7.6 Hz, Z CH); 6.75 ppm (t, 
0.6 H, J=7.6 Hz, E CH). 
IR (film): 3)= 1715,1645 cm-1. 
MS (EI): m/z= 156(M):. 
High resolution MS: C9H16021 calc. 156.1150, found 156.1159. 
GLC (10% SE30,120°C); RT= 323(Z), 399(E) s. 
Ethyl 2-methylpent-2-eneoate (34c) 
Lit. 67 bp 60-80°C/12 mmHg. 
1H NMR, 220MHz (CDC13/TMS): 8= 1.05 (t, 3 H, J=7.5 Hz, CHCH2CH3); 1.30 
(t, 3 H, J=7.1 Hz, OCH2CH3); 1.83 (s, 2.5 H, E CH3); 1.89 (s, 0.5 H, Z 
CH3); 2.19 (m, 1.7 H, E CHCH2); 2.45 (m, 0.3 H, Z CHCH2); 4.21 (q, 
2 H, J=7.1 Hz; OCH2); 5.94 (m, 0.15 H, Z CH); 6.77 ppm (m, 0.85 H, 
E CH). 
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IR (film): V - 1710,1650 cm-1. 
MS (EI): m/z= 142(M):. 
GLC (10% SE30,110°C); RT= 330(E), 440(2) s. 
Ethyl 2-methylhex-2-eneoate (34d) 
Lit. 65 bp 107-112°C/53 mmHg. 
1H NMR, 220MHz (CDC13/TMS): 6= 0.94 (t, 3 H, J=8 Hz, CH2CH2CH3); 1.29 
(t, 3 H, J-7 Hz, OCH2CN); 1.46 (m, 2 H, CH2CH2CH3); 1.83 (s, 2.6 H, 
E CH3); 1.89 (s, 0.3 H, Z CH3); 2.15 (m, 1.75 H, E %CH2CH2); 2.41 
(m, 0.25 H, Z C"H2CH2CH3); 4.20 (q, 2 H, J-7 Hz, OCH2); 5.93 (m, 0.15 
H, Z CH3); 6.77 ppm (m, 0.85 H, E CH). 
IR (film): V - 1715,1655 cm-1. 
MS (EI): m/z- 156(M).. 
High resolution MS: CgH1602, calc. 156.1150, found 156.1136. 
GLC (10% SE30,120°C); RT- 377(Z), 498(E) s. 
Ethyl 2-methylhept-2-eneoate (34e) 
Lit. 68 bp 69-71°C/3 mmHg. 
1H NMR, 220MHz (CDC13/TMS): 6m 0.93 (t, 3 H, J-7.1 Hz, CH2CH2CH2CH3); 
1.4 (complex, 7 H, CH2CH2CH2CH31 OCH2CH3); 1.84 (s, 2.5 H, E CH3); 
1.89 (s, 0.5 H, Z CH3); 2.18 (m, 1.6 H, E CH2CH2CH2CH3); 2.45 (m, 0.4 
H, Z CH? CH2CH2CH3); 4.20 (q, 2 H, J-7.1 Hz, OCH2); 5.95 (m, 0.2 H, Z 
CH); 6.77 ppm (m, 0.8 H, E CH). 
IR (film): V = 1715,1655 cm 
1. 
MS (EI): m/z= 170(M):. 
High resolution MS: C1OH18022 caic. 170.1307, found 170.1338. 
GLC (3% 0V17,120°C); RT= 208(Z), 299(E) s. 
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Ethyl 2,4,4-trimethylpent-2-eneoate (34f) 
1H NMR, 220MHz (CDC13/TMS): 6- 1.09 (s, 4.3 H, Z C(CH3)3); 1.18 (s, 
4.7 H, E C(CH3)3); 1.30 (overlapping t, 3 H, J=7.1 Hz, OCH2CH3); 1.90 
(d, 1.4 H, J=1.6 Hz, Z CCH3); 1.96 (d, 1.6 H, J=1.6 Hz, E CCH3); 4.20 
(overlapping q, 2 H, J=7.6 Hz, OCH2); 5.47 (s, 0.5 H, Z CH); 6.83 ppm 
(s, 0.5 H, E CH). 
IR (film): '= 1725,1710,1645 cm 
1. 
MS (EI): m/z= 170(M)t. 
High resolution MS: C10H18021 calc. 170.1307, found 170.1306. 
GLC (10% SE30,130°C); RT= 240(E), 370(Z) s. 
Ethyl 2-methyl-3-phenylprop-2-eneoate (34g) 
1H NMR, 220MHz (CDC13/TMS): 6" 1.35 (t, 3 H, Js7.1 Hz, 0CH2Cý3); 2.13 
(d, 3 H, J-1.6 Hz, CCH3); 4.29 (q, 2 H, Js7.1 Hz, OCH2); 7.41 
(complex, 5 H, Ph); 7.73 (d, 1 H, J-1.6 Hz, CH). 
IR (film): V - 3060,1710,1640 cm 
1. 
MS (EI): m/zs 190(M):. 
High resolution MS: C12H1402, calc, 190.0994, found 190.0996. 
GLC (3% SE30,150°C); RT- 397 s (95X). 
Ethyl 2-methyl-3-(4-nitrophenyl)-prop-2-eneoate (34h) 
The aldehyde component, 4-nitrobenzaldehyde, was added as a solid, in 
one portion, to the lithiated phosphonate. The reaction was exothermic 
and required external cooling with an ice-bath. After work up as above 
the ester was obtained as a yellow crystalline solid which was 
recrystallised to constant melting point (78-79°C) from ethyl acetate- 
petrol. A substantial amount of the ester co-crystallised with 
unreacted 4-nf trobenzaldehyde. 
1H NMR, 220MHz (CDC13/TMS): 6= 1.37 (t, 3 H, J=7.1 Hz, OCH2CH3); 2.13 
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(d, 3 H, J=1.7 Hz, CCH3); 4.32 (q, 2 H, J-7.1 Hz, OCH2); 7.56 (m, 2 H, 
Ar); 7.73 (bs, 1 H, CH, 8.28 ppm (m, 2 H, Ar). 
IR (film): 9 $ 3120,1700,1630,1600 cm-'. 
MS (EI): m/z- 235(M):. 
High resolution MS: C12H13NO4, calc. 235.0844, found, 235.0841. 
Elemental analysis: Found: C, 61.29; H, 5.56; N, 5.79. C12H13NO4 
requires C, 61.28; H, 5.53; N, 5.96%. 
Ethyl 2-methyl-3-(4-methoxyphenyl)prop-2-eneoate (341) 
1H NMR, 220MHz (CDC13/TMS): $n1.36 (t, 3 H, Jß'7.1 Hz, OCH2CH3); 2.16 
(d, 3 H, J-1.6 Hz, CCH3); 3.87 (s, 3 H, OCH3); 4.30 (q, 2 H, J=7.1 Hz, 
OCH2); 6.98 (m, 2 H, Ar); 7.46 (m, 2 H, Ar); 7.73 ppm (bs, 1 H, CH). 
IR (film): V 1705,1605,1510 cm-1. 
MS (EI): m/z= 220(M)+, 191(M-Et)+, 175(M-OEt)+, 146(M-C02Et)+. 
High resolution MS: C13H16031 calc. 220.1100, found 220.1109. 
GLC (3% SE30,180°C); RT= 408 s (98%). 
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CHAPTER 9 
Synthesis of(Xg-unsaturated carboxylic esters 
The following (Xß-unsaturated esters were synthesised from 
triethyl phosphonoethanoate and the appropriate ketone via the 
phosphonate modification to the Wittig reaction as detailed in chapter 
8. 
R RRICHO 
, _R (Et0)2PCHZC02Et 
' R1 
>=CHC02Et 
(45) 
Entry R R1 Scale 
/mmol 
Reaction 
time/h 
Yield 
/% 
45a107 Pr Pr 93 190 64 
45b Bu Bu 87 72 66 
45c108 Ph Ph 9 48 70 
45d109 i-Pr Me 76 6.5 70 
45e110 Ph Me 127 5 75 
45f111 
1-1 
Me 86 72 51 
45g112 a 68 20 70 
45h81 
ID 
177 15 66 
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Entry R R1 Scale 
/mmol 
Reaction 
time/h 
Yield 
/X 
45i64 
0 
77 17 76 
45j81 
0 
46 20 74 
45k81 
0 
149 168 74 
Ethyl 3-propylhex-2-eneoate (45a) 
Colourless oil. bp 92-94/15 mmHg. Lit. '07 bp 166.5°C/28 mmHg. 
1H NMR, 220 MHz (CDCI3/TMS): b' 1.94 (complex, 6 H, butyl CH3); 1.28 
(t, 3 H, J=7.6 Hz, OCH2CH3); 1.50 (complex, 4 H, butyl CH2); 2.13 (m, 
2 H, butyl CH2); 2.57 (m, 2 H, butyl CH2); 4.15 (q, 2 H, J-8.0 Hz, 
OCH2); 5.64 ppm (bs, 1 H, CH). 
IR (film): V - 1715,1645 cm -1 
MS (EI): m/z-184(M);, 156(M-Et)+, 139(M-OEt)+. 
High resolution MS: C21H20021 calc. 184.1463, found 184.1459. 
GLC (3% SE30,120°C); RT- 356 s (97%). 
Ethyl 3-butylhept-2-enoate (45b) 
Colourless oil. bp 116-118/15 mmHg 
1H NMR, 220 MHz (CDC13/TMS): 6- 0.93 (complex, 6 H, butyl CH3); 1.2- 
1.65 (complex, 11 H, butyl CH21 OCH2CH3); 2.15,2.63 (m, 2 H, CCH2); 
4.17 (q, 2 H, J=7 Hz, OCICH3); 5.67 ppm (bs, 1 H, CH). 
IR (film): Y- 1720,1645 cm-1. 
MS (EI): m/z-212(M):, 183(M-Et)+, 167(M-OEt)+, 155(M-Bu)+. 
High resolution MS: C10H18021 calc. 170.1307, found 170.1338. 
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GLC (3% SE30,130°C); RT= 573 s (100%). 
Ethyl 3,3-diphenylprop-2-enoate (45c) 
Colourless oil. Kugelrohr distilled; 220°C/1 mmHg. Lit-108 bp 152- 
156°C/0.1 mmHg. 
1H NMR, 220 MHz (CDC13/TMS): $°1.11 (t, 3 H, J=7.5 Hz, 0CH2Cn); 4.07 
(q, 2 H, J=7.5 Hz, OCH2); 6.38 (s, 1 H, CH); 7.3 ppm (complex, 10 H, 
Ph). 
IR (film): )" = 3045,1720,1660,1615,1595 cm- 
1. 
MS (EI): m/z-252(M):, 223(M-Et)+, 207(M-0Et)+, 178(M-000Et)+. 
High resolution MS: C17H16021 calc. 252.1151, found 252.1151. 
GLC (3% SE30,210°C); RT= 254 s (94%). 
Ethyl 3,4-dimethylpent-2-enoate (45d) 
Reaction mixture refluxed for 6.5h. Product Kugelrohr distilled; 
colourless oil bp 110°C/15 mmHg. Lit-109 bp 46-48°C/0.7 mmHg. 
Data for E isomer. 
1H NMR, 220 MHz (CDC13/TMS): $=1.07 (d, 6 H, J=6.9 Hz, CH(CH3)2); 
1.28 (t, 3 H, J=7.1 Hz, OCH2CH3); 2.14 (s, 3 H, CHCCH3); 2.35 (m, 1 H, 
CH(CH3)2); 4.16 (q, 2 H, J=7.1 Hz, OCH? CH3); 5.70 ppm (bs, 1 H, CH). 
IR (film): V= 1715,1645 cm 
1. 
MS (EI): m/z= 156(M)t, 127(M-Et)f, 111(M-OEt)+, 83(M-000Et)+. 
High resolution MS: CgH1602, calc. 156.1150, found 156.1148. 
GLC (3% SE30,120°C); RT= 387 s (E, 85%), 444 (2,15%). (Purity 98%) 
Ethyl 3-phenylbut-2-enoate (45e) 
Colourless oil. bp 92°C/0.3 mmHg. Lit-110 bp 127°C/10 mmHg. 
1H NMR, 220 MHz(CDC13/TMS): b=1.3 (complex, 3 H, OCH2CH3); 2.58 (s, 
3 H, CHCCH3); 4.20 (m, 2 H, O%CH3); 6.15 (bs, I H, CH); 7.40 ppm 
(complex, 5 H, Ph). 
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IR (film): ))- 1740,1715,1630 cm -1 
MS (EI): m/z= 190(M)±, 161(M-Et)+, 145(M-0Et)+. 
High resolution MS: C12H1402, calc. 190.0993, found 190.0986. 
GLC (3% SE30,150°C); RT- 190 s (Z, 13%), 320 s (E, 87%) 
Ethyl 3-methyl-3-(2-thienyl)but-2-enoate (45f) 
Isolation by flash chromatography eluting with 20% ether in petrol. E 
isomer, RF 0.6, Z isomer, RF-0.5. 
Data for E isomer. 
1H NMR, 220 MHz (CDC13/TMS): $$1.32 (t, 3 H, J-7.1,0CH2CH3); 2.63 
(s, 3 H, CHCCH3); 4.22 (q, 2 H, J-7.1 Hz, OCH2CH3); 6.28 (s, 1 H, CH); 
7.07 (dd, 1 H, J=4.9,4.9 Hz, SCHCHCH); 7.3 ppm (complex, 2 H, 
SCHCHCH). 
IR (film): )) - 3105,1710,1615,1520 cm 
1. 
MS (EI): m/z- 196(M)T, 124(M-000Et)+. 
High resolution MS: C10H12SO2, calc. 196.0558, found 196.0575. 
GLC (3% SE30,1500C); RT; 300 s (Z, 15%), 400 s(E, 85%). 
Ethyl cyclobuylidene ethanoate (45g) 
Kugelrohr distilled; 120°C/10 mmHg. 
1H NMR, 220 MHz (CDCl3/TMS): $=1.27 (t, 3 H, J=7.1 Hz, OCH2CH3); 2.10 
(complex, 2 H, CCH2CH2); 2.86,3.16 (m, 2 H, CCH2); 4.17 (q, 2 H, 
J=7.7 Hz, OCH2); 5.63 ppm (complex, 1 H, CH). 
IR (film): )) - 1715,1675 cm-1. 
MS (EI): m/z-140(M);, 112(M-Et)+, 95(M-OEt)+, 67(M-000Et)}. 
High resolution MS: C8H1202, calc. 140.0838, found 140.0838. 
GLC (3% SE30,100°C); RT- 324 s (100%). 
Ethyl cyclopentylidene ethanoate (45h) 
Colourless oil. bp 69-72°C/0.6 mmHg. Lit. 
81 bp 71-72.5°C/I mmHg. 
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1H NMR, 220 MHz (CDC13/TMS): 6n 1.28 (t, 3 H, J=7.5 Hz, 0CH2C ); 1.7 
(complex, 4 H, CCH2CH2CH2); 2.45,2.78 (m, 2 H, CCH2); 4.26 (q, 2 H, 
J=7.5 Hz, OCH2); 5.83 ppm (m, 1 H, CH). 
IR (film): ))- 1715,1655 cm 
1. 
MS (EI): m/z=154(M);, 126(M-Et)+, 109(M-0Et)+, 81(M-000Et)+. 
High resolution MS: C9H1402, calc. 154.0994, found 154.0993. 
GLC (3% SE30,110°C); RT= 370 s (98%). 
Ethyl cyclohexylidene ethanoate (451) 
Colourless oil. bp 120°C/0.3 mmHg. Lit. 64 bp 88-90°C/10 mmHg. 
1H NMR, 220 MHz (CDC13/TMS): $=1.28 (t, 3 H, J-7.1 Hz, OCH2Cb); 1.63 
(complex, 6 H, CH2); 2.19 (m, 2 H, CH2); 2.85 (m, 2 H, CH2); 4.16 (q, 
2 H, J=7.1 Hz, OCH2); 5.62 ppm ( s, 1 H, CH). 
IR (film): )) 1720,1655,1455 cm-1. 
MS (EI): m/z= 168(M)t, 140(M-Et)+, 123(M-OEt)+, 95(M-COOEt)+. 
High resolution MS: C10H16021 calc. 168.1150, found 168.1143 
GLC (3% SE30,130°C); RT= 267 s (100%). 
Ethyl cycloheptylidene ethanoate (45j) 
Colourless oil. bp 100°C/0.07 mmHg. Lit. 
81 94-95°C/1 mmHg. 
1H NMR, 220 MHz (CDC13/TMS): 6=1.29 (t, 3 H, J=7.3 Hz, OCH2CH3); 1.5- 
1.8 (complex, 8 H, ring CH2); 2.38 (m, 2 H, ring CH2); 2.88 (m, 2 H, 
ring CH2); 4.16 (m, 2 H, OCH2); 6.73 ppm (bs, 1 H, CH). 
IR (film): V = 1715,1635 cm 
1. 
MS (EI): m/z= 182(M)t, 154(M-Et)+, 137(M-OEt)+, 109(M-COOEt)+. 
High resolution MS: C11H1802, calc. 182.1307, found 182.1298. 
GLC (3% SE30,150°C); RT 230 s (98%). 
Ethyl cyclooctylidene ethanoate (45k) 
Colourless oil. bp 74-75°C/0.25 mmHg. Lit-81 bp 81-83°C/0.58 mmHg. 
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1H NMR, 220 MHz (CDC13/TMS): 6' 1.2-2.0 (complex, 12 H, ring CH21 
OCH2CH); 2.33 (m, 2 H, CH2); 2.44 (m, 1 H, CH2); 2.77 (m, 2 H, CH2); 
4.26 (q, 2 H, JS7.1 Hz, OCH2); 5.76 ppm (bs, 1 H, CH). 
IR (film): y - 1710,1630 cm 
1. 
MS (EI): m/z- 196(M);, 168(M-Et)+, 151(M-OEt)+. 
High resolution MS: C12H2002, calc. 196.1464, found 196.1462. 
GLC (3X SE30,150°C); RT- 344 s (94X) 
Dihydroxylation of a -unsaturated esters 
The following-unsaturated esters were dihydroxylated by the 
method described below for ethyl cyclopentylidene ethanoate. 
Rrý 'CHCO2Et 
-ý ` 02Et 
ý R' HH 
(45) (46) 
Entry RR Scale 
/mmol 
Temp. 
/°C 
Time 
/h 
Yield 
/% 
46a Pr Pr 29 50-60 17 40 
46b Bu Bu 20 50-60 20 30 
46c i-Pr Me 20 40-50 15 30 
46d Ph Me 41 40 20 46 
46e 
I: > 
45 40-50 16 79 
46f 
0 
25 40-50 20 35 
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Ethyl 3-(l-hydroxycyclopentyl)-2-hydroxyethanoate (46e) 
To a stirred solution of ethyl cyclopentylidene ethanoate (8.515 
g, 45.3 mmol) in 98% formic acid (30 ml) was added a 30% solution of 
hydrogen peroxide (8.5 ml, 82 mmol). The mixture was stirred at 40- 
50°C for 16 h, evaporated under reduced pressure/35°C, and co- 
evaporated with toluene (2x40 ml) under reduced pressure/35°C. The 
residue was distilled in a Kugelrohr apparatus (150°C/0.15 mmHg) to 
give the 2,3-dihydroxy ester as a pale yellow oil (6.722 g, 35.8 mmol, 
79% yield). 
1H NMR, 220 MHz (CDC13/TMS): 8- 1.33 (t, 3 H, J: 7.6 Hz, OCH2CH3); 1.7 
(complex, 8 H, ring CH2); 2.23 (s, 1 H, CH2C(0H)CH2); 3.30 (d, 1 H, 
J=6.7 Hz, CH(OR)); 4.06 (d, 1 H, J-6.7 Hz, CH); 4.28 ppm (m, 2 H, 
OCH2). 
IR (film): l/ - 3475,1735 cm 1. 
MS (+ve CI, ammonia): m/z= 206(M+18)+, 188(M)+, 171(M-OH)+. 
High resolution MS: CgH1704 (M+H), calc. 189.1126, found 189.1136. 
GLC (3% SE30,130°C); RT= 320 s (90%). 
Ethyl 2,3-dihydroxy-3-propylhexanoate (46a) 
Isolated by flash chromatography, eluting with ethyl acetate-petrol 
1: 1. Colourless oil, RF 0.56. 
1H NMR, 220 MHz (CDC13/TMS): $a0.94 (complex, 6 H, propyl CH3); 1.4 
(complex, 11 H, propyl CH2, OCH2CH3); 2.41 (bs, 1 H, CH(OH)); 3.15 
(bd, 1H , J=7.1 Hz, PrCOH); 4.11 (d, 1 H, J-7.1 Hz, CH(OH)); 4.32 ppm 
(dq, 2 H, Ja7.1,1.3 Hz, OCH2). 
IR (film): y- 3470,1730 cm 1. 
MS (+ve CI, ammonia): m/z= 291(M+1)+. 
132 
High resolution MS: C11112304 (M+H), calc. 219.1596, found 219.1592. 
GLC (3% SE30,150°C); Rf 267 s (96%). 
Ethyl 3-butyl-2,3-dihydroxyheptanoate (46b) 
Isolated by flash chromatography, eluting with ethyl acetate-petrol 
1: 4. Colourless oil, RF 0.43. 
1H NMR, 220 MHz (CDC13/TMS): Ö'° 0.92 (complex, 6 H, butyl CH2); 1.2- 
1.75 (complex, 15 H, butyl CH2,0CH2CH3); 2.38 (bs, 1 H, C(OH)); 3.13 
(bd, 1 H, J-7.3 Hz, CH(OH)); 4.13 (d, 1 H, J$7.13 Hz, CH(OH)); 4.33 
ppm (q, 2 H, J-7.1 Hz, OCH2). 
IR (film): ))- 3490,1735 cm 
1. 
MS (+ve CI, ammonia): m/z" 264(M+18)+, 246(M)+, 229(M-OH)+, 
188(M-Bu)+. 
High resolution MS: C13H30NO4 (M+NH4), calc. 264.2174, found 264.2154. 
Ethyl 2,3-dihydroxy-3,4-dimethylpentanoate (46c) 
Isolated by flash chromatography, eluting with ethyl acetate-petrol 
1: 3. Colourless oil RF 0.2, (mixture of diastereoisomers). 
1H NMR, 220 MHz (CDC13/TMS): $-0.96 (complex, 6 H, CH(CH3)2); 1.09, 
1.14 (s, 3 H, C(OH)CH3); 1.34 (complex, 3 H, 0CH2Cj ); 1.83,2.05 (m, 
I H, CH(CH3)2); 2.46,2.54 (s, 1 H, C(OH)), 3.29,3.37 (d, I H, Ja7 
Hz, CH(0H)); 4.15 (complex, 1 H, CH(OH)); 4.31 ppm (complex, 2 H, 
OCH2). 
IR (film): ))= 3480,1730 cm 1. 
MS (EI): m/z= 191(M+1):, 173(M-OH)", 147(M-Pr)+, 117(M-000Et)+. 
High resolution MS: C9H1904 (M+H), calc. 191.1283, found 191.1291. 
Ethyl 2,3-dihydroxy-3-phenylbutanoate (46d) 
Isolated by flash chromatography, eluting with ethyl acetate-petrol 
1: 4. Pale yellow oil RF 0.2, (mixture of diastereoisomers). 
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1H NMR, 220 MHz (CDC13/TMS) (major diastereoisomer): $-1.17 (t, 3 H, 
J=7.1 Hz, OCH2CH3); 1.63 (s, 3 H, C(OH)CH3); 3.17 (d, 1 H, J=6.4 Hz, 
CH(OH)); 3.35 (s, 1 H, PhCOH); 4.18 (q, 2 H, J=7.1 Hz, OCH2); 4.35 (d, 
1 H, J=6.4 Hz, CH); 7.4 ppm (complex, 5 H, Ph). 
IR (film): V= 3480,1730,1495 cm-1. 
MS (+ve CI, ammonia): m/z= 242(M+18)+, 224(M)+, 207(M-OH)+. 
High resolution MS: C12H20NO4 (M+NH4), calc. 242.1392, found 242.1389. 
GLC (3% SE30,170°C); RT= 294 s. 
Ethyl 2-(1-hydroxycyclohexyl)-2-hydroxyethanoate (46f) 
Isolated by flash chromatography, eluting with ethyl acetate-petrol 
1: 4. Colourless oil RF 0.13. 
1H NMR, 220 MHz (CDC13/TMS): 5' 1.15-1.95 (complex, 13 H, ring CH21 
OCH2CH3); 2.67 (s, 1 H, C(OH)); 3.56 (d, 1 H, J=7.6 Hz, CH(OR)); 4.02 
(d, 1 H, J=8.0 Hz, CH(OH)); 4.33 ppm (q, 2 H, J-7.1 Hz, OCH2). 
IR (film): V- 3470,1730 cm 
1. 
MS (EI): m/z= 203(M+1):, 185(M-OH)+, 81(cyclohexyl-H)+. 
High resolution MS: C10H1904 (M+H), calc. 203.1284, found 203.1265. 
GLC (3% SE30,150°C); RT= 291 s (98%). 
Elemental analysis: Found: C, 59.15; H, 8.94. C10H1804 requires C, 
59.41; H, 8.91%. 
Oxidation of 2,3-dihydroxy esters with N-brömosuccinimide 
The following 2,3-dihydroxy esters were oxidised by the method 
described below for ethyl 2,3-dihydroxy-3-propylhexanoate. 
11 
R 02Et --ß 02 Et 
H 
(47) 
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Entry R R1 Scale 
/mmol 
Time 
/h 
Yield 
/X 
47a Pr Pr 10.2 3 79 
47b Bu Bu 4.5 15 93 
47c i-Pr Me 5.6 5 19 
47d Ph Me 9.4 14 78 
47e 10.8 17 60 
47f 6.8 6 51 
Ethyl 3-hydroxy-2-oxo-3-propylhexanoate (47a) 
Ethyl 2,3-dihydroxy-3-propylhexanoate (2.229 g, 10.2 mmol), N- 
bromosuccinimide (1.966 g, 11.0 mmol) and calcium carbonate (1.060 g, 
10.6 mmol) were stirred together in dry carbon tetrachloride (40 ml) 
under nitrogen with illumination and heat from a 100 W tungsten lamp. 
After 15 minutes a deep red colouration developed which dissipated 
over a3h period to give a yellow solution and a yellow solid. The 
mixture was cooled (ice bath), filtered and the solid washed with 
carbon tetrachloride (2x10 ml). The combined carbon tetrachloride 
portions were evaporated under reduced pressure to give a yellow oil. 
This was subjected to flash chromatography eluting with ethyl acetate- 
petrol 1: 7. Ethyl 3-hydroxy-2-oxo-3-propylhexanoate was obtained as a 
yellow oil RF 0.34 (1.733 g, 8.02 mmol, 79X). 
1H NMR, 220MHz (CDC13/TMS): 6- 0.89 (t, 6 H, J=7.6 Hz, CH2CH2CH3); 
1.15 (m, 2 H, C(OH)CH2CH? ); 1.37 (complex, 5 H, OCH2CH31 C(OH)CH2CH? ); 
1.80 (m, 4 H, C(OH)CH9); 3.28 (s, 1 H, OH); 4.37 ppm (q, 2 H, J=7.1 
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Hz, OCH2). 
IR (film): / - 3520,1740,1720 cm . 
MS (+ve CI, ammonia): m/z- 217(M+1)+, 143(M-C02Et)+, 115(M-00002)+. 
High resolution MS: C11112104 (M+H), calc. 217.1439, found 217.1409. 
GLC (PEG 20M, 180°C); RT= 597 s (100X) 
Elemental analysis: Found: C, 61.28; H, 9.39. C11H2004 requires C, 
61.11; H, 9.26%. 
Ethyl 3-butyl-3-hydroxy-2-oxoheptanoate (47b) 
Yellow oil isolated by flash chromatography eluting with ethyl 
acetate-petrol 3: 17 RF 0.52. 
1H NMR, 220MHz (CDC13/TMS): $-0.88 (t, 6 H, J°7.1 Hz, CH2CH2CH2CH3); 
0.97-1.50 (complex, 11 H, butyl CH21 OCH2Cb); 1.85 (m, 4 H, 
C(OH)Cý2); 3.29 (bs, 1 H, OH); 4.36 ppm (q, 2 H, J°8.0 Hz, OCH2). 
IR (film): 11 = 3515,1740,1725 cm-1. 
MS (EI): m/z- 245(M+1):, 171(M-C02Et)+. 
High resolution MS: C13H2504 (M+H), calc. 245.1752, found 245.1754. 
GLC (3% SE30,200°C); RT= 545 s (99%). 
Elemental analysis: Found: C, 63.57; H, 9.91. C13H2404 requires C, 
63.93; H, 9.84%. 
Ethyl 3,4-dimethyl-3-hydroxy-2-oxopentanoate (47c) 
Colourless oil isolated by flash chromatography eluting with ethyl 
acetate-petrol 1: 3 RF 0.43. There was accidental loss of product 
during work up. 
1H NMR, 220MHz (CDC13/TMS): $=0.87,0.99 (d, 3 H, J=7.1 Hz, CHCH3); 
1.38 (t, 3 H, J=7.1 Hz, OCH2Cn); 1.44 (s, 3 H, C(0H)CH3); 2.26 (m, 
I H, CH); 3.12 (s, 1 H, OH); 4.37 ppm (q, 2 H, J=7.1 Hz, OCH2). 
IR (film): V = 3520,1740(sh), 1725 cm-1. 
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MS (EI): m/z= 189(M+1):, 115(M-C02Et)+, 87(M-COC02Et)+. 
High resolution MS: C9H17O4 (M+H), calc. 189.1127, found 189.1130. 
GLC (3% SE30,100°C); RT= 409 s (100%). 
Ethyl 3-hydroxy-2-oxo-3-phenylbutanoate (47d) 
Pale yellow oil isolated by flash chromatography eluting with ether- 
petrol 1: 4 RF (ether-petrol 2: 3) 0.3. 
IH NMR, 220MHz (CDC13/TMS): b= 1.23 (t, 3 H, J-7.1 Hz, OCH2CH); 1.82 
(s, 3 H, C(OH)CH3); 4.05 (bs, 1 H, OH); 4.23 (q, 2 H, Ja7.1 Hz, OCH2); 
7.4 ppm (complex, 5 H, Ph). 
IR (film): V = 3500,3060,1740(sh), 1725,1600,1495 cm 1. 
MS (+ve CI, ammonia): m/z= 240(M+18)+, 223(M+I)+, 177(M-OEt)+, 121(M- 
COC02Et)+, 105(PhCO)+. 
High resolution MS: C12HI504 (M+H), calc. 223.0971, found 223.0998. 
Elemental analysis: Found: C, 64.66; H, 6.50. C12HI404 requires C, 
64.86; H, 6.31%. 
Ethyl 2-(I-hydroxycyclopentyl)-2-oxoethanoate (47e) 
Pale yellow oil isolated by flash chromatography eluting with ether- 
petrol 1: 1 RF 0.25. 
H NMR, 220MHz (CDC13/TMS): $=1.38 (t, 3 H, J-7.1 Hz, OCH2CH3); 1.85 
(complex, 6 H, ring CH2); 2.13 (complex, 2 H, ring CH2); 3.06 (bs, 
I H, OH); 4.37 ppm (q, 2 H, J=7.1 Hz, OCH2). 
13C NMR, 22.63 MHz (CDC13/CDC13 =$ 77.0 ppm): ba 13.8 (CH3); 24.9 
(C(OH)CH2CH2CH2); 38.9 (CH2C(OH)CH2); 62.2 (OCH2); 86.3 (C(OH)); 162.9 
(CO2CH2); 198.2 ppm (CO). 
IR (film):. = 3505,1725(b) cm 1. 
MS (EI): m/z= 186(M)+, 168(M-H20)+, 113(M-C02Et); 85(M-COC02Et). 
High resolution MS: C9H14O4, calc. 186.0892, found 186.0890. 
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GLC (3% SE30,140°C); RT= 580 s (100%). 
Ethyl 2-(I-hydroxycyclohexyl)-2-oxoethanoate (47f) 
Pale yellow oil isolated by flash chromatography eluting with ethyl 
acetate-petrol 1: 4 RF 0.63. 
1H NMR, 220MHz (CDC13/TMS): $=1.15-1.45 (complex, 4 H, ring CH21 
OCH2CH3); 1.50-1.95 (complex, 9 H, ring CH2); 2.85 (s, 1 H, OH); 
4.35 ppm (q, 2 H, J=7.1 Hz, OCH2). 
13C NMR, 62.896 MHz (CDC13/CDC13 - 677.0 ppm): S= 13.9 (CH3); 20.6 
(CH2CH2C(OH)CH2CH2); 24.9 (C(OH)CH2CH2CH2); 33.3 (CH2C(OH)CH2); 62.2 
(OCH2); 77.8 (C(OH)); 163.3 (C02CH2); 199.1 ppm (CO). 
IR (film): '/ - 3520,1740(sh), 1720 cm 
1. 
MS (EI): m/z= 201(M+1);, 183(M-0H)+, 99(M-COC02Et)+. 
High resolution MS: ClOH1704 (M+H), calc. 201.1126, found 201.1130. 
GLC (3% SE30,130°C); RT- 380 s (98). 
Elemental analysis: Found: C, 59.55; H, 8.48. C10H1604 requires C, 
60.00; H, 8.00%. 
Oxidation of ethyl 3,3-diphenylprop-2-eneoate to ethyl 3,3-diphenyl-3- 
hydroxy-2-oxopropanoate (44a) 
To a solution of ethyl 3,3-diphenylprop-2-eneoate (4.369 g, 17.3 
mmol)in 98% formic acid (12 ml) was added a 30% solution of hydrogen 
peroxide in water (5 ml, 48 mmol). The mixture was stirred et 65°C for 
12 h and evaporated under reduced pressure/40°C to give an pale brown 
solid. This was suspended in carbon tetrachloride (50 ml). Calcium 
carbonate (1.703 g, 17 mmol) and N-bromosuccinimide (3.00 g, 16.8 
mmol) were added and the mixture stirred under nitrogen with 
illumination and heat from a 100 W tungsten lamp for 20 h. The mixture 
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was filtered and evaporated under reduced pressure/35°C to give a 
yellow oil. The product was isolated by flash chromatography eluting 
with ethyl acetate-petrol 1: 4 RF 0.25 as a yellow oil (1.477 g, 30%). 
1H NMR, 220MHz (CDC13/TMS): 6m 1.25 (t, 3 H, Ja7.1 Hz, 0CH2%); 4.05 
(s, 1 H, OH); 4.26 (q, 2 H, J-7.1 Hz, OCH2); 7.40 ppm (complex, 10 H, 
Ph). 
IR (film): V = 3500,3060,1740(sh), 1725,1600,1495 cm 1. 
MS (+ve CI, ammonia): m/z- 302(M+18)+, 285(M+1)+, 239(M-OEt)+, 
183(M-COC02Et)+. 
High resolution MS: C17H1704 (M+H), calc. 285.1127, found 285.1148. 
Elemental analysis: Found: C, 72.07; H, 5.76. C17H16O4 requires C, 
71.83; H, 5.63%. 
Oxidation of ethyl cycloheptylidene ethanoate to ethyl 
2-(1-hydroxycycloheptyl)-2-oxoethanoate (44b) 
To a solution of ethyl cycloheptylidene ethanoate (3.177 g, 17.4 
mmol) dissolved in 98% formic acid (10 ml) was added a 30% solution of 
hydrogen peroxide in water (5 ml, 48 mmol). The mixture was strirred 
at 60-80°C for 17 h, evaporated under reduced pressure/40°C and co- 
evaporated with toluene (50 ml) under reduced pressure/40°C. High 
vacuum was applied for 2h to remove traces of toluene. The residue 
was dissolved in carbon tetrachloride (50 ml). N-bromosuccinimide 
(3.028 g, 17.0 mmol) and calcium carbonate (1.741 g, 17.4 mmol) were 
added and the mixture was stirred under nitrogen for 5h with 
illumination and heat from a 100 W tungsten lamp. A deep red 
colouration formed which gave way to a yellow solution and an orange 
solid. The mixture was filtered and evaporated under reduced 
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pressure/35°C to give a pale yellow oil. This was subjected to flash 
chromatography eluting with ethyl acetate-petrol 1: 4. Ethyl 
2-(1-hydroxycycloheptyl)-2-oxoethanoate, RF 0.1, was isolated as a 
yellow oil (1.291 g, 6.03 mmol, 35%). 
1H NMR, 220MHz (CDC13/TMS): 62' 1.38 (t, 3 H, Js7.1 Hz, 0CH2CH1); 0.95- 
1.90. (complex, 10 H, ring CH2); 2.12 (m, 2 H, ring CH2); 2.93 (s, I H, 
OH); 4.37 ppm (q, 2 H, J=7.1 Hz, OCH2). 
13C NMR, 45.28 MHz (CDC13/CDC13 - B7.7.0 ppm): 6- 13.7 (OCH2CH3); 22.0 
(CH2C(OH)CH2); 29.1 (CH2CH2C(OH)CH2CH2); 37.2 (C(OH)CH2CH2CH2CH2); 
62.0 (OCH2); 80.6 (C(OH)); 163.5 (C02CH2); 199.5 ppm (CO). 
IR (film): 1! a 3500,1735(sh), 1720 cm-1. 
MS (EI): m/z= 215(M+1):, 197(M-OH)+, 113(M-00002Et)+. 
High resolution MS: C11H1904 (M+H), calc. 215.1283, found 215.1265. 
GLC (3% SE30,150°C); RT- 410 s (100%). 
Elemental analysis: Found: C, 60.70; H, 8.39. C11H1804 requires C, 
61.68; H, 8.41%. 
Attempted isomerisation of methyl 3-hydroxy-3-methyl-2-oxobutanoate 
using aluminium trichloride and acetic anhydride 
Methyl 3-hydroxy-3-methyl-2-oxobutanoate and aluminium 
trichloride (619 mg, 4.6 mmol) were suspended in glacial acetic acid 
(20 ml) and acetic anhydride (5 ml) and set'aside at room temperature 
for 20 h. Water (60 ml) was added and the solution brought to pH 7 
with solid sodium hydrogen carbonate. The mixture was extracted with 
dichloromethane (100 ml). The dichloromethane was dried (MgSO4) and 
evaporated under reduced pressure/40°C to give a yellow oil (62 mg). 
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Proton NMR spectroscopy indicated a complex mixture containing neither 
starting material nor methyl 2-hydroxy-2-methyl-3-oxobutanoate. 
Attempted isomerisation of methyl 3-hydroxy-3-methyl-2-oxobutanoate 
using aluminium trichloride 
Methyl 3-hydroxy-3-methyl-2-oxobutanoate (76 mg, 0.5 mmol) and 
aluminium trichloride (37 mg, 0.3 mmol) were heated together in 
boiling toluene (2 ml) under nitrogen for 16 h. Water (5 ml) was added 
and the mixture was taken to pH 8 with saturated sodium hydrogen 
carbonate solution, filtered and extracted with dichloromethane 
(6x10 ml). The combined extracts were dried (MgSO4) and evaporated 
under reduced pressure/40°C to give a yellow oil (17 mg). Proton NMR 
spectroscopy indicated a complex mixture containing neither starting 
material nor methyl 2-hydroxy-2-methyl-3-oxobutanoate. 
Attempted isomerisation of methyl 3-hydroxy-3-methyl-2-oxobutanoate on 
neutral alumina 
Methyl 3-hydroxy-3-methyl-2-oxobutanoate (111 mg, 0.76 mmol) was 
stirred with neutral alumina (1.6 g, grade I) for 5 days. Benzene (10 
ml) was added and the slurry stirred for 20 h. The benzene was 
evaporated under reduced pressure/40°C and the alumina extracted with 
dichloromethane in a soxhlet apparatus. The'dichloromethane was 
filtered through celite and evaporated under reduced pressure/40°C to 
give a white gum (16 mg). Proton NMR spectroscopy indicated a complex 
mixture containing some starting material but no methyl 2-hydroxy-2- 
methyl-3-oxobutanoate. 
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Atempted isomerisation of methyl 3-hydroxy-3-methyl-2-oxobutanoate 
using aluminium t-butoxide 
Methyl 3-hydroxy-3-methyl-2-oxobutanoate (115 mg, 0.79 mg) and 
aluminium t-butoxide (907 mg, 3.7 mmol) were stirred together in 
boiling toluene (10 ml) under nitrogen for 24 h. The mixture was 
acidified with 4M hydrochloric acid and the toluene evaporated under 
reduced pressure/40°C. Water (2 ml) was added and the mixture 
extracted with dichloromethane (5x10 ml). The combined extracts were 
dried (MgSO4) and evaporated under reduced pressure to give a pale 
brown solid (30 mg). Proton NMR spectroscopy indicated a complex 
mixture containing neither starting material nor methyl 2-hydroxy-2- 
methyl-3-oxobutanoate. 
Attempted isomerisation of methyl 3-hydroxy-3-methyl-2-oxobutanoate 
using boron trifluoride etherate 
To a solution of methyl 3-hydroxy-3-methyl-2-oxobutanoate (240 
mg, 1.6 mmol) in glacial acetic acid (10 ml) and acetic anhydride (1.6 
ml) was added boron trifluoride etherate (1.6 ml). The homogeneous 
solution was set aside at room temperature for 17 h. Water (50 ml) was 
added and the solution extracted with dichloromethane (3x50 ml). The 
combined extracts were washed with saturated sodium hydrogen carbonate 
solution (50 ml). The aqueous phase was back-extracted with 
dichioromethane (3x50 ml). The combined dichloromethane portions were 
dried (MgSO4) and evaporated under reduced pressure/35°C to give a 
yellow oil, spectral data consistent with its formulation as methyl 
3-acetoxy-3-methyl-2-oxobutanoate (262 mg, 1.39 mmol, 87X). This was 
distilled in a Kugelrohr apparatus (90°C/0.5 mmHg) to give a 
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colourless oil (173 mg, 0.92 mmol, 58%). 
1H NMR, 220MHz (CDC13/TMS): $-1.62 (s, 6 H, C(CH3)2); 2.08 (s, 3 H, 
COCH3); 3.86 ppm (s, 3 H, OCHS). 
IR (film)st)= 1735 cm-1. 
MS (EI): m/z= 189(M)t, 129(M-OAc)+. 
High resolution MS: C8H1305 (M+H), calc. 189.0763, found 189.0770. 
GLC (3% SE30,110°C); RT- 239 s (100%) 
Elemental analysis: Found: C, 51.51; H, 6.46. C8H1205 requires C, 
51.06; H, 6.38%. 
Isomerisation of 3-hydroxy-3-methylpentan-2-one 
3-Hydroxy-3-methylpentan-2-one (256 mg, 2.2 mmol) and dibutyl tin 
oxide (27 mg, 0.11 mmo, 5 mol%) were heated together in boiling 
toluene (5 ml) under nitrogen for 14 days. The reaction was followed 
by GLC (PEG 20M, 100°C, RT (starting material) 700 s, (new product) 
770 s. ) The reaction mixture was extracted with deuterium oxide (2 ml) 
and the proton NMR spectrum determined. The signals observed were 
coincident with those of authentic 3-hydroxy-3-methylpentan-2-one and 
2-hydroxy-2-methylpentan-3-one. 
3-Hydroxy-3-methylpentan-2-one: 
IN NMR, 220MHz (D20/HOD = 65.00 ppm): 6- 0.96 (t, 3 H, CH2CH3), 1.52 
(s, 3 H, C(OH)CH3); 1.92 (m, 2 H, CH2CH3); 2.42 ppm (s, 3 H, COCH3). 
2-Hydroxy-2-methylpentan-3-one: 
IN NMR, 220MHz (D20/H0D = 65.00 ppm): $-1.16 (t, 3 H, CH2CH3), 1.53 
(s, 6 H, C(CH3)2); 2.87 ppm (q, 2 H, COCH2CH3). 
Integration of the proton NMR spectrum gave a ratio of 3-hydroxy-3- 
methylpentan-2-one to 2-hydroxy-2-methylpentan-3-one of 61: 39. 
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Attempted isomerisation of methyl 2-hydroxy-2-methyl-3-oxobutanoate 
Methyl 2-hydroxy-2-methyl-3-oxobutanoate (456 mg, 3.1 mmol) and 
dibutyl tin oxide (42 mg, 0.16 mmol) were heated together in boiling 
toluene (10 ml) under nitrogen for 18 h. No change was observed by GLC 
(PEG 20M, 70°C, RT= 500 s). Evaporation of the solvent gave the 
starting materials as judged by proton NMR spectroscopy. 
Dibutyl tin oxide-catalysed isomerisation of methyl 3-hydroxy-3- 
methyl-2-oxobutanoate 
Methyl 3-hydroxy-3-methyl-2-oxobutanoate (727 mg, 4.98 mmol) and 
dibutyl tin oxide were heated together in boiling toluene (3 ml) under 
nitrogen for 22 h. The reaction was monitored by GLC (10 % SE30, 
100°C, RT (starting material) - 320 s, RT (product) - 380 s. ) The 
solvent was evaporated under reduced pressure/40°C. The residue was 
distilled in a Kugelrohr apparatus (140°C/10 mmHg) to give methyl 
2-hydroxy-2-methyl-3-oxobutanoate as a colourless oil (587 mg, 4.02 
mmol, 81X). 
1H NMR, 220MHz (CDC13/TMS): 6= 1.60 (s, 3 H, C(OH)CH3); 2.30 (s, 3 H, 
COCH3); 3.83 (s, 3 H, OCH3); 4.23 ppm (s, 1 H, OH). 
I3C NMR, 22.63 MHz (CDC13/CDC13 =$ 77.0 ppm): 6= 21.4 (C(OH)CH3); 23.8 
(OCH3); 52.9 (COCH3); 80.8 (C(OH)); 171.6 (CO2CH3); 204.7 ppm (COCH3). 
IR (film): )) = 3505,1735(b) cm-1. 
MS (+ve CI, ammonia): m/z= 164(M+18)+, 147(M+1)+. 
High resolution MS: C6H1104, (M+H), calc. 147.0657, found 147.0656. 
GLC (3% SE30,80°C); RT 270 s. 
Elemental analysis: Found: C, 49.25; H, 7.13. C6H1004 requires C, 
49.31; H, 6.85%. 
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Dibutyl tin oxide-catalysed isomerisation of 3,3-dialkyl-3-hydroxy-2- 
oxocarboxylic esters 
A range of 3,3-dialkyl-3-hydroxy-2-oxocarboxylic esters was 
subjected to the isomerisation conditions as described above for 
methyl 3-hydroxy-3-methyl-2-oxobutanoate. 
a) Acyclic substrates having two identical alkyl substituents at 
the 3-position: 
RR 
Rg[02R1 R 
N02 
R1 
(37) (38) 
Entry R R1 Scale Catalyst Time Yield 
/mmol /mol% /days /X 
38a Me Me 5.0 3.0 1 81 
38b Pr Et 4.7 5.0 4 80 
38c Bu Et 3.6 4.4 7 88 
38d Ph Et 6.3 4.4 6 38 
Ethyl 2-hydroxy-3-oxo-2-propylhexanoate (38b) 
Colourless oil isolated by flash chromatography eluting with ethyl 
acetate-petrol 1: 9, RF 0.28. 
lH NMR, 400MHz (CDC13/TMS): 6= 0.89 (t, 3 H, J=7.4 Hz, 
C(OH)CH2CH2CH3); 0.91 (t, 3 H, J=7.3 Hz, COCH2CH2CH3); 1.27 (complex, 
5 H, OCH2CH3, C(OH)CH2CH2); 1.60 (m, 2 H, C(OH)CH2CH2); 1.77,2.06 (m, 
2 H, C(OH)CH2); 2.48,2.66 (dt, 1 H, J=18.0,7.1 Hz, COCH2); 4.17 (bs, 
1 H, OH); 4.23 ppm (dq, 2 H, J-7.2,2.2 Hz, OCH2CH3). 
IR (film): )%= 3500,1745(sh), 1720 cm-1. 
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MS (+ve CI, ammonia): m/z= 234(M+18)+, 217(M+1)+. 
High resolution MS: C11H2104 (M+H), calc. 217.1440, found 217.1458. 
GLC (PEG 20M, 180°C); RT= 595 s. 
Elemental analysis: Found: C, 61.64; H, 9.40. C11H2004 requires C, 
61.11; H, 9.26%. 
Ethyl 2-butyl-2-hydroxy-3-oxoheptanoate (38c) 
Colourless oil isolated by flash chromatography eluting with ethyl 
acetate-petrol 1: 4, RF 0-5- 
1H NMR, 220MHz (CDC13/TMS): 6= 0.89 (m, 6 H, butyl CH3); 1.15-1.65 
(complex, 11 H, butyl CH2, OCH2CHI); 2.00 (m, 2 H, C(OH)CH2); 2.62 (m, 
2 H, COCH2); 4.20 (s, 1 H, OH); 4.26 ppm (q, 2 H, J-7.1 Hz, OCH2). 
IR (film): ). ) 3500,1745(sh), 1725 cm 1. 
MS (EI): m/z= 245(M+1):, 227(M-0H)+, 171(M-C02Et)+. 
High resolution MS: C13H2404, caic. 244.1674, found 244.1652. 
GLC (3% SE30,1600C); RT= 314 s (97%). 
Elemental analysis: Found: C, 63.63; H, 9.73. C13H2404 requires C, 
63.93; H, 9.84%. 
Ethyl 2-hydroxy-3-oxo-2,3-diphenylpropanoate (38d) 
Yellow oil isolated by flash chromatography eluting with ethyl 
acetate-petrol 1: 4, RF 0.3. 
1H NMR, 220MHz (CDCI3/TMS): 6' 1.24 (t, 3 H, J-7.1 Hz, OCH2CHI); 4.25 
(m, 2 H, OCH2); 6.17 (s, 1 H, OH); 7.42-7.70 (complex, 8 H, Ph); 8.17 
ppm (m, 2 H, Ph). 
IR (film): V = 3400,3070,1755,1730,1605,1500 cm 1. 
MS (EI): m/z= 284(M)t, 211(M-C02Et)+, 105(PhCO)+. 
High resolution MS: C17H16041 calc. 284.1048, found 284.1054. 
GLC (3% SE30,200°C); RT= 533 s (98%). 
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Elemental analysis: Found: C, 71.65; H, 5.64. C17H1604 requires C, 
71.83; H, 5.63%. 
b) Cyclic substrates giving ring-expanded products: 
0002Et 
K H? 
:,. 
n 
H 
(39) 
H 
(CH2)n O2Et 
(40) 
Entry n Scale Catalyst Time Yield 
/mmol /mol% /h /% 
40a 4 6.3 2.0 14 90 
40b 5 2.0 2.0 48 79 
40c 6 4.9 2.6 16 90 
Ethyl 1-hydroxycyclohexan-2-onecarboxylate (40a) 
Colourless oil isolated by distillation in a Kugelrohr apparatus 
(100°C/0.8 mmHg). 
1H NMR, 220 MHz (CDC13/TMS): 6= 1.30 (t, 3 H, Ja7.1 Hz, OCH2CH3); 
1.63-2.10 (complex, 5 H, ring CH2); 2.63 (complex, 3 H, ring CH2); 
4.26 (q, 2 H, J=7.1 Hz, OCH2); 4.39 ppm (bs, 1 H, OH). 
13C NMR, 45.28 MHz (CDC13/CDC13 =677.0 ppm): $- 14.0 (OCH2CH3); 21.9, 
27.0,37.6,38.8 (ring CH2); 62.2 (OCH2); 80.62 (C(OH)); 170.0 
(CO2CH2); 207.2 ppm (CO). 
IR (film): V= 3460,1745(sh), 1720 cm-1. 
MS (EI): m/z= 186(M):, 142(M-C02):, 113(M-CO2E0 +. 
High resolution MS: CgH1404, caic. 186.0892, found 186.0890. 
GLC (3% SE30,120°C); RT 405 s (100%). 
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Elemental analysis: Found: C, 57.47; H, 7.54. C9H1404 requires C, 
58.06; H, 7.53%. 
Ethyl 1-hydroxycycloheptan-2-onecarboxylate (40b) 
The reaction was followed by GLC (3% SE30,130°C). RT (starting 
material) - 415 s, RT (product) = 489 s. The product mixture (starting 
material and product in the ratio 3: 97) was isolated as a colourless 
oil by distillation in a Kugelrohr apparatus (120°C/0.8 mmHg). 
1H NMR, 220MHz (CDC13/TMS): 6' 1.28 (t, 3 H, J=7.1 Hz, OCH2C); 1.3- 
2.35 (complex, 8 H, ring CH2); 2.60 (m, I H, ring CH2); 2.97 (m, 1 H, 
ring CH2); 4.23 (q, 2 H, J=7.1 Hz, OCH2); 4.29 ppm (bs, 1 H, OH). 
13C NMR, 22.63 MHz (CDC13/CDC13 -677.0 ppm): 6- 13.8 (OCH2CH3); 23.5, 
26.8,29.9,34.3,39.9 (ring CH2); 61.9 (OCH2); 83.2 (C(OH)); 170.5 
(CO2CH2); 209.4 ppm (CO). 
IR (film): V- 3480,1750,1715 cm-1. 
MS (EI): m/z= 200(M):, 127(M-C02Et)+. 
High resolution MS: C10H1604, calc. 200.1049, found 200.1047. 
Elemental analysis: Found: C, 60.58; H, 8.49. C10H1604 requires C, 
60.00; H, 8.00%. 
Ethyl 1-hydroxycyclooctan-2-onecarboxylate (40c) 
Isolated as a yellow oil by flash chromatography, eluting with ethyl 
acetate-petrol 3: 17, RF 0.28. 
Q, c H 
h, e 
k, g bd 
02Et 
i, l j, f 
1H NMR, 400 MHz (CDC13/TMS): 6= 0.90 (m, 1 H, c); 1.27 (t, 3 H, J=7 .1 
Hz, OCH2CH3); 1.40 (m, 2 H, j, k); 1.75 (m, 4 H, f, g, h, 1); 1.95 (m, 
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1 H, e); 2.15 (dt, 1 H, J=15.2,4.0 Hz, d); 2.39 (dt, 1 H, J=12.2,4.6 
Hz, b); 2.73 (m, 1 H, b); 3.06 (td, 1 H, J=12.4,3.7 Hz, a); 4.20 (q, 
2 H, J=7.1 Hz, OCH2); 4.42 ppm (bs, 1 H, OH). 
The COSY-45 spectrum (400 MHz, CDC13/TMS) is given as a contour 
plot in Figure 9.1. Table 9.1 gives the nature of the coupling between 
the multiplets, as deduced from the COSY-45 spectrum. "2" indicates a 
2-bond coupling and "3" indicates a 3-bond coupling. 
Table 9.1 
13C NMR, 45.28 MHz (CDC13/CDC13 =$77.0 ppm): 6= 13.7 (OCH2CH3); 22.0, 
23.9,25.2,29.9,30.2,36.7 (ring CH2); 61.8 (OCH2); 82.9 (C(OH)); 
170.2 (C02CH2) ; 208.0 ppm (C0). 
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IR (film): il - 3470,1745,1710 cm 1. 
MS (+ve CI, ammonia): m/z: 214(M)+, 141(M-C02Et)+. 
High resolution MS: C11H18041 calc. 214.1205, found 214.1187. 
GLC (3% SE30,150°C); RT 444 s. 
Elemental analysis: Found: C, 61.81; H, 8.72. C11H1804 requires C, 
61.68; H, 8.41%. 
c) Acyclic substrates bearing non-identical substituents at the 
3-position giving rise to product distributions: 
General procedure: 
The hydroxy keto ester (2 mmol) and dibutyl tin oxide (25 mg, 0.1 
mmol, 5 mol%) were heated together in boiling toluene (5 ml) under 
nitrogen. The solvent was evaporated under reduced pressure. The 
residue was suspended in ether (10 ml), filtered and evaporated under 
reduced pressure to give the crude product mixture. Product 
distributions were analysed by integration of the proton NMR spectrum. 
Me 
4{O2Et 
ýý 
RR 
Me., COC02Et Me C02Et 
00 
(41) (42) (4 3) 
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Starting 
material 
R Scale 
/mmol 
Catalyst 
/mol% 
Time 
/days 
Recovery 
/% 
Ratio 
(41)/(43) 
41a[33d] Et 2.3 6.7 0.9 71 1.0 
41b[33e] Pr 2.5 5.1 2.5 94 2.0 
41c[33f] Bu 3.1 5.2 5.2 92 2.5 
42d[47c] i-Pr 1.0 4.6 0.9 64 0.9 
41e[33g] t-Bu 1.5 7.2 3.0 82 2.5 
41f[33i] p-N02Ph 0.5 9.0 4.0 100 1.2 
42g[47d] Ph 1.0 4.0 0.9 48 2.7 
41h[33j] p-MeOPh 1.4 5.4 4.0 92 6.6 
Proton NMR data for the starting materials may be found in chapter 8. 
The data given here are for the new products generated by the 
isomerisation procedure. 
Ethyl 2-hydroxy-3-oxo-3-propylbutanoate (43b) 
1H NMR, 220MHz (CDC13/TMS): signals distinguishable 6- 0.94 (t, 3 H, 
J=7.1 Hz, propyl CH3); 1.30 (t, 3 H, J=7.1 Hz, OCH2CH3); 2.30 (s, 3 H, 
CH3CO); 4.27 ppm (q, 2 H, J=7.1 Hz, OCH2). 
Ethyl 2-butyl-2-hydroxy-3-oxobutanoate (43c) 
1H NMR, 220MHz (CDC13/TMS): signals distinguishable 6= 2.29 ppm (s, 
CH3CO). 
Ethyl 2-hydroxy-2-(1-methylethyl)-3-oxobutanoate (43d) 
1H 
NMR, 220MHz (CDC13/TMS): signals distinguishable 6= 0.81 (d, 3 H, 
J=7.1 Hz, CHCH3), 0.95 (d, 3 H, J=7.1 Hz, CHCH3); 1.31 (t, 3 H, J=7.1 
Hz, OCH2Cn); 2.45 (s, 3 H, CH3CO); 2.74 (m, 1 H, CH(CH3)2); 4.17 ppm 
(bs, 1 H, OH). 
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Ethyl 2,4-dimethyl-2-hydroxy-3-oxopentanoate (41d) 
1H NMR, 220MHz (CDC13/TMS): signals distinguishable 6- 1.11 (dd, 6 H, 
J=6.7,1.3 Hz, CH(CH3)2); 1.33 (t, 3 H, J=7.1 Hz, 0CH2Cý3); 1.61 (s, 3 
H, C(OH)C); 3.15 (m, 1 H, CH(CH3)2); 4.17 ppm (bs, 1 H, OH). 
Ethyl 2-(1,1-dimethylethyl)-2-hydroxy-3-oxobutanoate (43e) 
1H 
NMR, 220MHz (CDC13/TMS): signals distinguishable 6- 1.08 (s, 9 H, 
C(CH3)3); 2.32 ppm (s, 3 H, C(OH)CH-1). 
Ethyl 2-hydroxy-3-oxo-2-(4-nitrophenyl)butanoate (43f) 
1H NMR, 220MHz (CDC13/TMS): signals distinguishable 6- 2.25 (s, 3 H, 
CH3CO); 7.74 ppm (m, 2 H, Ar). 
HPLC (C18 reverse phase, methanol-water 3: 1,0.75 ml/minute, 
monitoring at 263 nm): RT (411)= 7.7 minutes; RT (43i)- 8.8 minutes. 
Ethyl 2-hydroxy-2-methyl-3-oxo-3-phenylpropanoate (41g) 
1H NMR, 220MHz (CDC13/TMS): signals distinguishable S= 1.15 (t, 3 H, 
OCH2Cn); 1.75 (s, 3 H, C(OH)Cn); 4.64 ppm (bs, 1 H, OH). 
Ethyl 2-hydroxy-3-oxo-2-phenylbutanoate (43g) 
1H NMR, 220MHz (CDC13/TMS): signals distinguishable 
6= 1.31 (t, 3 H, 
OCH2CH3); 2.23 (s, 3 H, CH3CO); 4.85 ppm (bs, 1 H, OH). 
Ethyl 2-hydroxy-2-(4-methoxyphenyl)-3-oxobutanoate (43h) 
1H 
NMR, 220MHz (CDC13/TMS): signals distinguishable 
b- 2.20 (s, 3 H, 
CH3CO); 3.86 ppm (s, 3 H, CH30Ph). 
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rUAPTFU in 
PLE-catalysed hydrolysis and ADC-catalysed decarboxylation of racemic 
ethyl 2-ethyl-2-hydroxy-3-oxobutanoate followed by autotitration 
Ethyl 2-ethyl-2-hydroxy-3-oxobutanoate (112 mg, 0.64 mmol) 
dissolved in water (5 ml) was treated with PLE (100 el, 5 mg/ml, 65 
units) at 32°C. The hydrolysis was followed at pH 7.5 by the uptake of 
1.104 M aqueous sodium hydroxide from an autotitrator. Reaction was 
complete after Ih. The solution was acidified to pH 6.5 with 
hydrochloric acid. ADC (1.1 mg, Novo batch 2) was added. The 
decarboxylation at pH 6.5 and 32°C was followed by the uptake of 1.115 
M hydrochloric acid from an autotitrator. 
Uptake of alkali: 0.475 ml, 0.52 mmol 
Uptake of acid: 0.457 ml, 0.51 mmol 
Consequtive PLE-catalysed hydrolysis and ADC-catalysed decarboxylation 
of racemic ethyl 2-ethyl-2-hydroxy-3-oxobutanoate followed by proton 
NMR spectroscopy 
To a solution of ethyl 2-ethyl-2-hydroxy-3-oxobutanoate (20 mg, 
0.11 mmol) in 1M pH 7.4 phosphate buffer (0.6 ml) was added PLE (40 
N1,10 mg/ml, 52 units). The hydrolysis was followed by proton NMR at 
220 MHz on a continuous wave instrument. Reäction was complete after 
50 minutes. ADC (0.4 mg, Novo batch 1) was added and the 
decarboxylation followed by proton NMR as before. Over a period of 
time there was a development of signals attributable to 3- 
hydroxypentan-2-one. Thereafter a slower development of signals 
attributable to 2-hydroxy pentan-3-one was observed. The relative 
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amounts of starting material and products were calculated from the 
ratio of the peak heights to the peak height of the triplet from the 
ethanol generated in the hydrolysis step. 
Acid; CH3000(OH)(Et)C02H 
Product 1; CH3000H(OH)Et 
Product 2; EtCOCH(OH)CH3 
Time 
/minutes 
Peak heights relative 
Acid Product 1 
to ethanol triplet 
Product 2 (x2) 
8 1.36 0.52 0.00 
13 1.00 0.69 0.00 
18 0.92 0.85 0.10 
21 0.89 0.87 0.10 
25 0.84 0.90 0.13 
44 0.69 0.94 0.26 
48 0.66 0.94 0.28 
53 0.61 0.94 0.31 
111 0.23 0.96 0.59 
153 0.00 0.97 0.80 
3-Hydroxypentan-2-one: 
1H NMR, 220 MHz, (H20/CH3CH2OH= 61.14 ppm): 5= 0.86 (t, 3 H, CH2Cb); 
1.70 (m, 2 H, CH2); 2.18 ppm (s, 3 H, CH3CO). 
2-Hydroxypentan-3-one: 
1H NMR, 220 MHz, (H20/CH3CH20H= 61-14 ppm): 6= 0.98 (t, 3 H, CH2CH3); 
1.33 (d, 3 H, CHCH3); 2.56 ppm (m, 2 H, CH2CH3). 
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Consecutive PLE-catalysed hydrolysis and ADC-catalysed decarboxylation 
of racemic ethyl 2-ethyl-2-hydroxy-3-oxobutanoate and analysis of the 
optical purity of the products 
Generation of racemic ketol mixture: Ethyl 2-ethyl-2-hydroxy-3- 
oxobutanoate (50 mg, 0.28 mmol) and ethyl 2-methyl-2-hydroxy-3- 
oxopentanoate (50 mg, 0.28 mmol) were treated with 3M aqueous 
potassium hydroxide (2 ml). After 2 minutes the solution was 
acidified to pH 1 with concentrated hydrochloric acid and saturated 
with sodium chloride. Carbon tetrachloride (0.5 ml) was added, the 
water adsorbed onto crushed 4A molecular sieves, and the mixture 
filtered through a glass wool plug. 
Enzymatic generation of ketol mixture: Ethyl 2-ethyl-2-hydroxy-3- 
oxobutanoate (38 mg, 0.22 mmol) was suspended in 1M pH 7.2 phosphate 
buffer (0.8 ml). PLE (100 jA1,5 mg/ml, 65 units) was added and the 
hydrolysis followed by proton NMR at 30°C. After 3h ADC (0.9 mg, Novo 
batch 1) was added and the decarboxylation followed by proton NMR at 
30°C. The decarboxylation was complete after 1.5 h. The solution was 
saturated with sodium chloride. Magnesium sulphate and carbon 
tetrachloride (0.8 ml) were added and the emulsion filtered through a 
glass wool plug. d6-Benzene (0.1 ml) was added and the proton NMR 
spectrum at 400 MHz determined in the presence of 2 equivalents of 
(S)-(+)-2,2,2-trifluoro-l-(9-anthryl)ethanol. The spectrum was re-run 
in the presence of added racemic ketol mixture. 
3-Hydroxypentan-2-one: 
1H NMR, 400 MHz (CC14, d6-benzene/benzene= 67.20 ppm): 6= 0.78 (t, 3 
H, J=7.37 Hz, CH2CH3); 1.31 (m, 1 H, CH2); 1.63 (m, 1 H, CH2); 1.78 
ppm (s, 3 H, CH3CO). 
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Peak heights: major peak 1.78 ppm 162 mm 
minor peak 1.81 ppm 6 mm 
Enantiomeric excess - 93% 
2-Hydroxypentan-3-one: 
1H NMR, 400 MHz (CC14, d6-benzene/benzene= $ 7.20 ppm): S= 0.91 (t, 3 
H, J=7.31 Hz, CH2CH3); 1.09 (d, 3 H, J=7.06 Hz, CHCH3); 2.09 ppm (m, 2 
H, CH2). 
Splitting of the doublet at 1.09 ppm was only observed in the 
presence of added racemic compound. This gave an estimated 
enantiomeric excess of enzymatically generated 2-hydroxypentan-3-one 
of >95%. 
Sequential PLE-catalysed hydrolysis and ADC-catalysed decarboxylation 
of racemic methyl 2-hydroxy-2-methyl-3-oxobutanoate 
To a solution of racemic methyl 2-hydroxy-2-methyl-3-oxobutanoate 
(34.5 mg, 0.24 mmol) dissolved in 1M pH 7.2 phosphate buffer (0.7 ml) 
was added PLE (100 . 1,5 mg/ml, 65 units) at 30°C. The hydrolysis of 
the methyl ester (followed by proton NMR spectroscopy) was complete 
after 1.5 h. ADC (0.8 mg, Novo batch 1) was added and the reaction was 
monitored as before at 30°C. The decarboxylation to give 3-hydroxy 
butan-2-one was complete after 1.5 h. Carbon tetrachloride (0.9 ml) 
was added, the water adsorbed onto crushed 4A molecular sieves, and 
the mixture filtered through a glass wool plug. d6-Benzene (0.2 ml) 
was added and the proton NMR spectrum determined at 400 MHz in the 
presence of 2 equivalents of (S)-(+)-2,2,2-trifluoro-1-(9- 
anthryl)ethanol. The spectrum was re-determined in the presence of 
added racemic 3-hydroxybutan-2-one. 
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3-Hydroxybutan-2-one: 
1H NMR, 400 MHz (CC14, d6-benzene/benzene =6 7.2 ppm): 6- 1.06 (d, 
3 H, J=7.1 Hz, CHCH3); 1.73 ppm (s, 3 H, COCH3). 
Peak heights: major peak 1.73 ppm 134 mm 
minor peak 1.73 ppm 5 mm 
Enantiomeric excess = 93% 
Treatment of racemic methyl 2-hydroxy-2-methyl-3-oxobutanoate with PLE 
and ADC 
To a solution of racemic methyl 2-hydroxy-2-methyl-3-oxobutanoate 
(23 mg, 0.16 mmol) and ADC ( 1.0 mg, Novo batch 1) in 1M pH 7.2 
phosphate buffer (0.6 ml) was added PLE (50 N1,5 mg/ml, 32 units). 
The reaction was followed at room temperature by proton NMR 
spectroscopy. Conversion of substrate into 3-hydroxybutan-2-one was 
complete after 3 h. Carbon tetrachloride (0.5 ml) was added, the water 
adsorbed onto crushed 4A molecular sieves, and the mixture was 
filtered through a glass wool plug. d6-Benzene (0.1 ml) was added and 
the proton NMR spectrum determined at 400 MHz in the presence of 2 
equivalents of (S)-(+)-2,2,2-trifluoro-l-(9-anthryl)ethanol. The 
spectrum was re-determined in the presence of added racemic 
3-hydroxybutan-2-one. 
3-Hydroxybutan-2-one: 
1H NMR, 400 MHz (CC14, d6-benzene/benzene = 67.2 ppm): 6= 1.08 (d, 
3 H, J=7.1 Hz, CHCH3); 1.76 ppm (s, 3 H, COCH3). 
No splitting was observed. Both enantiomers were observed on addition 
of racemic 3-hydroxybutan-2-one. Enantiomeric excess >99%. 
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PLE-catalysed hydrolysis and ADC-catalysed decarboxylation of racemic 
methyl 2-hydroxy-2-methyl-3-oxobutanoate followed by polarimetry 
A mixture of racemic methyl 2-hydroxy-2-methyl-3-oxobutanoate 
(33.4 mg, 0.23 mmol), ADC (2.9 mg, Novo batch 2) and PLE (50 1,5 
mg/ml, 32 units) was made up to a volume of 5 ml in a volumetric flask 
with 1M pH 7.2 phosphate buffer. An aliquot was transfered to a2 dm 
path length cell. Its optical rotation at 298 nm was monitored at room 
temperature. 
Final rotation = -0.711° at 23°C. 
Assuming total conversion of substrate to 3-hydroxybutan-2-one, then 
c=0.403 g/100 ml. Calculated specific rotation fC" D= -88°. Lit. 
84 
[GY]D -84 (c=0.6, H20). 
Sequential treatment of racemic ethyl 2-hydroxy-2-methyl-3- 
oxopentanoate with PLE and ADC at pH 7.2 
To a solution of racemic ethyl 2-hydroxy-2-methyl-3-oxopentanoate 
(25 mg, 0.14 mmol) in 1M pH 7.2 phosphate buffer (0.6 ml) was added 
PLE (100 111,5 mg/ml, 65 units) and the mixture incubated at 34°C. 
Hydrolysis of the ester was complete after 2h as judged by proton NMR 
spectroscopy. ADC (0.8 mg, Novo batch 2) was added and the 
decarboxylation was followed by proton NMR spectroscopy. The relative 
amounts of 2-hydroxy-2-methyl-3-oxopentanoic acid, 2-hydroxypentan-3- 
one and 3-hydroxypentan-2-one were calculated by comparison of the 
relevant peak heights from the compounds with that of the methyl 
triplet of the ethanol generated in the PLE-catalysed hydrolysis step. 
The proton NMR data for the Cl-hydroxyketones are given on page 157. 
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Time 
/minutes 
Peak heights as % of 
EtCOCH(OH)CH3 (x2) 
ethanol triplet 
CH3COCH(OH)Et 
3 31 10 
6 42 14 
9 56 16 
11 71 21 
14 73 24 
17 80 33 
19 83 42 
38 87 93 
Sequential treatment of racemic ethyl 2-hydroxy-2-methyl-3- 
oxopentanoate with PLE and ADC at pH 7.7 
To a solution of racemic ethyl 2-hydroxy-2-methyl-3-oxopentanoate 
(39 mg, 0.22 mmol) in 1M pH 7.7 phosphate buffer (0.6 ml) was added 
PLE (20 0 1,10 mg/ml, 26 units). The hydrolysis at 29°C was followed 
by proton NMR spectroscopy. The extent of reaction was calcuated by 
the peak height ratio of the methyl singlet in the ester and the acid. 
ADC (0.6 mg, Novo batch 1) was added and the decarboxylation was 
followed by proton NMR spectroscopy. The final product distribution 
comprised equimolar 2-hydroxypentan-3-one and 3-hydroxypentan-2-one. 
An unidentified compound was observed which disappeared during the 
course of the reaction. The relative amounts of starting material, 
hydroxyketones and the unidentified transient compound were calculated 
by comparison of representative peak heights with the ethanol 
generated in the PLE-catalysed step. 
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Transient compound: 
1H NMR, 220 MHz, (H20/CH3CH2OH = 61.04 ppm): $=1.13 (t); 1.85 (s); 
2.60 ppm (m). 
1H NMR data for the Cl-hydroxyketones are given on page 157. 
PLE-catalysed hydrolysis: 
Time/minutes % reaction Time/minutes % reaction 
4 14 40 79 
7 25 45 82 
12 38 50 84 
15 48 55 87 
21 62 60 89 
25 68 70 95 
33 74 95 97 
35 76 
ADC-catalysed decarboxylation: 
Time 
/minutes 
Peak heights as 
EtCOCH(OH)CH3 (x2) 
% of ethanol triplet 
CH3000H(OH)Et singlet 1.85 ppm 
4 24 2 123 
6 32 4 113 
8 42 6 103 
10 44 7 94 
12 52 10 87 
14 56 13 79 
16 56 15 74 
18 64 18 71 
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21 64 22 63 
25 66 32 58 
29 68 40 53 
34 66 53 51 
41 68 66 48 
49 70 78 42 
56 72 90 40 
68 72 106 36 
77 76 116 36 
85 76 117 33 
106 78 117 30 
122 80 115 26 
138 82 113 24 
147 82 112 23 
158 84 112 21 
173 84 111 20 
190 86 112 18 
207 86 111 16 
227 88 110 15 
1083 94 100 0 
The action of PLE and ADC on racemic ethyl 2-ethyl-2-hydroxy-3- 
oxopentanoate 
To a solution of racemic ethyl 2-ethyl-2-hydroxy-3-oxopentanoate 
(25.6 mg, 0.14 mmol) and ADC (4.1 mg, Novo batch 2) in 1M pH 7.2 
phosphate buffer (0.6 ml) was added PLE (100 ýl, 5 mg/ml, 65 units). 
The reaction was followed by proton NMR spectroscopy at 30°C. Total 
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conversion of starting material to 4-hydroxyhexan-3-one was observed 
after 2.5 h. Carbon tetrachloride (0.6 ml) was added, the water was 
adsorbed onto crushed 3A molecular sieves, and the mixture was 
filtered through a glass wool plug. d6-Benzene (0.1 ml) was added and 
the proton NMR spectrum was determined at 400 MHz in the presence of 6 
equivalents of (S)-(+)-2,2,2-trifluoro-l-(9-anthryl)ethanol. The 
spectrum was re-determined in the presence of added racemic 4- 
hydroxyhexan-3-one. In neither spectrum was splitting of the signals 
observed. Selective decoupling of the relevant multiplets to generate 
singlets also showed no conclusive splittings. 
4-Hydroxyhexan-3-one: 
1H NMR, 400 MHz (CC14, d6-benzene/benzene = $7.2 ppm): $ - 0.77 (t, 
3 H, J=7.5 Hz, CHCH2CH3); 0.92 (t, 3 H, J=7.5 Hz, COCH2CH3); 1.3 (m, 
1 H, CHCH2); 1.62 (m, 1 H, CHCH2); 2.1 ppm (m, 2 H, COCH2). 
The action of PLE and ADC on raceric ethyl 2-ethyl-2-hydroxy-3- 
oxopentanoate followed by polarimetry 
A mixture of racemic ethyl 2-ethyl-2-hydroxy-3-oxopentanoate 
(38.6 mg, 0.205 mmol), ADC (3.3 mg, Novo batch 2) and PLE (50 el, 5 
mg/ml, 32 units) was made up to a volume of 5 ml with 1M pH 7.2 
phosphate buffer in a volumetric flask. An aliquot was transferred to 
a2 dm path length cell. Its optical rotatiön at 289 nm was followed 
at room temperature. 
Final observed rotation = -0.727° at 27°C. Assuming total conversion 
of starting material to 4-hydroxyhexan-3-one, then c= 0.476 g/100 ml. 
Calculated specific rotation [GY)D = -76°. 
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The action of PLE and ADC on racemic ethyl 2-hydroxy-2-methyl-3- 
oxohexanoate 
To a mixture of racemic ethyl 2-hydroxy-2-methyl-3-oxohexanoate 
(37 mg, 0.2 mmol) and ADC (7.3 mg, Novo batch 2) in 1M pH 7.2 
phosphate buffer (0.6 ml) was added PLE (100 . 1,5 mg/ml, 65 units). 
The mixture was agitated at 33°C and the reaction monitored by TLC 
(ethyl acetate-petrol 3: 7); Starting material RF 0.41, new products 
RF 0.27. After 6h no starting material remained. Carbon tetrachloride 
(0.8 ml) was added, the water was adsorbed onto crushed 3A molecular 
sieves, and the mixture was filtered through a glass wool plug. d6- 
Benzene (0.1 ml) was added and the proton NMR spectrum was determined 
at 400 MHz in the presence of 2 equivalents of (S)-(+)-2,2,2- 
trifluoro-l-(9-anthryl)ethanol. The spectrum was re-run in the 
presence of added racemic 2-hydroxyhexan-3-one and 3-hydroxyhexan-2- 
one. 
3-Hydroxyhexan-2-one: 
1H NMR, 400 MHz (CC14, d6-benzene/benzene = 67.2 ppm): 
6- 0.75 (t, 
3 H, J=7.4 Hz, CH2CH3); 1.18-1.50 (complex, 6 H, propyl CH2 from both 
hydroxyketones); 1.74 ppm (s, 3 H, COCH3). 
Peak heights: major peak 1.74 ppm 147 mm 
minor peak 1.75 ppm 6 mm 
Enantiomeric excess = 92% 
2-Hydroxyhexan-3-one: 
1H NMR, 400 MHz (CC14, d6-benzene/benzene = 57.2 ppm): b= 0.81 (t, 
3 H, J=7.2 Hz, CH2CH3); 1.06 (d, 3 H, J=7.1 Hz, CHCH3); 2.01 ppm (m, 
2 H, COCH2). 
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Splittings were only observed on addition of racemic 2- 
hydroxyhexan-3-one. Estimated enantiomeric excess >95%. 
The action of PLE on racemic ethyl 2-hydroxy-3-oxo-2,3,3- 
trimethylpentanoate 
Racemic ethyl 2-hydroxy-3-oxo-2,3,3-trimethylpentanoate (41.9 mg, 
0.21 mmol) suspended in water (5 ml) at 32°C was treated with PLE 
(20 N 1,5 mg/ml, 13 units) and maintained at pH 7.5 by titration with 
0.11 M aqueous sodium hydroxide from an autotitrator. After 2h there 
had been no uptake of alkali from the autotitrator. 
The action of PLE on racemic methyl 1-hydroxy-2-oxocyclohexane 
carboxylate 
Racemic methyl 1-hydroxy-2-oxocyclohexanecarboxylate was treated 
with PLE as above. No reaction was observed. 
The action of ADC on racemic 2-hydroxy-3-oxo-2,3,3-trimethylpentanoic 
acid 
Racemic ethyl 2-hydroxy-3-oxo-2,3,3-trimethylpentanoate (26 mg, 
0.13 mmol) was treated with 3M aqueous sodium hydroxide (0.2 ml, 0.6 
mmol). After 2 minutes the solution was acidified to pH 7 with 4M 
hydrochloric acid. 1M pH 7.2 Phosphate buffer (0.6 ml) and ADC 
(2.2 mg, Novo batch 2) were added. The mixture was incubated at 30°C 
and its proton NMR spectrum recorded periodically. No change was 
observed over a4h period. 
1H NMR, 220 MHz (H20/CH3CH2OH = 63.55 ppm): $=1.10 (s, 9 H, C(CH3)3); 
1.31 ppm (s, 3 H, C(OH)CH3). 
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The action of ADC on racemic 1-hydroxycyclohexan-2-one carboxylate 
Racemic methyl 1-hydroxycyclohexan-2-one carboxylate (286 mg, 
1.66 mmol) was treated with 1M aqueous potassium hydroxide (2 ml). 
After 1.5 minutes the solution was acidified to pH 7 with 5M 
hydrochloric acid. ADC (1.8 mg, Novo batch 2) was added and the uptake 
of 1.01 M hydrochloric acid from an autotitrator at pH 6.5 and 32°C 
was monitored. There was no further reaction after 3 h. The solution 
was extracted with dichloromethane (4x20 ml). The combined extracts 
were dried (MgSO4) and evaporated under reduced pressure/30°C to give 
a yellow oil (69 mg, 0.6 mmol, 37%). 
Uptake of acid = 0.711 ml (0.718 mmol, 43%). 
1H NMR, 220MHz (CDC13/TMS): 6= 1.1-2.8 (complex, 8 H, CH2); 3.70 (bs, 
1 H, OH); 4.15 ppm (dd, I H, J=7,12 Hz, CH(OR)). 
IR (film): ) )= 3400,1710 cm 1. 
MS (EI): m/z= 144(M)t, 70(M-CO2)+. 
High resolution MS: C5H10020 calc. 114.0680, found 114.0680. 
ADC-catalysed deuterium incorporation into racemic acetoin 
Racemic acetoin (31 mg, 0.35 mmol) and ADC (0.7 mg, Novo batch 1) 
were suspended in deuterium oxide (0.6 ml) and incubated at 43°C. The 
proton NMR spectrum was determined periodically. After 5 days the 
reaction mixture was diluted to a volume of 15 ml with water. Racemic 
acetoin (110 mg, 1.25 mmol) was added and the solution was extracted 
with ether continuously for 10 h. Water (1.5 ml) was added to the 
ether phase. The ether was evaporated under reduced pressure/20°C. The 
deuterium NMR spectrum of the remaining aqueous phase was determined. 
1H NMR, 220 MHz (D20/HOD = &. 83 ppm): b= 1.37 (complex, 3 H, 
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CH(D)CH3); 2.23 (s, 3 H, COCH3); 4.43 ppm (q, 0.5 H, J=7.2 Hz, CH). 
2H NMR, 61.4 MHz (H20/H20 "64.76 ppm): 6"4.33 ppm (s, CH3CD). 
ADC-catalysed deuterium encorporation into racemic acetoin and 
analysis by vibrational circular dichroism 
Racemic acetoin (147 mg, 1.67 mmol) and ADC (3.1 mg, Novo batch 
2) were suspended in deuterium oxide (2 ml) and incubated at 34°C. The 
proton NMR spectrum was determined periodically. After 4 days the 
reaction mixture was diluted with water (10 ml) and extracted with 
ether continuously for 10 h. Carbon tetrachloride (10 ml) was added 
and the ether was distilled off at atmospheric pressure. The 
vibrational circular dichroism spectrum of the carbon tetrachloride 
solution and that of a carbon tetrachloride solution of (R)-(-)- 
acetoin of normal isotopic content was determined by Dr A. F. Drake at 
the Department of Chemistry, Birkbeck College, London. These spectra 
are shown on page 78. 
The action of ALS II and ADC on sodium pyruvate 
Sodium pyruvate (49.4 mg, 0.45 mmol), ADC (3.4 mg, Novo batch 2), 
TPP (3.6 mg, 8.8 N mol), FAD (1.1 mg, 1.4 Nmol) and magnesium chloride 
(12.2 mg, 0.13 mmol) were dissolved in 1M pH 7.2 phosphate buffer 
(0.8 ml). ALS II (5 (Al, 149 mg/ml, 11 units) was added and the 
solution was incubated in the dark at 37°C. The proton NMR spectrum 
was determined periodically. Acetoin was the sole observed product. 
Time/h % conversion Time/h % conversion 
0.25 
0.28 
59 
66 
1.00 98 
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The action of ALS II and ADC on sodium 2-oxobutanoate 
Sodium 2-oxobutanoate (55 mg, 0.44 mmol), ADC (5.2 mg, Novo batch 
2), TPP (3.8 mg, 9.3 mol), FAD (0.8 mg, 1.0 mol) and magnesium 
chloride (14 mg, 0.15 mmol) were dissolved in IM pH 7.2 phosphate 
buffer (0.8 ml). ALS II (5 1,149 mg/ml, 11 units) was added and the 
solution was incubated in the dark at 37°C. The proton NMR spectrum 
was determined periodically. The sole observed product was 4- 
hydroxyhexan-3-one. 
1H NMR, 220 MHz, (H20/TSS): 6- 0.89 (t, 3 H, J=7.6 Hz, CHCH2CH3); 1.03 
(t, 3 H, J=7.6 Hz, COCH2CH3); 1.76 (m, 2 H, CHCH2); 2.60 ppm (dq, 2 H, 
J=7.6,2.7 Hz, COCH7). 
Time/h % conversion Time/h % conversion 
0.7 15 7.7 86 
2.9 63 10.5 91 
3.7 70 23.8 97 
5.3 79 33.4 97 
The action of ALS II and ADC on sodium 2-oxobutanoate followed 
polarimetry 
Sodium 2-oxobutanoate (44.0 mg, 0.355 mmol) and ADC (3.0 mg, Novo 
batch 2) were dissolved in 0.1 M pH 7.2 phosphate buffer containing 
magnesium chloride (0.12 M), FAD (14 1AM) and TPP (2.4 mM). ALS II (10 
e1,149 mg/ml, 22.3 units) was added and the solution was made up to 5 
ml in a volumetric flask with more buffer solution. The solution was 
incubated at 37°C in the dark. Aliquots (1.03 ml) were removed 
periodically, diluted to a volume of 5 ml with water and the optical 
rotation was measured at 289 nm. The polarimeter had previously been 
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zeroed using the buffer solution diluted similarly. 
On the basis of complete conversion of starting material to 
product, then the concentration of 4-hydroxyhexan-3-one in the 
polarimeter cell = 0.0848 g/100 ml. 
Time Rotation temperature fell 
/h /° /°C /° 
3.4 -0.122 26 -72 
4.9 -0.133 27 -78 
8.3 -0.137 26 -81 
The action of ALS II and ADC on 2-oxo-2-phenylethanoic acid 
2-Oxo-2-phenylethanoic acid (79.4 mg, 0.53 mmol), ADC (2.4 mg, 
Novo batch 2), TPP (3.5 mg, 8.6 µmol), FAD (1.1 mg, 1.4 Owl) and 
magnesium chloride (10.2 mg, 0.11 mmol) were dissolved in 1M pH 7.2 
phosphate buffer (0.8 ml). ALS II (5 N1,149 mg/ml, 11 units) was 
added and the solution was incubated in the dark at 37°C. The proton 
NMR spectrum was determined periodically. There was no observable 
change over a 10 h period. 
The action of ALS II and ADC on equimolar sodium pyruvate and sodium 
2-oxobutanoate 
Sodium pyruvate (56.5 mg, 0.514 mmol), sodium 2-oxobutanoate 
(63.8 mg, 0.515 mmol), ADC (5.5 mg, Novo batch 2), TPP (1.4 mg, 3.4 
Nmol), FAD (2.9 mg, 3.7 umol) and magnesium chloride (10.5 mg, 0.11 
mmol) were dissolved in 
f1 
M pH 7.2 phosphate buffer (0.8 ml). ALS II 
(5 41,149 mg/ml, 11 units) was added and the solution was incubated 
in the dark at 37°C. The proton NMR spectrum was determined 
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periodically. The generation of signals attributable to 3- 
hydroxypentan-2-one was observed. 
lH NMR, 220 MHz, (H20/TSS): $-0.90 (t, 3 H, J=7 Hz, CH2CH3); 1.75 (m, 
2 H, CH2); 2.21 ppm (s, 3 H, COCHI). 
Time/h % conversion Time/h % conversion 
0.15 15 4.93 95 
1.05 87 7.72 95 
2.62 92 21.00 96 
The action of ALS II and ADC on equimolar sodium pyruvate and sodium 
2-oxobutanoate followed by ploarimetry 
Sodium pyruvate (34.0 mg, . 309 mmol), sodium 2-oxobutanoate (37.7 
mg, 0.304 mmol) and ADC (2.0 mg, Novo batch 2) were dissolved in 0.1 M 
pH 7.2 phosphate buffer containing magnesium chloride (0.12 M), FAD 
(14 NM) and TPP (2.4 mM). ALS II (10 N1,149 mg/ml, 22.3 units) was 
added and the was solution made up to 5 ml in a volumetric flask with 
more buffer solution. The solution was incubated at 37°C in the dark. 
Aliquots (1.03 ml) were removed periodically, diluted to a volume of 
5 ml with water and the optical rotation was measured at 289 nm. The 
polarimeter had previously been zeroed using the buffer solution 
diluted similarly. 
On the basis of complete conversion of starting material to 
product, then the concentration of 3-hydroxypentan-2-one in the 
polarimeter cell = 0.128 g/100 ml. 
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Time Rotation temperature [(X] 
/h /° /°C /0 
2.9 -0.225 26 -88 
4.5 -0.238 27 -93 
7.9 -0.240 26 -94 
The action of ALS II and ADC on equimolar sodium pyruvate and 2-oxo-2- 
phenylethanoic acid 
2-Oxo-2-phenylethanoic acid (78 mg, 0.52 mmol), sodium pyruvate 
(56 mg, 0.51 mmol), ADC (3.4 mg, Novo batch 2), TPP (4.9 mg, 12.0 
1A mol), FAD (2.0 mg, 2.6 mol) and magnesium chloride (14.3 mg, 0.15 
mmol) were dissolved in 1M pH 7.2 phosphate buffer (0.8 ml). ALS II 
(5 p1,149 mg/ml, 11 units) was added and the solution was incubated 
in the dark at 37°C. The proton NMR spectrum was determined 
periodically. There was no observable change over a 10 h period. 
Preparation of trans-cyclohexane-1,2-diol 
To a solution of cyclohexene (5 ml, 49.3 mmol) in 98% formic acid 
(50 ml) was added a 30% solution of hydrogen peroxide in water (17 ml, 
165 mmol). The stirred mixture was heated at 60-70°C for 2h to give a 
homogeneous solution. The solvent was evaporated under reduced 
pressure/50°C and the residue was heated with sodium hydroxide (7 g, 
175 mmol) in boiling water (50 ml) for 1 h. The solution was 
evaporated to dryness under reduced pressure/50°C. The residue was 
suspended in dichloromethane (50 ml) and filtered. The solid was 
washed with dichioromethane (3x40 ml). The combined dichloromethane 
portions were dried (MgSO4) and evaporated under reduced pressure/40°C 
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to give the diol as a white crystalline solid (4.960 g, 40.4 no®ol, 
82%). This was recrystallised from acetone to give a white crystalline 
solid mp 102-103°C (2.42 g, 42%). Lit. 63 mp 102-103°C. 
1H NMR, 220 MHz, (CDC13/TMS): 6- 1.26 (complex, 4 H, CH2); 1.70 
(complex, 2 H, CH2); 1.96 (complex, 2 H, CH2); 3.36 (complex, 2 H, 
CH(OH)CH(OH)); 3.51 ppm (bs, 2 H, OH). 
13C NMR, 22.63 MHz (CDC13/CDC13 = 677.0 ppm): $- 24.2 
(C(OH)CH2CH2CH2); 32.8 (CH2CH(OH)CH(OH)CH2)); 75.6 ppm (CH(OH)CH(OH)). 
IR (film): ))= 3300 cm 1. 
MS (EI): m/z= 116(M)t, 98(M-OH)+, 70(C5H10)+. 
High resolution MS: C6H1202, calc. 166.0837, found 166.0837. 
Reduction of 2-hydroxycyclohexanone with sodium borohydride in water 
A suspension of 2-hydroxycyclohexanone dinier (199 mg, 1.7 mmol 
with respect to monomer) in water (10 ml) was stirred for 1.5 days to 
give a homogeneous solution. Sodium borohydride (52 mg, 1.4 mmol) was 
added and the mixture was stirred for 24 h. The solution was acidified 
to pH 1 with concentrated hydrochloric acid and extracted with 
dichloromethane (4x30 ml). The combined extracts were dried (MgSO4) 
and evaporated under reduced pressure/40°C to give the diol mixture as 
a white crystalline solid (64 mg, 32X). 
Data for the trans-diol is given above. 
Isomer mixture: Data for the cis-diol; 
13C NNR, 22.63 MHz (CDC13/CDC13 = 577.0 ppm): 6= 21.4 
(C(OH)CH2CH2CH2); 29.9 (CH2CH(0H)CH(OH)CH2); 70.6 ppm (CH(OH)CH(OH)). 
Relative peak heights cis-diol: trans-diol 1: 1 
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Reduction of 2-hydroxycyclohexanone with sodium borohydride in 
methanol 
To a mixture of 2-hydroxycyclohexanone dimer (475 mg, 4.2 mmol 
with respect to monomer) and sodium borohydride (154 mg, 4.0 mmol) 
under nitrogen was added dry methanol (15 ml). The mixture became hot 
and formed a homogeneous solution after 3 minutes. After 10 minutes no 
starting material was observed by TLC (ethyl acetate). After 30 
minutes the solvent was evaporated under reduced pressure/40°C, the 
residue was dissolved in water (10 ml), acidified to pH 1 with dilute 
hydrochloric acid and extracted with dichloromethane (4x15 ml). The 
combined extracts were dried (MgS04) and evaporated under reduced 
pressure/40°C to give the diol mixture as a white crystalline solid 
(133 mg, 27%). 
Ratio of cis-diol: trans-diol as judged by 
13C NMR; 1: 1. 
Reduction of 2-hydroxycyclohexanone with sodium borohydride in ethanol 
To a mixture of 2-hydroxycyclohexanone dimer (442 mg, 3.9 mmol 
with respect to monomer) and sodium borohydride (143 mg, 3.8 mmol) 
under nitrogen was added dry ethanol (15 ml). After 
30 minutes no 
starting material was observed by TLC (ethyl acetate). After 50 
minutes the solvent was evaporated under reduced pressure/40°C, the 
residue dissolved in water (10 ml), acidified to pH 1 with dilute 
hydrochloric acid and extracted with dichloromethane (4x15 ml). The 
combined extracts were dried (MgSO4) and evaporated under reduced 
pressure/40°C to give the diol mixture as a white crystalline solid 
(177 mg, 39%). 
Ratio of cis-diol: trans-diol as judged by 
13C NMR; 1: 1. 
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Reduction of 2-hydroxycyclohexanone with sodium borohydride in 
propan-2-ol 
To a mixture of 2-hydroxycyclohexanone dinier (502 mg, 4.4 mmol 
with respect to monomer) and sodium borohydride (110 mg, 2.9 mmol) 
under nitrogen was added dry propan-2-ol (20 ml). The mixture was 
stirred vigorously at 0°C for 2h and for 24 h at room temperature. The 
solvent was evaporated under reduced pressure/40°C, the residue 
dissolved in water (10 ml), acidified to pH 1 with dilute hydrochloric 
acid and extracted with dichloromethane (4x15 ml). The combined 
extracts were dried (MgSO4) and evaporated under reduced pressure/40°C 
to give the diol mixture as a white crystalline solid (145 mg, 28%). 
Ratio of cis-diol: trans-diol as judged by 
13C NMR; 1: 1.45. 
Reduction of 2-hydroxycyclohexanone with lithium aluminium hydride 
To a stirred suspension of 2-hydroxycyclohexanone dimer (328 mg, 
2.9 mmol with respect to monomer) in dry ether (50 ml) at -75°C under 
nitrogen was added a suspension of lithium aluminium hydride (500 mg, 
13 mmol) in ether (40 ml) over a period of 20 minutes. The mixture was 
stirred at -75°C for 4h and at room temperature for 10 h, poured onto 
water (30 ml) and acidified to pH 1 with 4M hydrochloric acid. The 
aqueous layer was extracted with dichloromethane (4x50 ml). The 
combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure/35°C to give the diol mixture as a white crystalline 
solid (121 mg, 36%). mp 67-68°C 
Ratio of cis-diol: trans-diol as judged by 
13C NMR; 1.5: 1. 
174 
REFERENCES 
1. Walsh, C., Tetrahedron, 1982,38,871-909. 
2. Crout, D. H. G., and Hedgecock, J. R., J. Chem. Soc. Perkin 
Trans. 1,1979,1982-1989. 
3. Anatol, J., and Medete, A., Bull. Soc. Chim. France, 1972, 
189-192. 
4. Organic Sy nthesis, 2nd Edition, Coll. vol. 1,241-245 
5. David, S., and Thieffry, A., J. Chem. Soc. Perkin Trans. 1,1979, 
1568-1573. 
6. Considine, W. J., J. Organomet. Chem., 1966,5, 263-266. 
7. Mehrotra, R. C., and Gupta, V. D., J. Or ganomet. Chem., 1965,4, 
145-150. 
8. Smith, P. J., White, R. F. M., and Smith, L., J. Organomet. Chem., 
1972,40,341-353. 
9. David, S., and Thieffry, A., Tetrahedron Lett., 1981,22, 
2647-2650. 
10. Schloss, J. V., Van Dyk, D. E., Vasta, J. F., and Kutny, R. M., 
Biochemistry, 1985,24,4952-4959. 
11. LaRossa, R. A., and Schloss, J. V., J. Biol. Chem., 1984,259, 
8753-8757. 
12. Krampitz, L. O., Methods in Enzymology, 1957,3,277-283. 
13. Hill, R. K., and Sawada, S., Bioorg. Chem., 1979,8,175-189. 
14. Armstrong, F. B., Lipscomb, E. L., Crout, D. H. G., Mitchell, M. B., 
and Prakash, S. R., J. Chem. Soc. Perkin Trans. 1,1983, 
1197-1201. 
15. Andriamialisoa, R. Z., Langlots, N., and Langlois, Y., 
175 
Tetrahedron Lett., 1985,3563-3566. 
16. Heathcock, C. H., Mahaim, C., Schlecht, M. F., and Utawanit, T., 
J. Org. Chem., 1984,49,3264-3274. 
17. Kutney, J. P., Bunzli-Trepp, U., Chan, K. K., de Souza, J. P., 
Fujise, Y., Honda, T., Katsube, J., Klein, F. K., Leutwiler, A., 
Morehead, S., Rohr, M., and Worth, B. R., J. Am. Chem. Soc., 1978, 
100,4220-4244. 
18. Ando, M., Büchi, G., and Ohnuma, T., J. Am. Chem. Soc., 1975,97, 
6880-6991. 
19. Büchi, G., Matsumoto, K. E., and Nishimura, H., J. Am. Chem. Soc., 
1971,93,3329-3331. 
20. Hubert, A. J., and Starcher, P. S., J. Chem. Soc. (C), 1968, 
2500-2502. 
21. Coleman, J. E., Ricciuti, C., and Swern, D., J. Am. Chem. Soc., 
1956,78,5342-5345. 
22. Srinivasan, N. S., and Lee, D. G., Synthesis, 1979,520-521. 
23. Wolfe, S., Ingold, C. F., and Lemieux, R. U., J. Am. Chem. Soc., 
1981,103,938-939. 
24. King, G., J. Chem. Soc. (C), 1936,1788-1792. 
25. Freeman, F., Fuselier, C. O., Tetrahedron Lett., 1975,2133-2136. 
26 Lemieux, R. U., Kullnig, R. K., and Moir, R. Y., J. Am. Chem. Soc., 
1958,80,2237-2242. 
27. Wilberg, K. B., and Saegebarth, K. A., J. Am. Chem. Soc., 1957,79, 
2822-2824. 
28. Wilberg, K. B., and Geer, R. D., J. Am. Chem. Soc., 1966,88, 
5827-5832. 
29. Lee, D. G., and Brownridge, J. R., J. Am. Chem. Soc., 1974,96, 
176 
5517-5523. 
30. Fridovich, I., in "The Enzymes, " ed. Boyer, P. D., Academic Press, 
New York and London, 3rd edition, 1977,6,255-270. 
31. Hamilton, G. A., and Westheimer, F. H., J. Am. Chem. Soc., 1959, 
81,6332-6333. 
32. Fridovich, I., and Westheimer, F. H., J. Am. Chem. Soc., 1962,84, 
3208-3209. 
33. Warren, S., Zerner, B., and Westheimer, F. H., Biochemistry, 1966, 
5,817-823. 
34. Godtfredsen, S. E., and Ottesen, M., Carlesberg Res. Commun., 
1982,47,92-102. 
35. Robins, D. J., and Crout, D. H. G., J. Chem. Soc. (C), 1970, 
1334-1336. 
36. Blom, R. H., J. Am. Chem. Soc., 1945,67,494. 
37. Crout, D. H. G., Littlechild, J., Mitchell, B., and Morrey, S. M., 
J. Chem. Soc. Perkin Trans. 1,1984,2271-2276. 
38. Loken, J. P., and Stormer, F. C., Eur. J. Biochem., 1970,14, 
133-137. 
39. Juni, E., J. Biol. Chem., 1952,195,715-726. 
40. Lienhard, G. E., and Rose, I. A., Biochemistry, 1964,3,190-195. 
41. Knapp, F. F., Goad, L. J., and Goodwin, T. W., Phytochemistry, 1977, 
16,1677. 
42. Schutzbach, J. S., and Feingold, D. S., J. Biol. Chem., 1970,245, 
2476-2482. 
43. Chang, C-C., Laghai, A., O'Leary, M. H., and Floss, H. G., 
J. Biol. Chem., 1982,257,3564-3569. 
44. Palekar, A. G., Tate, S. S., and Meister, A., Biochemistry, 1971, 
177 
10,2180-2182. 
45. Battersby, A. R., Chrystal, E. J. T., and Staunton, J., 
J. Chem. Soc. Perkin Trans. 1,1980,31-42. 
46. Leistner, E., and Spencer, I. D., J. Chem. Soc. Chem. Commun., 
1975,378-379. 
47. Battersby. A. R., Nicoletti, M., Staunton, J., and Vieggaar, M., 
J. Chem. Soc. Perkin Trans. 1,1980,43-51. 
48. Battersby, A. R., Staunton, J., and Tippet, J., J. Chem. Soc. 
Perkin Trans. 1,1982,455-459. 
49. Orr, G. R., and Gould, S. J., Tetrahedron Lett., 1982,3139-3142. 
50. Allen, R. R., and Klinman, J. P., J. Biol. Chem., 1981,256, 
3233-3239. 
51. Rose, I. A., J. Biol. Chem., 1970,245,6051-6056. 
52. Rose, Z. B., J. Biol. Chem., 1966,241,2311-2313. 
53. Filler, R., Chem. Rev., 1963,63,21-43. 
54. Kruse, P. F., Geurkink, N., and Grist, K. L., J. Am. Chem. Soc., 
1954,76,5796-5797. 
55. Fieser, L. F., and Rajagopalan, S., J. Am. Chem. Soc., 1949,71, 
3935-3938. 
56. Fieser, L. F., and Rajagopalan, S., J. Am. Chem. Soc., 1949,71, 
3938-3941. 
57. Stuckwisch, C. G., Hammer, G. G., and Blau, N. F., J. Org. Chem., 
1957,22,1678-1680. 
58. Sheehan, J. C., and Hess, G. P., J. Am. Chem. Soc., 1955,77, 
1067-1068. 
59. Belleau, B., and Malek, G., J. Am. Chem. Soc., 1968,90, 
1650-1651. 
178 
60. Piancatelli, G., Scettri, A., and D'Auria, M., Synthesis, 1982 
245-257. 
61. Bowers, A. J., Halsall, T. G., Jones, E. R. H., and Lemin, A. J., 
J. Chem. Soc., 1953,2548-2560. 
62. Junge, W., and Heymann, E., Eur. J. Biochem., 1979,95,519-525. 
63. Swern, D., Org. React., 1953,7,378-433. 
64. Wadsworth, W. S., and Emmons, W. D., J. Am. Chem. Soc., 1961,83 
1733-1737. 
65. Tanikaga, R., Miyashita, K., Ono, N., and Kaji, A., Synthesis, 
1982,131-132. 
66. Larock, R. C., J. Org. Chem., 1975,40,3237-3242. 
67. Vieregge, H., Schmidt, H. M., Renema, J., Bos, H. J. T., and 
Arens, J. F., Rec. Trav. Chim., 1966,85,929-951. 
68. White, J. D., Takabe, K., and Prisbylla, M. P., J. Org. Chem., 
1985,50,5233-5244. 
69. Kinstle, T. H., and Mandanas, B. Y., J. Chem. Soc. Chem. Commun., 
1968,1699-1700. 
70. Aplin, R. T., and Frearson, M. J., Chem. Ind. (London), 1969, 
1663-1664. 
71. Stevens, C. L., Glenn, F. E., and Pillai, P. M., J. Am. Chem. Soc. 
1973,95,6301-6308. 
72. van der Westhuizen, J. H., Ferreira, D., and Roux, D. G., 
J. Chem. Soc. Perkin Trans. 1,1980,2856-2865. 
73. Crout, D. H. G., and Rathbone, D. L., J. Chem. Soc. Chem. Commun., 
1987,290-291. 
74. Turner, R. B., J. Am. Chem. Soc., 1953,75,3484-3488. 
75. Wendler, N. L., Taube, D., and Walker, R. W., Tetrahedron, 1960, 
179 
11,163-170. 
76. Oliveto, E. P., Gerold, C., Rausser, R., and Hershberg, E. B., 
J. Am. Chem. Soc., 1957,79,3594-3597. 
77. Fishman, J., J. Am. Chem. Soc., 1960,82,6143-6147. 
78. Stevens, C. L., Treat, T. A., and Pillai, P. M., J. Org. Chem., 
1972,37,2091-2097. 
79. Weisner, K., Chan, K. K., and Demerson, L., Tetrahedron Lett., 
1965,2893-2897. 
80. Van Rheenen, V., Kelly, R. C., and Cha, D. Y., Tetrahedron Lett., 
1976,1973-1976. 
81. Wolinsky, J., and Erickson, K. L., J. Org. Chem., 1965,30, 
2208-2211. 
82. Stoops, K. J., Horgan, D. J., Runnegar, M. T. G., and de Jersey, J., 
Biochemistry, 1969,8,2026-2033. 
83. Pirkle, K. J., and Hoover, D. J., Top. Stereochem., 1982,13, 
263-331. 
84. Crout, D. H. G., and Morrey, M., J. Chem. Soc. Perkin 
Trans. 1, 
1983,2435-2449. 
85. Crout, D. H. G., and Rathbone, D. L., J. Chem. Soc. 
Chem. Commun., 
1987, in press. 
86. Fulling, G., and Sih, C. J., J. Am. Chem. Soc., 1987,109, 
2845-2846. 
87. Otha, H., Ikemoto, Y., Chem. Lett., 1986,1169-1172. 
88. Rose, I. A., O'Connell, E. L., and Mortlock, R. P., Biochim. 
Biophys. Acta., 1969,178,376-379. 
89. Hanson, K. R., and Rose, I. A., Accounts of Chemical Research, 
1975,8,1-10. 
180 
90. Schloss, J. V., and Van Dyk, D. E., Methods in Enzymology, 1987, 
in press. 
91. Abell, L. M., O'Leary, M. H., and Schloss, J. V., Biochemistry, 
1985,29,3357. 
92. Ciskanik, L. M., and Schloss, J. V., Biochemistry, 1985,29,3357. 
93. Armstrong, F. B., Hedgecock, C. J. R., Reary, J. B., Whitehouse, D., 
and Crout, D. H. G., J. Chem. Soc. Chem. Commun., 1974,351-352. 
94. Stormer, F. C., J. Biol. Chem., 1968,243,3735-3739. 
95. Cram, D. J., and Kopecky, K. R., J. Am. Chem. Soc., 1959,81, 
2748-2755. 
96. Porai-Koshits, M. A., Antsyshkina, A. S., Pasynskii, A. A., 
Sadikov, G. G., Skripkin, Y. V., and Ostrikova, V. N., Inorg. Chim. 
Acta., 1979,34, L285-L287- 
97. Nakata, T., Tanaka, T., and Oishi, T., Tetrahedron Lett., 1983, 
2653-2656. 
98. Patel, D. V., Van Middlesworth, F., Donaubauer, J., Gannett, P., 
and Sih, C. J., J. Am. Chem. Soc., 1986,108,4603-4614. 
99. Katzenellenbogen, J. A., and Bowlus, S. B., J. Org. Chem., 1973, 
38,627-632. 
100. Katzenellenbogen, J. A., and Bowlus, S. B., J. Org. Chem., 1974, 
39,3309-3314. 
101. Cherest, M., and Felkin, H., Tetrahedron Lett., 1968,2199-2204. 
102. Morgan, L. R., Schunior, R. J., and Boyer, J. H., J. Org. Chem., 
1963,28,260-261. 
103. Iwakura, Y., Toda, F, and Torii, y., J. Org. Chem., 1966,31, 
2875-2878. 
104. Mori, M., Bull. Chem. Soc. Jpn., 1961,34,453-454. 
181 
105. Gakhokidze A. M., J. Gen. Chem. (USSR), 1947,17,1327-1331. 
106. Aberhart, D. J., J. Org. Chem., 45,5218-5220. 
107. Jones, W. A., Jacobson, J., and Martin, D. F., Science, 1966,152, 
1516-1517. 
108. Banda, F. M., and Brettle, R., J. Chem. Soc. Perkin Trans. 1, 
1977,1773-1776. 
109. Edwards, J. A., Mills, J. S., Sundeen, J., and Fried, J. H., 
J. Am. Chem. Soc., 1969,91,1248-1249. 
110. Texier-Boullet, F., Villemin, D., Ricard, M., Moison, H., and 
Foucaud, A., Tetrahedron, 1985,41,1259-1266. 
111. Miller, R. E., and Nord, F. F., J. Org. Chem., 1950,15,89-95. 
112. Gajewski, J. J., and Burka, L. T., J. Am. Chem. Soc., 1972,94 
2554-2556. 
182 
